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Tumour vasculature is known to be inefficient and abnormal due to poorly regu-
lated angiogenesis during tumour growth. This leads to irregular patterns of blood
flow which are spatially and temporally heterogeneous. Many investigations into
the characteristics of tumours are invasive and performed on animal models. How-
ever, continuous technological and theoretical advancement is leading to the use
of non-invasive imaging techniques, providing in vivo information on humans.
Here, data recorded using laser Doppler flowmetry (LDF) in malignant melanoma
and control lesions are analysed using techniques designed for application to non-
stationary, time-varying data. Many studies utilising LDF have previously revealed
increased blood flow in malignant lesions, but very little attention has been paid
to the dynamics of this blood flow, or how it changes over time. As it has been
demonstrated previously that the oscillations observed within blood flow data are
physiologically significant, failure to extract these characteristics loses informa-
tion about the underlying dynamical system from which the blood flow data were
recorded. Significant differences in blood flow dynamics are revealed and used in
the development of a diagnostic test for melanoma.
In addition to the characterization of the blood flow dynamics in melanoma,
possible causes for the observed changes are investigated and related to two widely
observed characteristics of cancer, intermittent hypoxia and altered cellular energy
metabolism. The former is explored through the analysis of blood flow and oxy-
genation data recorded during dry static apnoea, whilst the latter is modelled
using coupled phase oscillators.
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cells via endothelial cells.
Action potential A rapid rise and fall in the membrane potential of an excitable
cell, occurring when the membrane potential reaches a threshold value.
ADP Adenosine diphosphate. Precursor to ATP synthesis. ADP and phosphate
are required to synthesize ATP.
Aerobic respiration Energy producing reactions which require oxygen to gen-
erate ATP.
Anaerobic respiration Less efficient mechanism of energy production which
does not use oxygen.
Apnoea Suspension of breathing.
Apoptosis A very organised and controlled mechanism of cell death, abnormally
avoided by cancer cells.
Atherosclerosis An arterial disease characterized by the presence of fatty de-
posits on the vessel walls.
ATP Adenosine triphosphate, energy currency of the cell. ATP is used as an
energy source for protein synthesis, signalling and cell division, among many
other processes.
Autonomic nervous system The control system that regulates unconscious ac-
tions such as heart rate, breathing and digestion.
BF Blood flow.
Breslow depth A prognostic factor in melanoma of the skin related to how deep
the tumour has invaded the tissue.
Carcinogenesis The transformation of normal cells to cancer cells.
Clark level A descriptor for the level of invasion of melanoma in the skin, split
into 5 levels, where level 1 is the least invasive, and 5 is the most severe.
Cytosol The liquid inside cells in which the cellular organelles reside. Surrounded
by the plasma membrane.
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Dermoscopy A method for the noninvasive inspection of skin lesions using a
magnifier, a light source and a liquid medium.
DFA Detrended fluctuation analysis. A method to determine the statistical self
similarity of a signal at different timescales.
ECG Electrocardiogram. Method of recording the electrical activity of the heart.
EEG Electroencephalogram. Method of recording brain activity via electrical
signals.
FFT Fast Fourier transform. A fast algorithm for the computation of the Fourier
transform, which transforms a signal from the time domain to the frequency
domain.
FRET Fluorescence resonance energy transfer.
Haemoglobin An oxygen carrying protein found in the red blood cells.
HRV Heart rate variability. A measure of how the heart rate fluctuates over time.
Hypoxaemia An abnormally low level of oxygen in arterial blood i.e. haemoglobin
oxygen saturation below 90%.
Hypoxia A localized deprivation of oxygen in the body.
in vitro Studies of biological organisms or cells outside their usual context, e.g.
in test tubes or petri dishes.
in vivo Studies on intact biological organisms.
Lactate The end product of self-functioning glycolysis, i.e. when glycolysis is the
only energy source within the cell.
LDF Laser Doppler flowmetry. Method of blood flow measurement based on the
Doppler shift of incident light by moving red blood cells.
LSCI Laser speckle contrast imaging. Method of monitoring blood flow by ex-
ploiting speckle contrast patterns.
Membrane potential The difference in electric potential between the inside and
outside of a cell.
NADH Reduced form of nicotinamide adenine dinucleotide (NAD). Donates elec-
trons during redox reactions in cellular energy metabolism.
NIRS Near infrared spectroscopy. A method used to measure the changes in
concentration of oxy- and deoxy-haemoglobin in the blood.
NMD Nonlinear mode decomposition. A method for the extraction of oscillatory
modes from time series using time-frequency representations and surrogate
methods.
xv
NO Nitric oxide. Powerful vasodilator, i.e. relaxes smooth muscle cells surround-
ing blood vessels.
OXPHOS Oxidative phosphorylation. A highly efficient pathway for the forma-
tion of ATP which requires oxygen.
PFA Phase fluctuation analysis. Method of identifying chronotaxicity from a
single time series.
PFK Phosphofructokinase. Performs the committed step in glycolysis, the con-
version of fructose-6-phosphate to fructose-1,6-biphosphate.
Plasma membrane A selectively permeable phospholipid bilayer surrounding
the cell, separating it from its surroundings.
PORH Post occlusive reactive hyperemia. A method of inducing increased blood
flow following occlusion of a limb.
Proliferation An increase in cell number as a result of cell growth and division.
PU Perfusion unit. Arbitrary unit used in laser Doppler flowmetry.
Pyruvate An end product of glycolysis which can be converted to lactate or
acetyl-CoA to be used in the Krebs cycle.
rHb Relative haemoglobin. Value which varies with fluctuations of haemoglobin,
not an absolute value.
RSA Respiratory sinus arrhythmia. The natural variation of the heart rate during
each respiration cycle.
STO2 Venous oxygen saturation.
SNP Sodium nitroprusside. A vasodilator which not does require the presence of
endothelial cells to function.
Systemic In the context of the human body, a systemic process is one which
affects the whole body, for example the beating of the heart. The effects of
these processes may be observed at large distances from where they originate.
VEGF Vascular endothelial growth factor.
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1. Introduction
The human body is an incredibly complex biological machine, which, unlike many
man-made machines, functions continuously for the duration of its lifetime. The
number of simultaneously occurring chemical, physical and biological processes
within the body at any one time is almost impossible to comprehend, and yet
these continue without any conscious input. This facilitates not only basic essen-
tial functions, such as breathing, eating and sleeping, but also intelligence, memory
and countless others. These processes occur on all spatial scales within the body,
from the creation of new individual molecules in protein synthesis to the collective
behaviour of whole organs, such as the beating of the heart. Taking the heart
as an example, it is clear that the heart beat is an oscillatory process, without
which oxygen and other essential nutrients could not be delivered to tissues, or
waste products collected. Despite the importance of this oscillation, the existence
of such time-varying behaviour is not always appreciated at smaller scales. In fact,
whilst they may not initially appear as obvious as the heart beat or breathing, os-
cillations have been observed throughout the body, in cellular energy metabolism
[1], blood vessels [2], neurons [3], intracellular calcium [4], plasma membrane po-
tential [5], adenosine triphosphate (ATP) concentrations [6] and mitosis [7], to
name a few. It is therefore very important to understand the nature of these os-
cillations, and crucially, how they are affected by their environment. Due to the
complexity of the body, many studies focus on isolated subsystems, removed from
the body, to extract information about biological functions. However, whilst this
has resulted in huge leaps forward in terms of our knowledge of the underlying
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mechanisms of many processes, it cannot be known how much information is lost,
or even how the behaviour is changed, by removing these subsystems from their
natural environment. Considering that they are no longer functioning as part of a
whole, the natural behaviour of these subsystems, and their interactions, cannot
be observed. An example of this can again be seen in the heart. Outside the body,
the pacemaker cells of the heart will contract around 100 times per minute, much
higher than the average resting heart rate. However, once the heart is within the
body it is influenced by the autonomic nervous system, which lowers this rate to
around 60 beats per minute. Thus, it is clear that only observing the activity of
individual heart cells does not provide a realistic picture of the behaviour of the
heart in its natural environment within the body.
The continuous development of noninvasive imaging techniques is enabling the
collection of increasing amounts of data in vivo, providing functional information
about the human body in its natural state. Using the method of laser Doppler
flowmetry, at least six distinct oscillations have been observed in microvascular
blood flow, and have been attributed to various physiological functions, from the
systemic cardiac and respiratory functions down to local regulation of blood flow at
lower frequencies [2]. Knowledge of these oscillations and their physiological origins
allows pathological states to be investigated in terms of abnormalities in blood flow
dynamics, and this approach has been used in many studies of various pathologies,
including type 2 diabetes [8], obesity [9] and hypertension [10]. The noninvasive
nature of these studies means that spontaneous oscillations in blood flow can
be observed in health and disease, and attributed to alterations in physiological
processes depending on the observed dynamics.
One disease in which blood flow is expected to be altered is cancer, due to the
recruitment of new blood vessels by tumours in a process known as angiogenesis.
Usually, cancers are difficult to observe within their natural environment, due to
their location within the body, or the requirement for their swift removal. However,
as previously demonstrated [11, 12], skin cancer provides an opportunity to observe
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and characterise noninvasively the blood flow dynamics in malignant lesions using
laser Doppler flowmetry (LDF).
1.1 Outline of thesis
The main goal of this thesis is to utilise oscillations in microvascular blood flow to
investigate skin malignant melanoma, in order to test the hypothesis that blood
flow dynamics are altered in malignant melanoma when compared with atypical
lesions and normal skin. The data and analysis methods are also used to assess
whether local or systemic regulatory processes are altered in this state, and to
extract as much information as possible about the regulation of tumour vasculature
from these observations for use in the development of a diagnostic test. These
oscillations are also investigated in terms of their relationship to tissue hypoxia
and cellular energy metabolism.
Chapter 2 provides an introduction to the physiology of the cardiovascular
system and oscillations in microvascular flow in the context of skin malignant
melanoma. Chapter 3 describes the relevant measurement techniques used to
acquire the data presented in this thesis.
Chapter 4 introduces dynamical systems and highlights the importance of the
consideration of living systems as nonautonomous. This chapter also presents the
inverse approach techniques used to extract the results presented in this thesis,
and provides a brief review of the inverse approach as applied to the newly-defined
class of chronotaxic systems.
Chapter 5 investigates the blood flow dynamics in skin malignant melanoma,
as compared to controls. The results provide insights into the pathophysiology
of tumour vasculature and are also used in the development of a diagnostic test.
Analysis of data previously recorded during apnoea in free divers is presented in
chapter 6, which provides an opportunity to measure physiological parameters
during oxygen deprivation. The aim of this chapter is to investigate blood flow
and oxygenation dynamics during hypoxia, which has been implicated in cancer.
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Finally, chapter 7 seeks to investigate the altered cellular energy metabolism




Of all observable processes occurring within the body, very few may be consid-
ered as stationary. The vast majority vary with time, continuously reacting with
each other and their environment. These variations form the very basis of life.
Whilst studying the dynamics of whole systems, for example the cardiovascular
and respiratory systems, we must also consider the single cell and its organelles,
and everything in between. Only when all scales, and thus all oscillators, are
considered, may we truly begin to understand life.
Practical difficulties often make the observation of biological oscillations in vivo
impossible, therefore many studies have focussed on the separation of different
parts of biological dynamical systems which are readily accessible. Problems arise
here with the assumption that biological systems can be characterized by the sum
of their parts, i.e. that they are linear. In fact, the opposite is almost always true.
Living systems on all scales are subject to continuous perturbations, which may
be deterministic or stochastic and may arise from adjacent dynamical systems or
random fluctuations. Isolation of a single component of this large scale system
results in the loss of very important information about its behaviour within the
whole, which is likely to be fundamentally different, limiting the viability and
applicability of any resultant conclusions. To retain all available information, we
must consider living systems in their natural state as far as is possible. It is also
very important to observe their spontaneous dynamics, rather than introducing
unnatural perturbations to the system.
However, before beginning to study the interactions between physiological pro-
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cesses, it is important to understand their basic physiology and the techniques
which are used to observe them.
2.1 The circulatory system
The circulatory system comprises the cardiovascular system and the lymphatic
system, but here the focus will be on the cardiovascular system.
The origins of our current understanding of the cardiovascular system began in
1628, when William Harvey showed that arteries and veins are functionally con-
nected, and that blood circulates [13]. This was in stark contrast to the previous
model presented by the Ancient Greeks, in particular Galen, who viewed the ar-
teries and veins as two distinct networks, and concluded that the blood was food
that had been transformed in the liver for the nourishment of the body [14].
There are around 100,000 miles of blood vessels in the human body [15]. With-
out this transport and feedback system, it would be impossible for the body to
function. Problems arise within the vasculature in many disorders. Thus, it is
of vital importance to understand the mechanisms and processes involved in the
regulation and growth of the vasculature.
2.1.1 The cardiovascular system
We now know that the cardiovascular system is a connected system which includes
the heart, blood, blood vessels and the lungs, and its primary function is to deliver
nutrients continually and efficiently, via blood circulation, to the whole body and
to remove metabolic waste from the body effectively.
2.1.2 The heart
The heart pumps blood around the body, beating around 2.5 billion times in an
average lifetime [16]. The five litres of blood found in the average human body
is continuously circulated, with a whole cycle taking around one minute. The
6
heart is made up of three layers: the pericardium, a thin outer protective sack,
the myocardium, the specialized cells that make up the thick muscular wall of the
heart, and endocardium, which is the thin inner lining of the heart. The heart
has four chambers: two atria and two ventricles. The atria, at the top of the
heart, are smaller than the ventricles, which are located in the lower heart. The
stronger left ventricle pumps oxygenated blood to the whole body. Deoxygenated
blood returns to the heart into the right atrium, and is then pumped into the right
ventricle, through the tricuspid valve. From the right ventricle, blood is pumped
through the pulmonary valve, through the pulmonary artery to the lungs. The
oxygenated blood returns from the lungs through the pulmonary vein, into the left
atrium. From here, the blood is pumped through the mitral valve into the left
ventricle, where it is once again ready to be pumped to the tissues of the body, via
the aortic valve and the aorta. The heart contains valves to prevent the backflow
of blood. The heart also contains a muscular wall which divides the left and right
sides, called the septum. This prevents mixing of oxygenated and deoxygenated
blood. The heart itself, as a particularly demanding muscle, also requires its own
oxygen supply, obtained from coronary arteries, which branch from the aorta.
The heart generates regular electrical pulses in order to coordinate pumping
by instructing the cells to contract. The concept of the heart as an electrical
conducting system was first appreciated by Sunao Tawara in his 1906 monograph
[17, 18]. Soon after, Keith and Flack discovered the sinoatrial (SA) node [19],
providing an answer to the fundamental question: why does the heart beat? The
SA node, the primary pacemaker of the heart, is located in the right atrium, and
generates a normal sinus rhythm by generating impulses which then spread through
the cells of the heart. This gives rise to the most familiar biological oscillation,
the heart beat.
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2.2 Vascular structure and function
Blood flow, the movement of the blood through the cardiovascular system, is an
essential process for survival. If blood flow stops, the brain can only survive
without damage for up to three minutes at physiological temperatures, due to the
lack of oxygen delivery resulting in the irreversible death of neurons [20]. Other
tissues will also die following prolonged periods of inadequate perfusion, known as
ischemia [21].
The blood is the medium by which nutrients are delivered to all cells within the
body, and their waste collected for removal. Blood contains many different cells,
the most abundant being red blood cells, or erythrocytes, the carriers of oxygen.
White blood cells, or leukocytes, are also important for the immune system.
Blood flow is incredibly complex. Macrovascular flow dynamics, arising from
large and small arteries, depends on many factors, including the velocity of the
blood, the geometric properties of the vessel and the influence of the blood on the
vessel wall. Whilst complicated, these have been used to develop models in which
the main observed characteristics of arterial flow can be accurately recovered [22].
These models are based on the assumption that the vessel walls are impermeable.
Thus, it immediately becomes clear why different approaches must be used in the
case of the microcirculation, containing capillaries which are necessarily permeable,
allowing the passive diffusion of dissolved gases, ions and solutes across the vessel
wall [23]. This permeability arises from the arrangement of endothelial cells, and
varies with location and function [23]. Consideration of the intrinsic behaviour and
function of the blood vessels, and the role played by the endothelium is therefore
critical for the understanding of the regulation of blood flow. To assess the rela-
tionship between macro- and microvascular blood flow dynamics Urban£i£-Rovan
et al. performed measurements of blood pressure and basal skin blood flow in dia-
betic patients and controls [24]. They found that except from a significant positive
correlation between systolic pressure and the endothelial frequency interval in dia-
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betic patients on the right side of the body, macro- and microvascular changes do
not progress simultaneously. This highlights the requirement for models of macro-
and microvascular blood flow to be specific to each system.
Arteries carry oxygenated blood from the heart to the rest of the body. Two
exceptions to this are the pulmonary artery and umbilical arteries which carry
deoxygenated blood. Arteries are under the most pressure in the vascular system,
as the blood they are transporting is required at large distances from the heart.
They withstand the pressure generated by the heart with their strong muscular
walls. The largest artery is the aorta, directly connected to the left ventricle of the
heart. This then branches into smaller arteries, arterioles, and finally capillaries.
Arterial walls are made up of many layers. The outer layer, the tunica adven-
titia (or externa), is a strong outer covering composed of connective tissue as well
as collagen and elastic fibres. These fibres allow the arteries to stretch to prevent
overexpansion due to the pressure of the blood flow. The middle layer, the tunica
media, is composed of smooth muscle and elastic fibres. The inner layer, the tunica
intima, is composed of an elastic membrane lining and smooth endothelium that
is covered by elastic tissues.
Veins transport deoxygenated blood back to the heart and are under less pres-
sure than arteries. Consequently, the muscular middle layer of a vein is thinner
than in an artery. Because of the lower pressure, and the required movement of
blood against gravity, veins contain valves to prevent the back flow of blood. The
largest veins are the vena cava, the superior vena cava and inferior vena cava,
which transport blood directly to the right atrium of the heart. Smaller veins are
called venules, and are also connected to the capillaries.
2.2.1 The microvasculature
The groundbreaking work of Harvey, whilst proving that arteries and veins were
connected, did not demonstrate how they were connected. In fact, the capillaries
which serve this purpose were observed by Leonardo da Vinci, but he did not link
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Figure 2.1: Capillary structure. Modified from [28].
them to their role in linking arterioles and venules [25]. The mystery was solved in
1661 by Marcello Malpighi, when he observed blood coursing through a network
of small tubes on the lung surface and in the distended urinary bladder of the
frog, and speculated that these capillaries were the connection between arteries
and veins [26, 25]. Independently, Van Leeuwenhoek also observed red blood cells
and their movement through the capillaries in 1688 [27]. These findings constitute
the earliest observations of blood flow in the microvessels.
Capillaries are the smallest vessels in the body, usually measuring around 5-10
µm. They connect arterioles and venules to complete the blood transport network.
The flow of blood from an arteriole, through a capillary bed and into a venule
is known as microcirculation. The capillary bed is a collection of capillaries which
form an interweaving network, and contains two types of vessels; vascular shunts
and true capillaries. True capillaries are where exchange of substances occurs.
Depending on vasomotor nerves and chemical conditions, the blood can bypass
the capillary bed through the vascular shunt, also called a metarteriole, to divert
blood to another area of the body. At their smallest, capillaries are made up of
only a layer of endothelial cells, to allow fast diffusion of water, oxygen and carbon
dioxide through their walls, amongst other substances.
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2.2.2 The endothelium
Initially considered only as tunnels, in the 1800s Reckinghausen observed that
blood vessels are actually canals lined with cells [29]. These cells were identified
and termed endothelial cells by Wilhelm His in 1865, who differentiated the inner
lining of body cavities from epithelium [30, 31], yet the detailed study of the
endothelium only began in the 1950s with Howard Florey describing their structure
but not realising the magnitude of their importance [32].
The realization by Jaffe, Nachman and members of their laboratory that en-
dothelial cells were the key to understanding how the vascular wall worked in
health and disease led to them culturing human umbilical endothelial cells for the
first time in 1973 [33] leading to an explosion in the field of vascular biology [34].
Vascular endothelial cells form a continuous monolayer in all blood vessels.
Once viewed as an inert barrier between blood and tissues, it is now known that
this vital organ has many essential functions, including maintaining the fluidity of
the blood [35], regulation of the flow of nutrients and biologically active molecules
[36], and signalling [37]. The endothelium varies between sites, with almost every
organ having its own adaptation of endothelial structure depending on functional
requirements [38]. The endothelium also plays an essential role in angiogenesis,
the development of new blood vessels from existing vasculature, by dividing and
migrating in response to growth factors such as vascular endothelial growth factor
(VEGF) [39] (see below).
However, the first crucial role of the vascular endothelium to be discovered was
its effect on vascular tone, and thus blood flow regulation, through the release
of vasoactive substances [36]. This began in 1976, when Moncada and colleagues
discovered that blood vessels secrete a vasodilatory substance, prostacyclin [40].
In 1980, Furchgott and Zawadzki [41] discovered that the vasodilator acetylcholine
(ACh), a very potent vasodilator in vivo, did not always induce the same response
in vitro. They discovered that the reason was that endothelial cells had been acci-
dentally removed during preparation, and deduced that their presence is essential
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for vasodilation to occur using ACh. They also demonstrated that ACh stimulates
the release of a substance termed endothelium-derived relaxing factor (EDRF).
EDRF was later identified as nitric oxide (NO) by Ignarro et al. [42] and indepen-
dently by Palmer et al. [43], both in 1987. A third vasodilator was discovered when
vasodilation was still observed after blocking NO and prostacyclin production, and
named endothelium-derived hyperpolarizing factor (EDHF) [44], and shown to be
distinct from EDRF by Chen et al. [45]. In 1989, another endothelial secretion
was discovered, this time a vasoconstrictor named endothelin [46].
Substances secreted by endothelial cells induce responses within the vascular
wall, resulting in vessel constriction or dilation to modulate the blood flow as
required. For example, NO acts to relax the smooth muscle cells by activating
guanylyl cyclase, which then raises the cyclic guanosine monophosphate (cGMP)
concentration [47]. This increases the activity of cGMP-dependent protein kinase
(PKG) which in turn activates myosin light-chain phosphatase (MLCP)[47]. This
then induces relaxation by reducing the concentration of phosphorylated myosin
regulatory light-chain subunits in vascular smooth muscle [47]. Via sensing of the
shear stress induced by blood flow by the anionic polyelectrolyte heparan sulphate
proteoglycan (HS-PG), the endothelial cells act on the smooth muscle cells to in-
duce a flow-dependent vasodilation in response to increased blood flow, whilst a
decrease in blood flow will induce vasoconstriction [48]. This flow-dependent reg-
ulation by the endothelium was first demonstrated in dogs in vivo by Pohl and
colleagues in 1986 [49]. Endothelial dysfunction, mainly characterized through
impaired sensing by a reduction in the availability of vasodilators and an increase
in endothelium-derived contracting factors, has now been associated with many
pathologies, including atherosclerosis [50], other chronic inflammatory diseases
such as psoriasis, rheumatoid arthritis and inflammatory bowel diseases [51], hy-
pertension [52], diabetes [53], impaired renal function [54], erectile dysfunction
[55], Alzheimer's disease [56], preeclampsia [57] and obesity [58]. Thus, it is clear
that a focus on vascular regulation is very important in the understanding of the
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development of many diseases, especially at the level of the microvasculature.
2.2.3 Vasomotion and flowmotion
Vasomotion is the rhythmical change in tone exhibited within arteries, predomi-
nantly within the microcirculation [59], but also demonstrated in large muscular
arteries [60, 61]. The mechanisms and physiological importance for vasomotion
are still not fully understood, thus it remains an intense area of research.
Vasomotion was observed for the first time by Jones in 1852 in the circulation
of a bat wing [62], and has been widely observed in both humans and animals ever
since, both in vivo and in vitro. Both the in vivo and in vitro approaches provide
their own benefits. Studying vasomotion in vivo allows the behaviour of the vessel
walls to be studied in their natural environment, as affected by systemic and
local regulatory processes. In contrast, in vitro studies have provided information
about the intrinsic behaviour of the vessels themselves, and allows experimental
conditions to be finely tuned in order to pinpoint directly the cause of different
phenomena, whilst in vivo their origins may not be so clear due to difficulties
in measurement. In vivo, it is a challenge to observe vasomotion directly, but it
has been demonstrated to be possible using intravital microscopy [63], optical-
resolution photoacoustic microscopy [64], and optical coherence tomography [65].
In vitro, vasomotion with a frequency ranging from 0.01 to 0.3 Hz is seen in
isolated arteries from various species and in blood vessels from different areas of
the body [66, 67]. It has been observed that the frequencies of vasomotion observed
in vitro correspond well with those observed in the myogenic frequency interval
(around 0.1 Hz) in vivo [67, 68], providing evidence for the automated nature of
oscillations observed at myogenic frequencies, and the local in vivo regulation that
the neurogenic and endothelial contributions provide (see below).
The first studies of vasomotion in different conditions in vivo used intravital
microscopy, and demonstrated that vasomotion frequency and amplitude are af-
fected by pH, temperature and partial pressure of oxygen changes [69], and arterial
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pressure [70]. Another way to observe vasomotion indirectly in vivo is by measur-
ing the effects of these variations in the vascular wall on the blood flowing through
them, which will be oscillatory as a result. This is known as flowmotion [71], and
has since been widely utilised via the application of laser Doppler flowmetry to
study vasomotion noninvasively.
For vasomotion to occur, i.e. for macroscopic oscillations in a blood vessel to be
observed, the oscillations in individual smooth muscle cells must be synchronised
[72]. The origins of these individual cellular oscillations are debated, and could
arise from membrane potential oscillations, cytosolic oscillations (i.e. calcium os-
cillations) or metabolic oscillations [72]. On a completely automated level, in
response to increased blood pressure, a dilation of vessels will act so as to decrease
the pressure [73].
Vasomotion occurs at a wide range of frequencies, which have been shown to
vary depending on vessel size by Colantuoni et al. [74], with the frequency of va-
somotion higher in small arteries than larger vessels in hamsters. This conclusion
was based on the frequency with the largest amplitude in the Fourier transform
of the vessel diameter time series, and thus does not take into account variations
in this frequency, which were clearly present. This study also demonstrated that
vasomotion was strongly suppressed during anaesthesia [74]. This effect was later
confirmed in humans in vivo by Landsverk et al. who found significant reductions
in oscillatory activity associated with myogenic, sympathetic and endothelial re-
lated vasomotion [75] during general anaesthesia, as measured by laser Doppler
flowmetry (see below).
Most available in vivo data on the prevalence of vasomotion has been obtained
using LDF [67], but care must be taken in the interpretation of these results, due
to the single point nature of LDF and the fact that it is not possible to visu-
alise the underlying blood vessels. As a result, it is difficult to know whether the
measurement area contains only capillaries, or a mixture of vessel types. Another
issue is the systemic influences on LDF, and care must be taken to avoid record-
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ing locations at which the cardiac component is very strong and will overpower
more subtle, locally generated oscillations. New techniques which allow imaging
of blood flow, such as laser Doppler perfusion imaging (LDPI) and laser speckle
contrast imaging (LSCI) may provide solutions to these issues, but LDF has been
shown to be sufficient to study vasomotion non-invasively [76] as long as care is
taken to minimise variability through optimal probe placement and sufficiently
long recording times.
A large proportion of the current knowledge on vasomotion is derived from
animal studies. Vasomotion in humans has been found to depend heavily on
experimental conditions and pathology. Alterations in vasomotion have been ob-
served in many pathological states. Reduced vasomotion has been observed in
type 2 diabetes [8], obesity [9] and hypertension [10]. In the case of type 2 di-
abetes, it was shown that microcirculation could be improved by synchronizing
smooth muscle cell activity and thus increasing vasomotion [8]. Vasomotion in-
duced by electrical stimulation of the cervical sympathetic nerve was also shown
to be abolished at high and low temperatures [77]. The same study provided
evidence that vasomotion enhances tissue perfusion, highlighting its vital role in
oxygen delivery to tissues. The effects of temperature on spontaneous vasomotion
in humans in vivo was investigated by Sheppard et al. using local skin cooling and
heating in combination with LDF [78]. They found that local cooling increased
the myogenic response, yet lowered the frequency of vasomotion in this interval,
whilst heating the skin decreased myogenic activity whilst significantly increasing
blood flow, which demonstrates the maximum, sustained vasodilation of the lo-
cal vessels during heating. The effects of different dynamics of the temperature
change were also investigated by Vuksanovi¢ et al. who found that a steady level
of skin blood flow must be significantly perturbed by a thermal shock to cause
vasodilation/constriction [79]. They also found that the temperature flow curves
obtained during heating and cooling demonstrated hysteresis, indicating bistable
or multistable blood flow levels for a given temperature stimulus [79].
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Many efforts have been made to identify the exact mechanisms involved in
vasomotion, but it is also important to understand why vasomotion occurs, if it
provides any physiological advantages, and if so, what are they? It is strongly
believed that vasomotion provides important benefits, particularly for oxygen, ion
and nutrient delivery via the blood, and thus it remains an intense area of research.
2.2.4 The relationship between vasomotion and tissue
oxygenation
Although not universally demonstrated, there is strong evidence to suggest that
there are benefits of vasomotion for tissue oxygenation.
In 1991, Bertuglia et al. induced hypoxia and hyperoxia in hamsters and ob-
served the effects on vasomotion, by using an edge detection algorithm to track
changes in the diameter of microvessels observed within a skinfold window prepa-
ration and applying the Fourier transform and autoregressive modelling to the
resultant time series to find the dominant vasomotion frequency [80]. They found
that hypoxia (8,11, and 15% O2 gas mixture inspiration) increased the frequency
of vasomotion and decreased mean diameters of vessels, whilst hyperoxia (100%
O2) reduced the frequency of vasomotion and also decreased mean diameters in
the smallest vessels. Rücker et al. studied the response of the microvasculature in
tissues to reduced perfusion, and found that these conditions induced vasomotion
in muscle capillaries but not in the periosteum, subcutis or the skin [81]. They con-
cluded that this demonstrated a beneficial effect of vasomotion on the oxygenation
of local tissues.
Theoretical modelling has shown that in well oxygenated tissue, vasomotion
appears to have little effect on tissue oxygenation [82]. However, in tissue with
hypoxic regions, blood flow oscillations with high amplitude and low frequency
(0.0250.05 Hz) significantly reduced tissue hypoxia [82], but importantly only
when myoglobin was not present, though myoglobin is usually not present under
physiological conditions. This verifies what was previously modelled by Tsai & In-
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taglietta, that low frequency oscillations are beneficial for local tissue oxygenation
[83]. This supports vasomotion as an induced response to tissue hypoxia. Using
combined LDF and optical reflectance spectroscopy (ORS), Thorn et al. revealed
an association between vasomotion at low frequencies associated with endothelium
and oxygen extraction; this does not, however, imply causality [84].
The extensive study of blood flow dynamics has led to universally accepted
frequency bands of oscillatory activity in blood flow, as discussed in detail below.
However, the dynamics of resting blood oxygenation are not so well characterised,
but oscillations in oxygenation at rest have recently been demonstrated in skeletal
muscle [85]. Skin blood oxygenation can be studied using optical techniques based
on the absorption spectra of oxy- and deoxygenated haemoglobin, in methods such
as near infrared spectroscopy (NIRS) and optical reflectance spectroscopy (ORS).
Skin blood oxygenation reflects the activity of the underlying tissue, which is likely
to result in relatively slow changes due to finite diffusion times. ORS has been
used to non-invasively study skin oxygenation at rest, and provides a measure
of mean blood oxygen saturation, STO2, at a recording depth dependent on the
spacing of the probe fibres. By recording LDF and ORS simultaneously, Bern-
jak et al. demonstrated significant phase coherence at frequencies below around
0.1 Hz between oscillations in blood flow and blood oxygen saturation in the skin
microcirculation recorded at the same skin site [86], which may indicate causal
connections between them. It was found that the value of oxygen saturation alone
cannot be accepted as a definitive marker of tissue oxygenation, as two differ-
ent types of oxygenation `swings' were observed, which were indistinguishable in
terms of STO2, but different in terms of oxygenated haemoglobin (HbO2) and de-
oxygenated haemoglobin (Hb) behaviours [87]. HbO2 and Hb can be calculated
from STO2 and relative haemoglobin (rHb) using the relation STO2 = HbO2 ×
100/(HbO2 + Hb) [84], where rHb = HbO2 + Hb. Recently, a study in which
blood flow and blood oxygenation were measured simultaneously showed that the
relationship between microvascular blood flow and STO2 at rest and during var-
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ious physiological perturbations, including breath-holds, can be described by a
one-phase association curve fit with a plateau in STO2 of 84% for blood flow (BF)
> 50 perfusion units (PU) [88]. This study also showed strong evidence for mul-
tiple, synchronized, time-varying oscillations in both microvascular BF and tissue
oxygenation in healthy skin [88], but that although they appear to be modulated
by similar processes, this is not simultaneous.
In summary, vasomotion is a highly variable phenomenon, affected by many
different parameters, including blood flow, blood pressure, tissue oxygenation, en-
dothelial secretions, local and systemic innervation, temperature and health. It has
been widely observed in many settings, and physiological advantages are emerg-
ing. It is therefore of great importance to be able to observe and characterise
vasomotion in vivo in humans.
2.3 Evaluation of microvascular function
2.3.1 Skin microvascular blood flow
The most widely used technique for the assessment of skin microvascular blood flow
is laser Doppler flowmetry (LDF), also known as laser Doppler fluxmetry. Based on
the Doppler effect, LDF uses laser light to measure the velocity of red blood cells,
identified by how much the frequency of the incident light is shifted. LDF was used
to measure blood flow in vivo in the undisturbed microcirculation for the first time
in human skin by Stern et al. [89, 90], following its use in the rabbit retinal artery
[91]. The resulting signal, the blood flow, flux or perfusion, represents not only
the velocity of the red blood cells, but also their concentration. This technology
was further expanded in the technique of laser Doppler perfusion imaging (LDPI)
[92], based on the same principles but scanning a larger area of interest rather
than a single point as in LDF, which can measure only a volume of 1 mm3 or less,
depending on the incident wavelength [93]. LDPI decreases spatial variability,
but the scanning involved means that it cannot match the temporal resolution
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of LDF. Used interchangeably, depending on requirements, these advances paved
the way for a whole new field of noninvasive investigation of blood flow in the
microcirculation in health and disease, which has been shown to vary widely in
different pathologies.
The ability to directly measure the blood flow in the microcirculation using
LDF has been exploited in many investigations which seek to assess microvascular
function [94]. The most basic tests involve the calculation of mean blood perfusion,
and comparison between different states of health and disease. However, it has
been shown that basal flux values are highly variable and depend on many factors,
including recording site and skin temperature [93]. Even when taking these factors
into account, microvascular blood flow is constantly fluctuating in a non-constant
way, as will be discussed below, and thus average flow values do not provide an
accurate representation of the underlying dynamics.
In an attempt to improve the reliability of results, many studies have used LDF
to evaluate the reactivity of the skin microcirculation by quantifying its response
to well characterised provocations, for example during postocclusive reactive hy-
peremia (PORH). PORH involves a period of arterial occlusion by a cuff. This cuff
is then released following a specified amount of time, and the resulting initial peak
followed by sustained hyperemia in skin blood flux measured with LDF. Various
parameters are measured, including maximum flux and time to resting flux, the
latter of which was shown to have the best discriminative power in distinguishing
between patients with peripheral arterial obstructive disease and healthy controls
[95]. PORH has also been used to demonstrate microvascular dysfunction in many
other pathologies, including diabetes [96], hypertension [97] and chronic renal fail-
ure [98]. The popularity of PORH arises from its apparent high reproducibility
when considering absolute values [99]. Four major factors have been proposed to
be involved in the PORH response: metabolic vasodilators, endothelial vasodila-
tors, the mygogenic response and sensory nerves [93], highlighting the complexity
of this response. Thus care should be taken when attributing this to a single
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mechanism, particularly endothelial function. The assessment of the behaviour
of the endothelium is often the end goal of these studies, as it is known to regu-
late vascular smooth muscle tone, for example by the release of nitric oxide (NO).
Regardless of the reason for the response observed in PORH, it is useful for the
assessment of the efficacy of pharmacological interventions, such as the treatment
of hypertension [10].
PORH is often performed along with iontophoresis and thermal hyperemia. All
three provocations provide a characteristic flux response, but they do so by differ-
ent physiological mechanisms. Iontophoresis involves drug delivery across the skin
by using a local electric current. Two drugs commonly used in the assessment of
the microcirculation with iontophoresis are acetylcholine (ACh) and sodium nitro-
prusside (SNP). ACh indirectly induces smooth muscle relaxation, and therefore
vasodilation, via the stimulation of the release of NO, vasoactive prostanoids and
endothelium derived hyperpolarizing factor from the vascular endothelium [100].
Importantly, ACh will only have a vasodilatory effect in the presence of endothelial
cells, as discussed previously [41]. In contrast, SNP is a nitrovasodilator, acting
directly on the smooth muscle cells [101], and therefore does not rely on the pres-
ence of endothelium to induce vasodilation. These different mechanisms allow the
evaluation of endothelial function by comparing ACh and SNP induced vasodila-
tion during iontophoresis [102], as measured by changes in blood flow using LDF.
However, it has been shown that the current used during iontophoresis may induce
increased blood flow even in the absence of drugs [103], for example when using
water [104] or NaCl solution [105] as electrolytes. This highlights the importance
of the careful planning of iontophoresis protocol for the purposes of endothelial
assessment, to minimise these effects. To investigate the effects of voltage on
skin blood flow, Bandrivskyy et al. studied the varying voltages required during
iontophoresis to maintain a constant current, and found no correlation between
voltage and changes in blood flow with any of the electrolytes used (deionised
H2O, NaCl solution, ACh and SNP) [103].
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Thermal hyperemia involves local heating of the skin and measurement of the
subsequent increase in cutaneous blood flow, with the maximum dilation of the
vessels reached at around 42oC in healthy humans [106]. Again, the reproducibil-
ity of thermal hyperemia depends on the parameter studied [107], but when used
correctly provides a simple method for the examination of microvascular and en-
dothelial function [108].
Whilst these provocation techniques for the evaluation of skin microvascular
function are well established and widely used, the exact mechanisms by which they
alter skin blood flow are still debated, and are known to vary between recording
locations. This leads to uncertainty in exactly which processes are being induced,
and to what extent each one is affecting the vasculature, especially in completely
noninvasive studies. Therefore, whilst they remain useful in studies of systemic
conditions and pharmacological testing, where a global difference is assessed, they
are not completely reliable in separating specific underlying mechanisms of mi-
crovascular regulation, including endothelial function. The perturbations also re-
move any information about the resting state dynamics of the underlying area,
and thus the effects of spontaneous vasomotion.
2.3.2 Blood flow dynamics for the evaluation of skin
microvascular function
Although LDF studies initially only considered average perfusion values or re-
sponses to various stimuli, it was soon discovered that LDF signals contained
much more information than originally thought. Longer recordings led to conclu-
sions that data recorded with LDF is highly variable and not reproducible. In
fact, the opposite is true, once these variations are treated in the correct way.
In healthy skin, sustained oscillations have consistently been observed in blood
flow signals arising from the microcirculation as recorded by LDF [109, 110, 2].
In light of this fact, studies were performed in which the Fourier transform was
used to extract information about the frequency of these oscillations, but this ap-
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Figure 2.2: Typical blood flow signal obtained with laser Doppler flowmetry,
with cardiac oscillations and respiratory modulation shown. PU = perfusion units
(arbitrary).
proach is not suitable for such time-varying data. The breakthrough came when
Stefanovska et al. applied the wavelet transform (see Chapter 4.2.3) to LDF sig-
nals [110], allowing the accurate simultaneous observation in time and frequency
of these biological oscillations and their continuously varying characteristics. This
approach is also ideal for the observation of low frequency oscillations, due to
the logarithmic scale of the wavelet transform. This led to many studies which
sought to further characterise the oscillations present in skin blood flow, and their
physiological origins.
Whilst it is obvious that the beating of the heart has a huge influence on the
blood flow, particularly in larger vessels, the dynamics of blood flow is also gov-
erned by many other physiological processes. A crucial influence, independent of
the systemic heart and respiratory influences, is the local phenomenon of vasomo-
tion. In addition to the intrinsic movement of the vessels, and the effects of the
vascular endothelium as detailed in section 2.2.2, the amplitude and frequency of
vasomotion is also influenced by neurogenic factors. A typical LDF blood flow
signal is shown in Figure 2.2.
Extensive spectral analysis of signals obtained using LDF has provided a deeper
understanding of the oscillations found in these signals, and their physiological
origins. To date, six distinct frequency intervals have been identified, containing
different oscillatory processes corresponding to various functions within the body
[68, 111, 112, 113]:
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Interval I  Cardiac interval (0.62 Hz). A dominant oscillation around 1 Hz
can be detected at all points on the body, and can reliably be attributed to cardiac
function by comparisons with a simultaneously recorded ECG. Depending on the
proximity of the LDF probe to large vessels in addition to the capillaries, the
effective contribution of the heart will vary. It is therefore recommended to avoid
LDF measurements in the proximity of these large vessels, to allow observation of
the dynamics at lower frequencies, which generally have lower power contributions.
Interval II  Respiration interval (0.1450.6 Hz). A slower oscillation around
0.3 Hz has also been observed, and was shown to originate from respiration by
Bollinger et al. in 1993 [114, 115]. The contribution of the respiration to LDF
signals is not as strong as in the cardiac oscillations, and is not always detectable.
Interval III  Myogenic interval (0.0520.145 Hz). This interval contains oscil-
lations resulting from intrinsic myogenic activity of vascular smooth muscle cells,
as previously discussed in the context of vasomotion. This means that oscillations
in this frequency are inherent to the vessel wall, and have been observed both in
vivo and in vitro [67]. Proof of this classification was shown when oscillations in the
region of 0.11 Hz were unchanged during local and ganglionic nerve blockade [116].
The myogenic response is the passive local regulation of blood flow by the smooth
muscle cells, in reaction to increased blood pressure [73]. One debated topic in
this area currently is the observation and characterization of waves around 0.1 Hz
which are deemed to be of a different origin to the myogenic response, sometimes
known as Mayer waves, and observed in arterial pressure signals. Although these
waves are usually enhanced during states of sympathetic activation, an underlying
mechanism has still not been identified [117]. The origin of oscillations at this
frequency is still uncertain, and is likely to consist of a combination of different
physiological processes depending on vessel type.
Interval IV  Neurogenic interval (0.0210.052 Hz). This is where neurogenic
(sympathetic) activity manifests. The involvement of the sympathetic nervous sys-
tem (SNS) in this interval was proven by Söderström et al. using LDF recordings
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on skin flaps in which it is known that there is no sympathetic activity, as com-
pared to LDF recordings on intact skin [73]. Differences were observed between
0.02-0.05 Hz, and thus these can be attributed to sympathetic nerve activity. This
activity provides another fundamental mechanism for the control of blood flow
by rhythmically discharging and influencing the relaxation and contraction of the
blood vessels [73], as described by Malpas [118]. Landsverk et al. provided further
evidence for the origin of the oscillations in this interval when evaluating the ef-
fects of brachial plexus block on the skin microcirculation [119], which is known to
induce sympathetic impairment [120]. Using LDF and the wavelet transform they
found that the relative amplitude of the oscillations within the 0.0095 to 0.021
and 0.021 to 0.052 Hz range was reduced, indicating an inhibitory effect on both
endothelial and sympathetic activity. The sympathetic origin of oscillations in this
interval was also demonstrated in rats by Bajrovic et al. when the relative energy
of blood flow significantly decreased in the neurogenic interval (4 times higher
frequency in rats) following partial denervation of the hind limb [121].
Intervals V & VI  Oscillations arising from endothelial activity. This has been
tested using various vasoactive substances, in the presence of endothelial cells, and
following their removal [122, 67]. Interval V, from 0.0095 to 0.021 Hz, was first
found to contain oscillations due to endothelial activity through the use of the
endothelial dependent vasodilator acetylcholine (ACh) and the endothelial inde-
pendent vasodilator sodium nitroprusside (SNP) [123]. This endothelial activity
was found to be partly mediated by nitric oxide (NO) [102]. In a later study,
even lower frequency oscillations in the frequency interval 0.005 to 0.0095 Hz were
observed [68], forming interval VI. In contrast to interval V, oscillations in this in-
terval were found not to be NO dependent, arising instead from other endothelial
mechanisms such as endothelium-derived hyperpolarizing factor (EDHF) [68]. To
ensure that these conclusions based on iontophoresis arose as a result of endothe-
lial activity and not as a result of current induced blood flow increases, Veber et
al. performed iontophoresis using the same protocol as used by Kvandal et al.
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[102] but replacing ACh and SNP with deionised water and NaCl solution [124].
They found that although in iontophoresis with deionised water (a low conduc-
tance electrolyte), cathodal current stimulates more than anodal current, this does
not affect a specific frequency interval more than the others. They also showed no
difference in blood flow when using iontophoresis with NaCl, a high conductance
solution, and concluded that the differences observed previously using ACh and
SNP, both highly conductive solutions, were indeed a result of endothelial activity
[124].
The complexity of blood flow signals arises from the coupling between all of
these physiological processes, and likely other additional effects. Locally, these
manifest through the modulation of vasomotion by the contributions discussed
above. The introduction of this coupled oscillator model of the cardiovascular sys-
tem by Stefanovska & Bra£i£ in 1999 [125, 2] meant that skin blood flow recordings
could be used to extract information about underlying processes in states with al-
tered microvascular regulation by calculating the contributions of the oscillations
in each frequency interval, usually using time-frequency analysis methods such as
the wavelet transform, and comparing between states and subjects. This approach
has been shown to be reliable and reproducible [76]. The characterisation of blood
flow dynamics at rest continues to be used to investigate the skin microvascula-
ture in many studies, including in hypertension [10], congestive heart failure [113],
ageing [112], obesity [9], athletes [126], diabetes [127] and critical limb ischemia
[128]. The method has also been extended to the study of blood flow in cancer,
which will be discussed in detail below.
2.3.3 Skin microvasculature as a model for the
microvasculature
Studies of the skin microcirculation have been used in the assessment of skin mi-
crovascular dysfunction in many pathologies due to the noninvasive nature of the
techniques and the ease with which signals can be recorded using LDF [129]. How-
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ever, many of these studies seek to use the skin microvasculature as a model for
generalized microvascular function, particularly in systemic diseases such as hyper-
tension, diabetes and atherosclerotic coronary artery disease [130]. Although this
approach is seen by some to require more investigation [131, 132], the rationale
behind this assumption is that the circulatory system behaves as a single entity,
with the dynamics observed in skin blood flow providing a tool for the investiga-
tion of both local and global mechanisms [133], and that the methodologies used
to evoke an integrated vascular response represent physiology that is not unique
to the cutaneous microvascular bed [130]. Therefore, the noninvasive evaluation
of local skin microvascular function in cancer may provide insights into cancer
microvasculature in general.
2.4 Microvascular blood flow in cancer
Cancer is a large group of diseases, characterized by unregulated cell growth. In
normal, healthy cells, the balance between the creation of new cells by cell division
and the natural death of cells, apoptosis, is tightly regulated. A cell can become
cancerous when the genetic information that it contains is changed in some way,
or mutated. Many cell mutations can occur, but it is those which cause acceler-
ated or uncontrolled growth which are particularly dangerous. Most cells contain
tumour suppressor genes, to prevent cell growth from becoming out of control,
but mutations can cause the loss of this gene, and thus the apoptosis signalling
pathway is disrupted, effectively resulting in immortal cells [134]. Carcinogenesis
is not usually the result of just one mutation, but several [135]. Potentially cancer-
ous cells are present in most humans, but the immune system usually recognises
damaged cells and destroys them before they can proliferate. Problems arise when
a cancer cell is allowed to divide. The cells then very efficiently evolve to adapt to
their surroundings. Cancer cells express growth factors, for the purpose of creating
ideal surroundings and establishing a blood supply, whilst remaining unaffected
by any growth factor inhibition control directed toward them by the host. This
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uncontrolled growth will result in a tumour which could potentially grow indefi-
nitely, diverting the vital nutrients required by the body away from healthy cells
and toward its own cells, stimulating further growth. Once a tumour has a blood
supply, the possibility of the cancer spreading around the body, or metastasizing,
greatly increases. During metastasis, cancer cells can settle anywhere in the body
served by vasculature, and proliferate to form secondary tumours. Therefore, un-
derstanding of tumour vasculature and the flow dynamics of the blood supply is
of critical importance in the fight against cancer.
2.4.1 Tumour angiogenesis
Once cancerous cells begin to proliferate, a point will eventually be reached when
this tumour growth cannot be sustained without extra resources from the body.
In order to obtain these resources, and also to effectively dispose of the high levels
of waste products produced by the cells, a new blood supply to the tumour must
be established. A tumour can grow up to 1-2 mm before it requires its own blood
supply [136]; at sizes beyond this, diffusion is no longer adequate to satisfy the
demands of the rapidly proliferating cells. At this critical point, the cancer cells will
begin signalling to the body, requesting a greater volume of blood. The existing
blood vessels will then sprout new branches toward the signals, at rates of up to
1mm per day [137]. This process is known as angiogenesis, and is separate to
vasculogenesis, which is the formation of new vessels where there were originally
none.
The origins of angiogenesis research were in the early 20th century. When
observing the growth of blood vessels around tumours in 1939, Ide et al. were the
first to suggest that tumours release specific factors for the purposes of stimulating
the growth of blood vessels from observations of tumour tissue transplanted into
the rabbit ear [138, 139]. Then, in 1945 Algire & Chalkley demonstrated that
tumours actively attract new blood vessels [140]. In 1968, Greenblatt & Shubik
showed that following tumour transplantation in the hamster cheek pouch stroma,
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a vasoproliferative effect was observed even when the tumour was separated from
the vessels by a barrier which blocked the passage of cells [141], confirming that
there was indeed a diffusible substance which induced angiogenesis.
Judah Folkman, known by many as the father of angiogenesis research [142],
proposed in 1971 that tumour growth is angiogenesis dependent, and that angio-
genesis inhibitors could be used in the treatment of cancer [143], a theory which
was initially not very well received. Also in 1971, in another paper, Folkman et
al. isolated a growth factor responsible for tumour angiogenesis for the first time
from human and animal neoplasms [144].
Since this pioneering work led to a huge interest in angiogenesis research, many
angiogenic growth factors have been discovered, with vascular endothelial growth
factor (VEGF) being of particular importance [145]. VEGF was first discovered
in 1983 by Senger et al., and was initially called vascular permeability factor [146],
due to its observed effects on the permeability of the microvessels in guinea pigs,
hamsters and mice. VEGF is expressed in most types of human cancer, with
increased expression associated with a less favourable prognosis in various can-
cer types [147, 148]. In addition to VEGF, many other angiogenic growth fac-
tors have been observed, including: acidic fibroblast growth factor (aFGF), an-
giogenin, basic fibroblast growth factor (bFGF), heparinase, hepatocyte growth
factor, interleukin-8, placental growth factor (PGF), platelet-derived endothelial
cell growth factor, pleotropin, prostaglandins E1, E2, transforming growth fac-
tor α(TGFα), transforming growth factor β(TGFβ) and tumour necrosis factor
α(TNFα) [149]. These growth factors then activate receptors in the endothelial
cells of the surrounding vasculature. The endothelial cells in the parent capillary
produce enzymes to break down the basement membrane (a thin sheet of fibres
underlying the epithelium). The endothelial cells then escape from the original ves-
sel, proliferate, and form sprouts, elongating the vascular tree, migrating through
the extra-cellular matrix in the direction of the signals until the required blood
supply is established [150]. This process is known as sprouting angiogenesis, and
28
was initially considered exclusively as the mechanism by which tumour vasculature
is established. However, more recently other processes of neovascularization have
been discovered in tumours [151]. Intussusceptive angiogenesis, in which preex-
isting vessels may split in two by the formation of transvascular tissue pillar into
the lumen of the vessel, requires much less time and energy than the proliferation
of endothelial cells. New vessel growth may also be aided by the recruitment of
endothelial progenitor cells which circulate in the blood stream, but this occurs
less in humans than in mouse models where they may contribute up to 100% of
the vasculature [152].
Another interesting, and unexpected, observation arises in some cancer cases.
Folkman et al. observed that while a primary tumour is thriving, it actually
releases angiostatin into the circulation. Angiostatin is an angiogenesis inhibitor,
being investigated for anticancer therapy. This angiostatin prevents metastatic
tumours from forming whilst the primary tumour thrives. Unfortunately, if this
tumour is removed, then so is the source of angiostatin, and metastatic tumours
are much more likely to appear [153].
It has also been found that tumours may develop a secondary circulation sys-
tem of vasculogenic structures lined not by endothelial cells, but tumour cells [151].
This `vasculogenic mimicry' has been observed in melanoma, suggesting that ag-
gressive melanoma cells may generate vascular channels devoid of endothelium,
independently of angiogenesis [154].
Although angiogenesis is a major factor in the development of a tumour from
dormant to malignant, it is not associated only with tumour growth. It also plays
an important role in growth and the healing of wounds. Angiogenesis can also be
used to treat cardiovascular disease, as well as many other conditions characterized

















Figure 2.3: Diagram of the different stages of melanoma. Modified from [158]
2.4.2 Angiogenesis in melanoma
Human malignant melanoma, the most deadly skin cancer, is a highly metastatic
tumour, with poor prognosis. Initially, melanoma in situ undergoes a radial growth
phase. The onset of angiogenesis during this radial growth phase then leads to the
development of the vertical growth phase, with tumour thickness and stage of
invasion determining prognosis [157]. This then leads to metastatic melanoma
(see Figure 2.3).
Angiogenesis in melanoma is initiated by growth factors including VEGF,
bFGF, aFGF, platelet derived growth factor (PDGF), PGF and transforming
growth factors α and β (TGF-α and β), and is essential for melanoma tumour
growth and metastasis [159]. It has been shown that the secretion of VEGF by
melanoma cells has been correlated to the transition from the radial to the vertical
growth phase [160, 161].
Increased vascularity of cutaneous melanomas has previously been shown to be
an important prognostic factor [162], but this has not been universally observed
[163].
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2.4.3 Blood flow in cancer
Blood flow in tumours has long been known to be spatially and temporally het-
erogeneous, for an early review see [164]. Overall perfusion rates vary widely
depending on the recording location within the tumour, the size and stage of the
tumour, and the tumour microenvironment.
Although the functional aim of angiogenesis is to increase tissue perfusion via
the development of new vessels, the process is rarely efficient in tumours, i.e. in-
creased microvascular proliferation does not necessarily mean an increase in blood
flow, due to deregulated tumour angiogenesis. It was demonstrated in endometrial
carcinomas that microvascular proliferation was negatively correlated with tumour
blood flow, and also that low tumour blood flow is a poor prognostic factor [165].
Once angiogenesis has been initiated by a tumour, new vessels will be rapidly
formed as a result of the release of the growth factors discussed previously. The im-
balance between pro- and anti-angiogenic growth factors that allows this angiogenic
switch results in immature, dysfunctional, dilated, tortuous vessels [166]. Whilst
normal vessels possess a well organized architecture with dichotomous branching,
tumour vessels are disorganized, with trifurcations and branches with uneven di-
ameters [167]. Unlike normal vessels, there is no relationship between vessel size
and red blood cell velocity in tumours [167].
The abnormalities, both in structure and function, of tumour vessels leads to
heterogeneous, intermittent blood flow [168], and highly permeable vascular walls,
due to fenestration of the endothelium [169], resulting in leaky vessels. These
characteristics may vary across the tumour and even in the same location over
time. Although smooth muscle cells do surround some tumour vessels, usually the
local co-opted vessels rather than the newly formed ones [164], they do not func-
tion as normal contractile cells, thus directly affecting their blood flow regulatory
mechanisms [136].
Physical pressure from the growing tumour also restricts blood flow [170], and
is also the main reason for the lack of functional lymphatics within tumours [171],
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as lymphatic vessels are not suited to such high pressures.
The endothelial cells which result from angiogenesis may be also distinctly dif-
ferent to normal endothelial cells, being disorganized, loosely connected, branched,
overlapping and sprouting [172, 169], and with fundamental differences in terms
of gene expression [173], all of which may limit their ability to act as vascular
regulators, and therefore have an impact on blood flow.
The combination of inadequate vascular function and altered endothelial cells
found in tumours will inevitably influence the dynamics of the blood flow in tu-
mours due to changes in blood flow regulation, both intrinsic to the vessel wall
and via endothelial mechanisms.
Various techniques have been used to study blood flow in tumours in vivo,
including nuclear magnetic resonance imaging [168] and Doppler ultrasound [174].
Recently, laser Doppler techniques such as laser Doppler perfusion imaging (LDPI)
and laser Doppler flowmetry (LDF), traditionally used to characterise microvas-
cular function, have been applied to the study of blood flow in many cancer types,
including, but not limited to, breast cancer [175], gastric adenocarcinomas [176]
and colorectal cancer [177]. Kragh et al. demonstrated that angiogenic activity
can be estimated in vivo using LDF and NIRS [178].
2.4.4 Noninvasive diagnosis of melanoma
Melanoma is currently diagnosed and treated depending on a number of factors,
including its size, shape and level of metastasis (if any). An initial examination of
melanoma seeks to evaluate the following characteristics [179]:
Asymmetry - Ordinary moles are usually symmetrical, whereas a melanoma will
usually be irregular in shape.
Border  Moles also generally have a well defined border, in melanoma, this can
be jagged and irregular.
Colour  A mole rarely has more than one shade of brown. A telltale sign of
melanoma is the presence of different colours, such as brown mixed with black,
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pink, red, white or blue.
Diameter  Normal moles are usually no bigger than 6mm, but a melanoma will
usually be more than 7mm across.
Evolving  Most moles do not change over time, so if any changes in size, colour
or shape are noticed, this could be an indication that the mole has developed into
a melanoma.
The prognosis of melanoma depends on various factors, the main ones being
the thickness of the tumour, and whether it is ulcerated (broken skin). The thick-
ness of the tumour is measured on the Breslow scale [157], with a thickness greater
than 4mm leading to a poor prognosis; ulceration also reduces chances of survival.
Any lesion presented which meets one or more of the clinical features above is con-
sidered clinically atypical, and is usually further investigated by means of pattern
analysis using a microscopy based technique known as dermoscopy [179]. Der-
moscopy is a widely used, non-invasive method of further inspection of an atypical
lesion, and has been shown to reduce the number of biopsies required [180] and
improve diagnostic accuracy of skin malignant melanoma compared to inspection
by the unaided eye [181], but this accuracy strongly depends upon the expertise
of the examiner [182]. With the aid of dermoscopy, vascular structures can be
observed in skin lesions. Despite the improved specificity provided by dermoscopy,
many biopsies are still performed unnecessarily, causing discomfort and distress to
patients. Therefore, non-invasive techniques for the diagnosis of skin melanoma
remain an active area of research. Various techniques have been developed based
on quantification of changes in colour, shape, size and blood flow; for a review see
[183]. A high proportion of these are based on digital imaging and other imaging
tools, including magnetic resonance imaging (MRI) and positron emission tomog-
raphy (PET) scans, gene profiling, and laser based technologies.
In this thesis, it is the blood flow, as measured by laser Doppler flowmetry, that
is investigated for the non-invasive characterisation and diagnosis of skin malignant
melanoma.
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2.4.5 Blood flow in skin cancer
The accessible nature of skin cancer in particular has led to many studies of blood
flow using laser Doppler techniques in basal cell carcinoma [184, 185, 186, 187]
and melanoma [184, 12, 188]. Compared to other methods [189, 183, 190], laser
Doppler flowmetry is relatively cheap, simple to use, requires little training and
is not subjective, in contrast to many imaging techniques. It is also superior
to Doppler ultrasound, which does not register blood flow until tumours reach a
thickness of around 0.8mm [191].
In 1992, Tur et al. demonstrated elevated average blood flow in basal cell
carcinoma and melanoma when compared to non-cancerous skin lesions using LDF
[192], providing a basis for its role in the characterization of tumour blood flow
and diagnostic potential. Enejder et al. demonstrated how LDPI could be used to
follow the perfusion of BCCs over time following treatment, showing a reduction
in perfusion with healing [185].
The elevated blood flow observed in melanoma was correlated with vascular-
ization [174], which has been shown to rise gradually during tumour progression
[193].
Stücker et al., due to concerns about the applicability of single point LDF in
pigmented lesions, used LDPI to study blood flow in benign melanocytic naevi,
malignant melanomas, and basal cell carcinomas, and found significantly higher
flow values in melanocytic naevi than in basal cell carcinomas, and highlighted the
role of inflammation in these results [184]. They also concluded that LDPI was
not sensitive enough to distinguish between inflamed melanocytic naevi and malig-
nant melanomas, based on average perfusion values. In a later study, Stucker et al.
further elaborated on their findings in an attempt to evaluate LDPI average per-
fusion values for differential diagnosis of pigmented skin tumours [11]. They com-
pared malignant melanomas to clinically suspicious dysplastic melanocytic naevi
and basal cell carcinomas, again finding elevated blood flow in melanomas. Un-
fortunately, this method only provided a specificity of 48% when distinguishing
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malignant melanoma from clinically suspicious naevi.
Whilst average blood perfusion values may provide some insight into the tu-
mour blood flow, it is clear that single point LDF has a relatively low repro-
ducibility when using average values alone, due to the inherent time-variability of
the blood flow signal, as discussed above. PORH has been performed on basal cell
carcinoma lesions and imaged using laser speckle contrast imaging (LSCI), but
this method limits the recording site to locations on the body in which perfusion
can be successfully occluded, namely the limbs [187].
As skin cancer may occur anywhere on the body, more robust results may be ob-
tained by measuring perfusion in the lesion and in the contralateral site on healthy
skin, to allow location specific effects to be taken into account. Analysis of these
signals using techniques for the characterization of their intrinsic dynamics then
allows an assessment of the underlying vasculature by investigating the frequency
intervals known to correspond to vascular regulatory processes. Based on this
approach, Häfner et al. directly addressed the question of how to distinguish be-
tween inflammation and tumour induced angiogenesis by applying wavelet analysis
to LDF signals recorded from basal cell carcinomas and psoriasis [186]. Basal cell
carcinomas were used as a model of tumour associated angiogenesis, whilst psoria-
sis was used as a model of inflammatory associated angiogenesis. They found that
the blood flow dynamics observed in both cases were completely different, with re-
duced sympathetic activity observed in basal cell carcinomas but not in psoriasis,
demonstrating that even though inflammation is present and average blood per-
fusion is increased, psoriasis maintains its vascular regulatory mechanisms, whilst
BCC does not.
Häfner et al. [12] also combined laser Doppler flowmetry with wavelet analysis
in order to quantify altered vasomotion in malignant melanoma and to facilitate
diagnosis between benign and malignant melanocytic lesions in vivo. The conclu-
sion was reached that melanoma blood vessels likely exist independently of auto
regulatory processes by which they would usually be governed. They also found
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arterial pulsation was a dominant feature in blood flow signals and that this causes
more homogeneous blood flow and reduces the contributions of other blood flow
oscillations. However, blood flow recordings in this study were for only 3.3 minutes,
which according to previously defined criteria only allows oscillations to be reliably
viewed down to a frequency of around 0.03 Hz. Indeed, the lowest considered fre-
quency was 0.15 Hz, excluding part of the myogenic, and all of the neurogenic and
endothelial related frequency intervals. It has been shown previously that charac-
teristic oscillations in blood flow can be found at frequencies much lower than this,
but these will not be visible in such a short recording time. This study also did
not include dysplastic naevi as controls, so the very high sensitivity and specificity
are likely to be reduced in less clear-cut cases of diagnosis. This provides an op-
portunity to further improve understanding of blood flow dynamics in melanoma
by increasing the length of recording time and including atypical dysplastic naevi.
2.4.6 Renormalization of the vasculature
The vital role that angiogenesis plays in the development of cancer makes it an
ideal target for anti-cancer drugs. Anti-angiogenic therapy is a highly active area
in cancer research and treatment since it was introduced by Folkman [143, 194].
The aim is to halt tumour growth by preventing angiogenesis, thus starving the
tumour of oxygen, whilst poisoning it with its own waste. The most successful ap-
proach is to target endothelial cells and inhibit their growth [195]. In comparison
with cancer cells, the endothelial cells lining the vasculature are genetically more
stable. This stability means that targeting endothelial cells with anti-angiogenic
therapy will be more advantageous than targeting the cancer cells directly with
chemotherapy, as endothelial cells are less likely to mutate, or acquire drug resis-
tance [196]. As with most areas of cancer research however, there are conflicting
theories. While the idea sounds promising, genetic abnormalities have been shown
in endothelial cells, which means they could also acquire resistance, albeit probably
not as quickly. This cancer of the endothelial cells, or haemangiosarcoma, is a very
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common occurrence in dogs, rare in cats, and very rare in humans [197]. Another
direction of anti-angiogenic therapy is interference with angiogenic factors such as
VEGF and fibroblast growth factor (FGF) [195]. Despite promising results, the
effects of anti-VEGF therapy in human solid tumours have not been as successful
as expected [166].
Although lots of treatments focus on destroying the tumour vasculature, it
has also been shown that normalization of the vasculature is sometimes possible
and can increase treatment efficacy. The inability of the blood and lymphatic
vasculature to work efficiently results in the widely observed characteristics of the
tumour microenvironment, hypoxia and low pH [198]. Hypoxia will arise from the
poor blood perfusion of the area resulting in limited oxygen delivery, while low pH
will be induced by the build up of waste products of the increased metabolism of
rapidly proliferating cells, further exacerbated by a metabolic switch to glycolysis.
The presence of hypoxia reduces the efficacy of radiation treatment for tumours,
as oxygen is a potent chemical radiosensitizer. Therefore, normalizing tumour
vasculature, whilst perhaps seeming counterintuitive, has been investigated as a
promising direction for the improved effectiveness of cancer treatment in hypoxic
tumours by reinstating a functional blood supply and thus facilitating the delivery
of therapeutic agents and normalizing the tumour microenvironment [199, 166].
This suggests that the ability to regulate blood flow in vessels formed during
tumour angiogenesis may not be completely absent, but may be influenced or
suppressed by microenvironmental factors.
2.5 Potential microenvironmental influences on
microvascular blood flow
It is becoming more apparent to cancer researchers that only considering cancer
cells outside of their microenvironment results in the loss of valuable information
and may give rise to unrealistic models. Any cell or collection of cells in situ will be
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continuously interacting with the surrounding cells and tissues. Failure to account
for environmental interaction effects is likely the reason that 90% of drugs which
exhibit preclinical activity are relative failures in human models [200]. It is now
accepted by modern cancer biologists that cancer is not only an accumulation of
genetic mutations leading to excessive proliferation, but is also heavily dependent
on the growth environment [200].
2.5.1 Metabolic and microvascular responses to hypoxia
As discussed above, hypoxia is a major feature of solid tumours [201]. Hypoxia
results from inadequate perfusion and contributes to cancer treatment resistance
[202]. It also results in a phenotype which favours tumour progression [202, 203].
As a result, tumour hypoxia is a poor prognostic factor in many malignancies [135].
Severe hypoxia can result in a failure to generate enough energy to maintain
cellular functions. If prolonged, hypoxia will result in cell death. Therefore, cells
have many mechanisms in place to respond efficiently to hypoxia, and thus try
to regulate cellular oxygen concentration within a narrow range [204]. The main
response to hypoxia in cells is the expression of hypoxia-inducible factors such as
HIF-1α, first identified in 1992 by Semenza & Wang [205], which then play a role in
cell proliferation, angiogenesis, metabolism and apoptosis [206]. Significant effects
of hypoxia on the microcirculation have recently been demonstrated in rabbits
[207], highlighting the need for further investigation into the dynamics of this
response and the possible links to carcinogenesis.
The expression of hypoxia-inducible factors in response to hypoxia in tumours
has been implicated in the widely observed metabolic switch to glycolysis in cancer
cells [208] (see below). In hypoxic conditions, glycolysis will be the main source of
adenosine triphosphate (ATP) within the cell, even though it is much less efficient
than oxidative phosphorylation (OXPHOS), which requires oxygen in order to
produce ATP. Local hypoxia may also induce angiogenesis in a tumour through
VEGF-A expression [149, 39], in an attempt to increase blood perfusion, thus
38
altering the structure of the tumour microvasculature.
Hypoxia has been implicated as one of many possible causes of cancer [209,
210], with cancer cells taking advantage of some of the hypoxic responses, e.g.
angiogenesis and cell proliferation, whilst suppressing others, e.g. apoptosis [206].
Although hypoxia can be crucial in the evolution and survival ability of tumours
[211], through stimulation of angiogenesis, its role in carcinogenesis is not so clear,
as some cancer cells appear to switch to glucose metabolism before exposure to
hypoxic conditions [212].
The role of hypoxia in melanoma development
The primary microenvironment of melanoma, the skin, is unusual in that it is
known to be hypoxic (1.5-5% O2), at least in some areas. Although highly hetero-
geneous, it has been shown that while the dermis is well oxygenated, the epidermis
is sometimes modestly hypoxic [213]. This hypoxia could be a consequence of the
relatively large distance from superficial blood vessels, as oxygen will only travel
a finite distance from capillaries to cells before it is completely metabolized, esti-
mated to be around 180 µm [206]. Knowing the oxygenation status of the skin and
other tissues allows us to reasonably assume that any experiments carried out on
cancer cells above these levels, e.g. in atmospheric oxygen conditions, may not pro-
vide meaningful results. Indeed, it has been shown that cells grow better in mildly
hypoxic environments than in atmospheric levels of O2, with atmospheric con-
ditions actually causing cellular ageing, and human melanocytes benefiting from
growing in a more physiological environment [214]. Combining this knowledge with
the tendency of tumours to be hypoxic allows us to begin to build up a picture of
the early stages of melanoma. It appears that the skin provides an optimal mi-
croenvironment for melanoma progression, with ideal proliferation conditions and
promotion of avoidance of apoptosis. Physiologically normal hypoxia, as present in
the skin, is not cause for concern. HIF-1 activates many oxygen responsive genes
involved in survival, apoptosis, glucose metabolism and angiogenesis [214]. These
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functions are finely balanced in normal skin, but are disrupted during severe hy-
poxia (<0.5% O2). This leads to the hypothesis that melanoma may be promoted
by low oxygen conditions in the skin [215].
2.5.2 Cellular energy metabolism
Cellular energy metabolism encompasses many processes, ultimately resulting in
the production of ATP, the fuel continuously used by cells for many essential func-
tions, such as maintenance of ionic balance across their membranes, signalling and
protein synthesis. Every day, we turnover the equivalent of our body weight in
ATP [216]; thus our understanding of every stage of cellular energy metabolism
is of crucial importance. A diagram of cellular energy metabolism can be seen
in Figure 2.4. Novel imaging techniques have provided insights into the function
of metabolic pathways, including methods based on pH changes [217, 218], mea-
surements of nicotinamide adenine dinucleotide (NADH) levels in glycolysis [219],
measurements of mitochondrial membrane potential [220], and direct measure-
ments of ATP release [221]. These have led to the growing understanding that
many diseases can be associated with metabolic dysfunction, including diabetes
[222] and cancer [223, 210, 224, 225].
Two main pathways are involved in the production of ATP: glycolysis, and ox-
idative phosphorylation (OXPHOS). The balance between these energy pathways
is tightly regulated through their mutual interactions, according to supply and
demand [226, 1, 227]. Both processes are required for normal energy production
within a cell; however in a healthy cell, OXPHOS dominates [212]. In contrast,
in a dysfunctional cell, ATP production via glycolysis may increase and dominate
even in the presence of oxygen [228]. This effect has been shown to be favoured in
cancer cells [224], known as the Warburg effect [229, 212, 230].
ATP may be produced in two cellular locations. Glycolysis occurs in the cyto-
plasm of the cell, and the Krebs cycle and oxidative phosphorylation (OXPHOS)






























Figure 2.4: Diagram of cellular energy metabolism. ATP production in a cell
(thick lines) occurs via glycolysis using glucose, and when oxygen is present ATP
is produced via oxidative phosphorylation (OXPHOS) using the products of gly-
colysis. Both processes are oscillatory, and can influence each other. Couplings
between these processes, as well as external influences are shown by dashed lines.
duced by each process in differing ratios depending on cell type and current energy
requirements.
For example, in the absence of oxygen, or in cells with low energy requirements,
such as endothelial and yeast cells, glycolysis may be the primary source of energy
metabolism [231]. Glycolysis is much less efficient than OXPHOS, producing only 2
ATP molecules for each glucose molecule, compared to 38 ATP molecules resulting
from the combined processes of glycolysis, the Krebs cycle and OXPHOS [206].
Therefore, for cells which consistently require larger amounts of energy and have
functional mitochondria, e.g. cardiac myocytes, the latter pathway is used. In this
case, 88% of the total cellular energy is produced via OXPHOS due to its efficiency,
with the other 12% being produced equally from glycolysis and the Krebs cycle
[224].
ATP synthesis occurs through complex interactions between metabolic pro-
cesses. Glycolysis converts glucose to pyruvate, and produces ATP and NADH.
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The pyruvate is used during pyruvate decarboxylation, the products of which are
used in the Krebs cycle. This releases more ATP and leads to production of
substrates which are used to create a hydrogen ion gradient across the inner mito-
chondrial membrane. This gradient then drives the production of ATP from ADP
and inorganic phosphate, in the process of oxidative phosphorylation [225].
Evidently, energy metabolism via glycolysis and OXPHOS are complex proce-
dures, subject to many feedback mechanisms at different points in their respective
cycles. This allows the cell continuously to meet energy demands even when sub-
jected to external perturbations. In order to gauge their required rates, based
on current production and requirements, the two processes must be coupled to
maintain the correct balance between supply and demand.
Metabolic oscillations in health and diseases
Metabolic oscillations are dynamical processes dominated by two main compo-
nents, mitochondrial and glycolytic oscillations. These oscillations can be observed
using different techniques, some based on changes in glycolytic intermediates [219],
and some based on observation of changes in mitochondrial membrane potential
[232].
Oscillations attributed to glycolysis have long been observed in many types
of cells, including yeast [233], pancreatic β cells [234, 235, 226] and muscle cells
[1]. Glycolytic oscillations were first observed by Duysens & Amesz in 1957 whilst
studying the fluorescence of glycolytic intermediates in yeast [236]. The source of
these oscillations was first proposed by Ghosh & Chance [237] as an enzymatic step
catalyzed by phosphofructokinase (PFK) [7]. This is still debated, however. There
is now lots of evidence to suggest that the reaction involving PFK is responsible for
their origin [238, 226, 219], but not exclusively, as glycolytic oscillations in yeast
have been found to have frequencies that are also dependent on glucose trans-
port across the cell membrane [239]. Interestingly, the metabolic switch observed
in cancer cells results in a metabolism which has been shown to have features
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in common with yeast metabolism [228]. In addition to the observation of the
existence of glycolytic oscillations, their presence has been shown to provide an
advantage in maintaining a high ATP/ADP ratio [240].
Oscillations in the mitochondria have been observed since almost 50 years ago
[241], and it was Chance & Yoshioka who demonstrated that they could be sus-
tained over many cycles [242].
Mitochondrial oscillations can be considered in two separate cases. In the
physiological, or healthy, domain, small amplitude oscillations can be observed
in mitochondrial membrane potential ∆ψm. These have been associated with
cycles of oxidation [243, 241], and extramitochondrial factors, such as the plasma
membrane potential ∆ψ or Ca2+ [226]. In cases of oxidative stress or substrate
deprivation, the inner mitochondrial membrane potential may destabilise, causing
depolarization and oscillation [220, 244], forcing synchronous oscillations within
the mitochondrial network [232, 245, 220].
Independent of their cause, metabolic oscillations may manifest as ATP oscil-
lations. ATP oscillations have been observed in the cytosol of human single islet β
cells, which were shown to be affected by glucose concentration, with oscillations
present at both low and high glucose concentrations, with those at high concen-
trations exhibiting an increase in their period of oscillation [246]. Kwon et al.
observed ATP oscillations during chondrogenesis, which is the process by which
cartilage is developed, which were found to depend on glycolysis and mitochondrial
respiration, which in turn were revealed to depend on Ca2+ oscillations with an
anti-phase relationship [6]. Measurements in yeast cells with oscillatory glycolysis
revealed oscillations in ATP and also a slow decrease in ATP [247, 248]. It has
also been demonstrated that oscillations in ATP concentration are tightly coupled
to intracellular water dynamics, affecting the overall state of the cytoskeleton of
the cell, coupling the chemistry and physics of the system [249].
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Metabolic alterations in cancer
In the 1920s, Otto Warburg discovered that cancer cells display a metabolic switch
to glycolysis, even in the presence of oxygen, a phenomenon now known as the War-
burg effect [229]. From these observations, Warburg concluded that the respiration
of all cancer cells is damaged; a conclusion which is still debated [230].
Two of many universal observations in cancer cells are: 1) their metabolism is
altered, and 2) genetic mutations are present [250]. Which, if any, of these is re-
sponsible for carcinogenesis is still unknown, but increasing evidence suggests that
mitochondrial dysfunction plays a key role [212, 251, 225]. Most other properties
observed in cancer cells can be explained as consequences of this dysfunction [224].
The metabolism of a cancer cell has to meet the increased energy requirements
of a constantly proliferating cell, whilst still maintaining the correct balance of
ATP. Too little ATP and the cell will not have enough energy to function, whilst
over-production of ATP will disrupt cellular processes [224]. The excess lactate
secreted by cancer cells can be explained by upregulation of glycolysis, following
increased glucose uptake. Decreased mitochondrial activity has also been observed
in cancer cells [225]. This preference for glycolysis even in the presence of oxygen
can be explained either by mitochondrial dysfunction, or a survival advantage pro-
vided by a switch to glycolysis [251]. Cellular energy metabolism within tumours
is highly heterogenous, with both oxygenated and hypoxic regions [252], depending
on the distance to the local blood supply.
It has been shown that tumour mitochondria are structurally and functionally
abnormal, and incapable of meeting cellular energy requirements [224]. The mi-
tochondrial proton gradient required for OXPHOS is disrupted, which may force
the cell to rely on glycolysis for ATP production, even when oxygen is abundant.
If healthy cells spend prolonged periods of time in this state, without repair of the
mitochondria, it may lead to genetic instability and disorder within the cell [224].
This may cause mutations to arise, and facilitate the onset of carcinogenesis.
Within such complex metabolic processes, in normal and cancer cells, it is un-
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feasible to assume stationarity of the balance between supply and demand; it is
inevitably time-dependent. Indeed, it has been shown that oscillations are present
in cellular metabolism. Understanding these oscillations and their interactions, and
considering how they are altered during the metabolic transition to a glycolysis
dependent state may prove extremely useful in the characterization of carcinogen-
esis.
Effects of altered energy metabolism on microvasculature
The global effects of the metabolic switch to glycolysis may directly affect the
microvasculature, either through alterations in signalling (i.e. initiation of angio-
genesis, as described above) or by changes to the tumour microenvironment.
During aerobic and/or anaerobic glycolysis and ATP hydrolysis, hydrogen ions
are formed and are actively transported out of the cell, through the interstitial
space, to the blood vessels, where they can be transported away from the site
[253]. The altered metabolism in cancer cells, i.e. the high glycolytic rate, coupled
with reduced drainage of waste products due to inadequate tumour vasculature
leads to a build-up of H+ ions which decreases the extracellular pH, i.e. the mi-
croenvironment becomes more acidic [198, 253, 254, 255].
In 1880, Gaskell demonstrated that acid solutions evoke vascular smooth muscle
cell relaxation [256, 257]. Changes in pH modulate the responsiveness of the
smooth muscle cells to vasoconstrictor stimuli [258]. It has since been shown
that altered pH can promote changes in vascular smooth muscle tone, with low
pH values inducing vessel dilation [257]. A reversible abolition of vasomotion
has also been demonstrated outside of a very narrow pH range in hamster cheek
pouch arterioles [69], providing evidence of the importance of microenvironmental
stability for effective vascular regulation. Acidic extracellular pH in melanoma was
shown to promote angiogenesis [255].
The reactivity of the blood vessels within a tumour may depend on their origin.
Those which already existed in the host but have been co-opted by the tumour
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[151] may still retain their ability to regulate blood flow in the right conditions,
whilst vessels arising from tumour induced angiogenesis may never be capable of
such responses due to their inadequate structure [259]. Therefore, the exploitation
of potentially functional and mature blood vessels in tumours by introducing va-
sodilators is an active area of research [259], highlighting the necessity of vascular
regulation.
2.6 Summary
Oscillations in microvascular blood flow can be quantified in health and disease,
providing a tool for the investigation of pathologies in which vascular regulation is
altered. One such pathology is cancer, which is likely to demonstrate altered blood
flow dynamics due to many simultaneous factors: the development of new, yet
dysfunctional, vessels via angiogenesis, alterations in cellular energy metabolism
to become more robust to limited nutrient availability, and the subsequent effects of
these factors on the tumour microenvironment resulting in reduced vessel reactivity
and inadequate tissue perfusion due to hostile conditions.
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3. Physiological measurement
The observation and measurement of spontaneous dynamics within living systems
is becoming increasingly feasible with the introduction of new measurement tech-
niques based on various physical principles from optical to electrical effects. This




The heart is one of the most important oscillators in the human body. The elec-
trical activity of the heart can be non-invasively monitored in time using an elec-
trocardiogram (ECG). An ECG tracks the electrical changes in the heart during a
heartbeat. The average resting heart rate is between 60 and 90 beats per minute
(BPM), with a resting heart rate outside of these boundaries indicative of an un-
derlying medical condition. In athletes, the resting heart rate is generally lower,
due to an increased stroke volume, which is the volume of blood pumped out of
the heart with each beat. As cardiac output is the product of heart rate and stroke
volume, an increase in the latter allows the required resting cardiac output to be
maintained with a lower heart rate. In addition to monitoring changes in heart
rate, the specific waveform observed during one cardiac cycle may provide valu-
able information on the health of the heart. A typical heartbeat ECG is shown







Figure 3.1: Typical one-cycle ECG trace
initial part representing right atrial depolarization and the terminal portion the
left atrial depolarization. A fraction of a second after the P wave begins, the atria
contract. The Q wave is a downward deflection after the P wave and represents
septal depolarization. The R wave is usually the easiest wave to identify, and can
thus be used to calculate heart rate, and heart rate variability. It represents early
ventricular polarization. The S wave represents the late ventricular depolarization.
The T wave represents repolarization of the ventricles [260]. All these waves can
differ in shape, and in some cases be absent, and are used in the early detection
and diagnosis of heart conditions.
3.1.2 Heart rate variability
Heart rate variability (HRV) can be calculated directly from an ECG signal by
marking the locations of the R-peaks, and considering the distance between them
as a complete period of oscillation with phase between 0 and 2pi. The instantaneous
frequency is then the reciprocal of the time period between each pair of R-peaks. R-
peaks are chosen because they are the most prominent component of the heart beat,
and are present in every cycle. A disadvantage of this method is that the resolution
depends on the period of oscillation, i.e. no instantaneous frequency or phase
information is available between events. As the sampling frequency of the HRV
obtained from this method will vary depending on the period, linear interpolation
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must be performed on the signal. To retain the same resolution as the original
time series, the instantaneous frequency can also be extracted from the wavelet
transform of the ECG signal using ridge extraction methods, as in nonlinear mode
decomposition (NMD) [261]. HRV can be investigated by studying the obtained
signal using methods which will characterise the temporal fluctuations, for example
the continuous wavelet transform.
Heart rate varies naturally within a breathing cycle; it will slightly increase dur-
ing inspiration and slightly decrease during expiration. This variation is known as
respiratory sinus arrhythmia (RSA) [262]. The presence of RSA indicates efficient
feedback mechanisms in the heart, it is evidence of the heart constantly respond-
ing to the needs of the body. Whilst the heart rate can be an indicator of general
health, with a low resting heart rate generally associated with a high level of phys-
ical fitness, e.g. in athletes, and a prolonged high resting heart rate, or tachycardia
(>100 bpm) a possible indicator of cardiac problems, it is the variability of the
heart rate which provides us with the most information. For example it has been
shown that heart rate variability decreases with age [112].
Heart rate variability is widely considered as a measure of the performance of
the autonomic nervous system. Lower HRV has been implicated in many physiolog-
ical conditions, such as congestive heart failure, diabetic neuropathy, susceptibility
to sudden death, atherosclerosis and hypertension. It has also been shown to be a
predictor of mortality after myocardial infarction [263]. Decreased HRV has also
been found in major depressive disorder and coronary heart disease, both of which
are hypothesized to be linked to vagal function [264].
3.1.3 Respiration
Respiration can be measured either mechanically, i.e. direct measurement of chest
displacement, or via analysis of expired carbon dioxide levels. Respiratory rate can
be calculated used the marked events method explained above. Using respiration
and heart rate signals it is possible to investigate cardiorespiratory coupling [265].
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Figure 3.2: Diagram demonstrating the principles and recording area of laser
Doppler flowmetry. From [266]
3.2 Blood flow
3.2.1 Laser Doppler flowmetry
Laser Doppler flowmetry (LDF), exploits the Doppler effect to calculate blood
flow (or flux) in laser illuminated microvessels (see Figure 3.2). The photons
from a beam of light directed into the tissue will be scattered by both static and
moving particles. The moving red blood cells impart a Doppler shift to the photon,
depending on the scattering angle, the wavelength, and the velocity vector of the
cell [267]. If a wave with frequency ω is scattered from a moving particle with
velocity v, the Doppler shift is




Figure 3.3: Scattering of a photon with a wave vector kI by a moving red blood
cell with velocity v.
where kI is the incident wave vector, ks is the wave vector of the scattered wave,
and β is the angle between the velocity vector and the scattering vector, defined
as kI − kS (see Figure 3.3). If α is the scattering angle, and λ the wavelength of
the light, the Doppler shift can then be written as [267]
∆ω = 2(2pi/λ)|v| sin(α/2) cos β. (3.2)
The large number of vessels and moving particles in the microcirculation means
that the photons will inevitably undergo multiple Doppler shifts, giving a range
of shifts even if all particles have the same speed [267]. The Doppler shifted light
will interfere with non-Doppler shifted light on the photodetector, generating a
dynamic speckle pattern, causing the current signal of the detector to fluctuate.
The power spectrum of these fluctuations then provides information about the
flux and concentration of the red blood cells [267], as the first moment of order,
or mean frequency, of the power spectrum is linearly proportional to these values.
These methods do not provide absolute velocity values, therefore blood flow, or
flux, is measured in perfusion units (PU). The perfusion signal is the average






Figure 3.4: Example wavelet transform of a laser Doppler flowmetry blood flow
signal, demonstrating peaks in the six frequency intervals described in Section
2.3.2.
A LDF probe contains an optical fibre, through which laser light propagates,
with an emitter and detector, spaced according to the depth of light penetration
required. This technique has been used extensively to study the microcirculation,
providing essential insights into the oscillations present in blood flow. Of particular
importance was the discovery of six characteristic peaks in the frequency spectrum
of LDF signals [68] (see Figure 3.4). These peaks have been reliably attributed to
various physiological oscillatory processes as described in Section 2.3.2.
The advantage of LDF is its non-invasiveness, and its ability to measure the
microculatory blood flow in real time, with a high sampling frequency. A dis-
advantage is that it provides only a single point measurement, and therefore no
spatial information from the surrounding tissue.
3.2.2 Laser Doppler perfusion imaging
Laser Doppler perfusion imaging (LDPI) is based on the same principles as LDF,
but scans many points to create a blood flow image rather than the single point
information provided by LDF. LDPI is ideal for the spatial imaging of blood flow
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at the same depth afforded by LDF, but the scanning time results in relatively
poor temporal resolution.
3.2.3 Laser speckle contrast imaging
When illuminating a diffuse object, laser light will produce a random interference
effect know as a speckle pattern. If the illuminated object moves, or consists of
moving parts, the speckles over the moving area(s) will fluctuate in intensity in a
manner related to the velocity of the movement. This velocity information can be
extracted by imaging the speckle pattern and calculating the local speckle contrast,
a measure of the blurring caused by intensity fluctuations [268].
Since the discovery of lasers, speckle patterns caused by random interference
have resulted in much research into methods to reduce their effects. More re-
cently, this phenomena has been studied in its own right, and has been found
to be applicable to many different areas of science. One area in which it has
proven particularly useful is in biomedical imaging of blood flow [268, 269]. Laser
speckle contrast imaging (LSCI) provides superior temporal resolution to LDPI,
but cannot penetrate as far into the tissue.
LSCI is based on the fact that movement in an area on which a speckle pattern
is projected will cause blurring upon image capture, to an extent which depends
on the velocity of the movement and the exposure time of the camera [270]. High
velocities will cause the most blurring, and areas in which there is no movement





where σ and 〈I〉 are the standard deviation and mean, respectively, of the intensity
of a grid of pixels from the image. This value can be calculated spatially or
temporally, depending upon the application. A window (typically 5×5 or 7×7
pixels) is moved across the imaged speckle pattern, and its central value set to the
speckle contrast value for the window. Low speckle contrast values correspond to
53
high blood perfusion values.
To represent these speckle contrast values in terms of flux values, Brownian mo-














where τc is correlation time (time taken for the autocorrelation to fall to a pre-
determined low level), and T is camera integration time. In theory, the speckle
contrast, K, should vary between 0 (high perfusion) and 1 (very low perfusion,









If we assume that perfusion is proportional to the mean velocity of scatterers
then perfusion is inversely proportional to the correlation time. Applying this







LSCI systems are commercially available, but a system can be built at a much lower
cost [272]. A system was developed within the Department of Physics at Lancaster
University using a Raspberry Pi with an infrared camera and an IR laser diode,
with processing performed in MatLab. A raw image and the corresponding laser
speckle image from this system can be seen in Figure 3.5.
3.3 Blood oxygenation
The colour difference between oxygenated and de-oxygenated blood can be ex-
ploited via their differing absorption spectra to observe relative changes in blood
oxygenation and volume. Blood oxygenation measurements will vary depending





Infrared laser diode (780nm)
Sample
Diffuse light
Figure 3.5: Top  diagram of the laser speckle imaging setup. Images were
obtained using a Thorlabs DCC1545M camera and a 780nm infrared laser diode.
Image processing was performed in MatLab. Bottom  Flux image map of the
fingers of the left hand, obtained using an analysis window of 7×7 pixels (left),
and the raw image with visible speckles (right). Regions of high perfusion are
shown in red, whilst regions of low perfusion are dark blue.
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flowmetry (LDF) assessment [273]
Laser Doppler perfusion





imaging (LSCI) procedures [275]
Table 3.1: Overview of techniques for the measurement of blood flow. Specific
values depend on the setup used.
saturation of peripheral oxygenation, SpO2, using a probe which is usually placed
on the earlobe or fingertip. The pulse oximeter transmits light of two wavelengths
into the skin to ascertain absorbance due to arterial blood, whilst correcting for
effects from other tissues. Pulse oximetry is particularly useful for detecting sys-
temic alterations in oxygen carriage, for example in hypoxaemia.
Near infrared spectroscopy (NIRS) utilises NIR light to measure relative changes
in haemoglobin concentration. In the optical window between 700 and 900nm, bi-
ological tissues are considered almost optically transparent; therefore haemoglobin
dominates light absorption. Water and other chromophores such as fat and melanin
are assumed not to change over time, allowing observed changes to be attributed
to haemoglobin. Differences in the absorption spectra of oxygenated and deoxy-
genated haemoglobin allow the two to be distinguished using at least two light
sources of different wavelengths, one above and one below the isosbestic point
where the absorption is identical (see Figure 3.6). Some systems incorporate a
source at this wavelength to enable calculations of total haemoglobin, to verify
the Hb and HbO2 values. At least two different wavelengths are required for the
calculations, with the inclusion of more wavelengths reducing error. Relative con-
centration is calculated as a function of total photon path length using the modified
Beer-Lambert law [276, 277],































Figure 3.6: Absorption spectra for oxygenated and deoxygenated haemoglobin
(red and dark red lines, respectively) and water (blue line). The optical window in
which biological tissues are considered almost optically transparent is highlighted
in grey (700900nm).
where A is light attenuation, ε is an extinction coefficient, c is substance concen-
tration, d is the distance between source and detector, DPF is the differential
path length factor and G is signal loss due to scattering. The Beer-Lambert law is
only valid in non-scattering media, and thus is not applicable in biological tissue.
NIRS is widely used to monitor haemodynamic responses to brain activation.
3.4 Summary
Constant technological advancement allows continuous improvements in tempo-
ral and spatial resolution of existing techniques, whilst making new ones feasible.
This is leading to the acquisition of more biological data in vivo than ever before,
providing the opportunity to view functions within the body without perturba-
tion in both healthy and diseased states. With these new possibilities comes the




This chapter comprises three main sections. The first presents the theoretical back-
ground of dynamical systems, in particular nonautonomous systems and chrono-
taxic systems, followed by a review of the inverse approach to dynamical systems
in Section 4.2. Methods for the detection of chronotaxic systems via the inverse ap-
proach are then reviewed in Section 4.3. Finally, Section 4.4 expands these inverse
approach methods to new scenarios using numerical simulations, and the methods
are also applied for the first time to brain dynamics using real experimental EEG
data.
4.1 Introduction





where the infinitesimal change in x in infinitesimal time intervals t is described
by some function f acting on the previous state of x. This differential equation
describes the evolution of the system in continuous time. When time is discrete,
iterated maps may be used [278], but only continuous time and thus differen-
tial equations are considered in this thesis. A dynamical system which explicitly
depends on time, as is also the case in most biological systems, is known as nonau-
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tonomous, with the simplest case being
dx
dt
= f(x, t). (4.2)
Linear dynamical systems, i.e. those with linear output, are exactly solvable. The
vast majority of biological systems are nonlinear [7], making their analysis more
difficult, but also more interesting. Unlike linear systems, nonlinear dynamical
systems may exhibit self-sustained oscillations, and in this case will result in a
stable limit cycle in the phase space of the system. A limit cycle is an isolated
closed trajectory, which neighbouring trajectories will either spiral towards or away
from depending on its stability [278].
These considerations of deterministic models are important in the characteri-
zation of the dynamics of biological oscillations.
4.1.1 Nonautonomous systems
The theory of nonautonomous dynamical systems has increasingly been recognised
as a necessity in the treatment of the inherent time-variability of biological systems
[279]. Closer inspection of the dynamics observed in nature suggests that previous
approaches to the characterization of temporal fluctuations in these observations
may be insufficient. At first glance, biological fluctuations may appear random,
leading to their description by stochastic models [280]. The complexity observed in
biological systems has also led to attempts to treat them with chaos theory [281];
however this does not allow for the apparent stability of these systems, irrespective
of their initial conditions or perturbations to their trajectories. Such characteristics
of biological oscillators suggests underlying determinism or control of both their
amplitudes and frequencies even with continuous perturbations. This phenomenon
of biological systems resisting a natural tendency to disorder was discussed in terms
of free energy minimization [282] and separation of internal and external states, but
this approach is still based on random dynamics. A closely related yet more natural
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approach is to consider them as nonautonomous systems, which are explicitly time
dependent. Approaches based on reformulation of nonautonomous systems as
higher dimensional autonomous systems introduce unnecessary complexity whilst
failing to describe accurately the dynamics arising from nature, where systems
are open and subject to continuously variable external perturbations. Many living
systems may be considered as nonautonomous oscillatory systems, with such time-
varying dynamics being observed in individual mitochondria [220], the cardio-
respiratory system [112, 283], the brain [284] and blood flow [110].
4.1.2 Chronotaxic systems
Although stability of the amplitude dynamics of an oscillator can be achieved
with autonomous self-sustained limit cycle oscillators, the frequency of this oscil-
lation could be easily changed by weak external perturbations [285]. To account
for a case where this frequency of oscillation is also robust to perturbations, yet
time dependent, a completely new approach is required. Thus, nonautonomous
systems with stable yet time-varying frequencies were recently addressed, and for-
mulated as chronotaxic systems [285, 286, 287]. Chronotaxic systems possess a
time-dependent point attractor provided by an external drive system. This allows
the frequency of oscillations to be prescribed externally through this driver and
response system, giving rise to determinism even when faced with strong pertur-
bations.
Chronotaxic (chronos  time, taxis  order) systems were introduced [285, 286,
287] in order to provide a framework in which a nonautonomous dynamical system
may possess time-varying amplitudes and frequencies which are stable, i.e. able to
resist continuous external perturbations.
Nonautonomous dynamical systems, and thus chronotaxic systems, are defined
by the following system,
p˙ = f(p); x˙ = g(x,p), (4.3)
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(a) (b)
Figure 4.1: (a) Moving point attractor in a chronotaxic system. (b) Simplest
case of a chronotaxic system, x, driven by p
where p ∈ Rn, x ∈ Rm, f : Rn → Rn, g : Rm × Rn → Rm, where n and
m can be any positive integers. Crucially, the solution x(t, t0,x0) of Eqs. (4.3)
depends on the actual time t as well as on the initial conditions (t0,x0), whereas
the solution p(t − t0,p0) depends only on initial condition p0 and on the time of
evolution t− t0. The driven system x is nonautonomous, i.e. it is described by an
equation that explicitly depends on time. x is assumed to be observable, whilst
the driving system p may not be, as is the case in many real systems. Therefore,
the observable dynamics of x are used to infer information about the evolution of
the system p, with the assumptions that in the case of chronotaxicity it will create
a time-dependent steady state in the dynamics of x, (see Figure 4.1(a))
The system x is considered as a thermodynamically open system, and in addi-
tion to the driving p which makes the system chronotaxic, external perturbations
are also considered, arising from everything outside x and p which may influence
the system. In the absence of external perturbations, the dynamics of x will re-
duce to the time-dependent steady state determined by p. This unperturbed state,
also known as a point attractor, is denoted xA(t). Assuming that for any initial
condition x0 at time t0 the solution of the system asymptotically approaches the




|x(t, t0,x0)− xA(t)| = 0, (4.4)
which can only be satisfied when the chronotaxic system is not perturbed. There-
fore, this condition is not sufficient to define the time-dependent point attractor in
a real system, especially when considering the stability of the system at the current
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time t, not the infinite future. To resolve this, a condition of pullback attraction
must also be satisfied by xA(t) in a chronotaxic system,
lim
t0→−∞
|x(t, t0,x0)− xA(t)| = 0. (4.5)
Considering the condition 4.5 at all times t > −∞, it follows that xA should also





The asymptotic convergence in the infinite future starting from the infinite
past allows the dynamics of x(t, t0,x0) to deviate from xA during a certain finite
time interval, meaning that during this time interval the ability of the system
to resist external perturbations will be absent. Therefore, another condition for
chronotaxicity is that the system should satisfy the condition of contraction. This
means that in phase space there should be a contraction region C(t) within which
any two trajectories x1,x2 of the system inside the contraction region xi(t, t0,x0i) ∈
C(t), i = 1, 2, can only converge,
d
dt
|x1(t, t0,x01)− x2(t, t0,x02)| < 0. (4.7)
This contraction region can be finite, and thus trajectories may leave the area.
It is therefore required in a chronotaxic system that the contraction region should
contain a finite area A′, A′ ⊂ C, such that solutions of the system starting in A′
never leave it, ∀t0 < t, ∀x0 ∈ A′(t0), x(t, t0,x0) ∈ A′(t).
Providing the above conditions are met, the dynamics of p may be stochastic
or chaotic, but the dynamics of x, when unperturbed, will still be deterministic.
Real life systems can be modelled by perturbed chronotaxic systems, in which a de-
terministic and a stochastic component may be observed, but the system will still
retain a deterministically defined frequency and resist continuous external pertur-
bations provided that they are not too strong, and will revert to the unperturbed
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case in their absence.
The next step following this knowledge of the underlying dynamics of chrono-
taxic systems is to extract the deterministic components in data from living sys-
tems in order to reduce their complexity and study the underlying dynamical
processes.
Example chronotaxic systems and their identification via the inverse approach
are discussed in Section 4.3.
4.2 Inverse approach to dynamical systems
A wide range of observed properties in living systems can be explained by con-
sidering them as nonautonomous. Despite this, difficulties in their analysis as
such have led to many unsuccessful attempts to apply methods more suited to
autonomous systems. In deterministic systems, phase space analysis is usually the
first point of call, i.e. reconstruction of the attractor in phase space. This approach
works well for autonomous systems, but does not consider the possibility of time-
dependent attractors [279]. To incorporate time-dependence into these systems,
extra dimensions in phase space are required, introducing unnecessary complexity
to the problem.
Many signal analysis methods assume stationarity of the frequency distribution
of the data, but in nonautonomous systems this assumption is not valid. Single
variable time-series, particularly those from living systems, must be treated as
arising from nonautonomous dynamical systems, due to time-dependent influences
of variables other than the one under study. Approaches based on windowing
have been applied in order to attempt to treat time-variability in data, but these
potentially lose crucial information. For example, in phase space reconstruction,
the window may not be of a sufficient size to capture the whole of the attractor,
or its variations in time. Application of the Fourier transform to nonstationary
data will result in a blurred or misleading power spectra, severely limiting its
usefulness. The windowing approach has been applied here with some success,
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but the windowed Fourier transform introduces frequency resolution limitations
based on window size; the better the time resolution, the worse the frequency
resolution (known as the Gabor limit [288]). The fixed time-frequency relationship
at all scales in a windowed Fourier transform severely limits its usefulness for the
analysis of low frequency oscillations. This problem can be addressed using the
continuous wavelet transform, which provides a logarithmic frequency scale (see
Section 4.2.3). This simultaneous observation of the time and frequency domains is
extremely useful in the visualization of dynamical systems and their time evolution.
As a result, development of wavelet-based methods specifically for the treatment
of time-dependent dynamics is now a very active field of research [289], including
wavelet phase coherence [290], the synchrosqueezed transform [291] and wavelet
bispectrum [292].
4.2.1 Time domain
Instantaneous frequency and phase
The instantaneous frequency of an oscillation can be obtained as the time deriva-
tive of the phase, assuming that the phase can be defined for each cycle, and
that the phase is separable from the amplitude. The calculation of instantaneous
frequency via the marked events method has already been discussed in Section
3.1.2. Another method for the calculation of instantaneous phase is the Hilbert
transform, which converts a real signal into a complex one known as an analytic
signal, containing amplitude and phase information of the oscillation. The Hilbert
transform is superior to the marked events method in that it provides a time res-
olution equal to the sampling frequency, whilst in the marked events method this
resolution can only be equal to the frequency of events, which also means that the
resolution may vary over time. However, the Hilbert transform is quite limited
in terms of the time series to which it can be applied, for example it can only be
used in time series in which a single oscillation is present. As previously discussed,
extraction of instantaneous phase from time-frequency representations provides
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Figure 4.2: Linear interpolation can be used to remove spikes of short duration.
As an example, the spike at around 687 seconds can be seen in the inset in black,
and the interpolation line across it in red. It is important to retain as much of the
original signal as possible, here 99.62% remains.
good resolution whilst allowing the investigation of multi-mode signals.
Preprocessing
Preprocessing of a signal is important to provide optimal conditions for analysis
but it is important to keep data manipulation to a minimum. In data recorded
from living systems, artefacts may arise from movement or other, non-physical,
influences. The characteristics of these artefacts determines how they should be
dealt with. If their duration is much shorter than the frequencies of interest, they
can be removed by simple linear interpolation across the spike (see Figure 4.2).
If there are multiple spikes, or their duration is very long, i.e. comparable to the
frequencies being studied, then they should be either cut from the data, if they
occur close to either end, or the data should be discarded. Under no circumstances
should the data be spliced, i.e. joining non-consecutive intervals of data.
Another thing to consider in preprocessing is filtering. If mean values are to be
calculated, or frequency analysis is to be applied to the signal, the data should be
detrended to remove trends and effects of frequencies lower than those of interest,
which may affect results. Detrending can best be achieved using a moving average
method, in which a window of a defined width in time is moved along the signal,
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Figure 4.3: A detrended blood flow signal (black). A 200s window was used in
a moving average, to calculate the trend (yellow), removing all frequencies below
0.005 Hz. The mean is also subtracted.
and the central value is set to the mean of the window. This can be used to filter
or smooth signals, depending on the window size used. For frequency, or time-
frequency analysis, it is also necessary to subtract the average of the signal, as
shown in Figure 4.3.
Detrended fluctuation analysis
The complexity of a time series can be quantified using fractal analysis. Detrended
fluctuation analysis (DFA) is used to determine the statistical self-similarity of a
signal at different timescales, with less strict assumptions about the stationarity
of a signal than the auto-correlation function. The scaling of these fluctuations is
determined by the self-similarity parameter α, where fluctuations at time scales
equal to t/a can be made similar to those at the larger time scale t by multiplying
with the factor aα.
In order to calculate α, the time series is integrated in time and divided into
sections of length n. For each section the local trend is removed by subtracting a
fitted polynomialusually a first order linear fit [293, 112]. The root mean square
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where Y (t) is the integrated and detrended time series and N is its length. The
fluctuation amplitude F (n) follows a scaling law if the time series is fractal. By
plotting logF (n) against log n, the value of α is simply the gradient of the line.
For completely uncorrelated white Gaussian noise the parameter for α has a value
of 0.5, while integrated white Gaussian noise returns a value of 1.5.
4.2.2 Frequency domain
Before analysing a signal in the frequency domain the frequency range which it is
possible to observe based on the characteristics of the data must be considered.
The maximum observable frequency in a signal is equal to half the sampling fre-
quency, defined as the Nyquist frequency. This limit prevents aliasing. Aliasing
occurs when the sampling frequency is not sufficiently high to capture accurate
information about the system being observed. The lowest observable frequency is
equal to 1/l, where l is the length of the time series, ensuring that at least one pe-
riod of oscillation is possible in the measured time series. One also cannot resolve
the amplitude of two oscillations which have a difference in frequency of less than
1/l. In practice, particularly when dealing with signals from living systems, it is
more reliable to define the lowest frequency of observation as 1/5l [294].
The Fourier transform
Any physical process can be described either in the time domain or in the fre-
quency domain. In the time domain, the values of a quantity f are given as a
function of time, f(t), whereas in the frequency domain the process is described
as the amplitude of the process F as a function of frequency, F (f). Both are
representations of the same function which provide different kinds of information.
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If time is measured in seconds, the units of frequency will be Hertz, or cycles per
second.
A Fourier series expresses a periodic function as an infinite series of sines and
cosines,
f(t) = a0 +
∞∑
ω=1
[aω cosωt+ bω sinωt], (4.9)
where ω is the angular frequency and a0, aω and bω are Fourier coefficients.
Data resulting from biological recordings will involve discrete sampling. For








The Fourier transform will show peaks at frequencies of periodic terms contained
in the time series. The Fourier transform is symmetric, with both positive and neg-
ative frequencies calculated. However, negative frequency components are usually
discarded, and the positive components doubled to compensate.
The Fourier transform assumes that the signal on which it is performed is
stationary, i.e. that the frequency components do not vary with time. In the
vast majority of biological signals, there is some degree of time variance, which
even if deterministic will not be distinguishable from stochastic variations in a
basic Fourier transform. The sinusoidal basis of the Fourier transform may also
misrepresent oscillations which have more irregular shapes. An example time series
containing low frequency oscillations between 0.001 and 0.01 Hz is shown in Figure
4.4. The fast Fourier transform (FFT) of this signal is compared with the FFT
of 1/f (or pink) noise, demonstrating that it is difficult to distinguish between
the deterministic oscillations in the simulated data and the pure noise signal. In
contrast, a continuous wavelet transform of the same data reveals a distinct, time-
varying oscillation, highlighting the benefits of considering time and frequency
information simultaneously.
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Figure 4.4: Comparison of the Fourier transforms of simulated low frequency os-
cillations and 1/f noise. (a) Simulated data with oscillations varying in frequency
between 0.001 and 0.01 Hz. (b) FFT of the data in (a). (c) DFA exponent of the
data in (a) suggests anti-correlated. (d) FFT of 1/f noise (pink noise). (e) DFA
exponent of 1/f noise is around 1, as expected. (f) Continuous wavelet transform
of the data in (a), shows oscillations are present with varying frequency.
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4.2.3 Time-frequency analysis
Short time Fourier transform
The Short Time Fourier Transform (STFT) or windowed Fourier transform (WFT)
goes some way to solve the problems with the Fourier transform, by dividing the
signal into `windows' within which the signal can be approximated as a stationary
one. This method provides a time-frequency representation, in which the FFT
is calculated for each window, and the middle value of the window in the STFT
representation set to the resultant FFT values.
The STFT still has its limitations. The window size must be decided depending
on whether the user requires good time resolution or good frequency resolution,
one cannot have both simultaneously [288]. Also, the linear frequency resolution
of the STFT means that it performs poorly in resolving separate oscillatory modes
when analysing low frequency components in data.
Continuous wavelet transform
The optimal solution to the previously discussed limitations is the wavelet trans-
form. This simultaneously examines the signal in time and frequency, and allows
good resolution in both through the use of an adaptive window. If this process is
carried out in discrete steps, it is known as a discrete wavelet transform (DWT)
which has no overlap between frequency bands. If continuous, it is a continu-
ous wavelet transform (CWT). The superiority of the CWT over the FFT when
analysing a chirp signal is demonstrated in Figure 4.5.












where s is a scaling factor, t is a location on the signal in time and ψ is the wavelet
function. The wavelet transform is obtained by moving a wavelet function along
all locations of the signal. For each location, a full range of scales of the wavelet is
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Figure 4.5: (a) Nonlinear chirp signal (quadratic) sin(2pi × 0.0001 × time2) has
a frequency which increases with time. (b) The Fourier transform is unable to
properly represent the signal in (a) in the frequency domain, due to the time-
variation. (c) The continuous wavelet transform in (c) and the 3D version in (d)
show how the frequency changes with time using a 3D map showing time and
frequency information simultaneously.
used, and can be adjusted depending on the range of frequencies to be investigated.
The value obtained from the convolution of the wavelet function with the signal
at these times and frequencies will be large if there is a good match (if the signals
are out of phase, a large value will still be given but it will vary between real
and imaginary parts if a complex wavelet is used). In this way, a whole picture
of a signal can be created, with the axes time, frequency and amplitude, which
is the value of the transform at each scale as shown in Figure 4.6. The wavelet
power spectrum can be calculated as the modulus square of the wavelet transform
integrated over frequency [289],





|WT (ω, t)|2dω. (4.11)
The time average of PW provides a representation of the whole time series, which
can be used to compare between power spectra of different signals. Whilst this
may seem to be a reduction to the functionality of the Fourier transform, time-
averaged wavelet power provides superior resolution at low frequencies for time-
varying oscillations due to the logarithmic frequency scale (see Figure 4.7).
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Figure 4.6: Example of the translation of wavelets of different scales (top) across
a blood flow signal (middle) in time. The results of the convolution of the wavelet
with the time series are plotted for each scale and location (bottom).
Wavelet types
There are many different wavelets, each having its own applications. Particularly
useful are complex wavelets, which allow the separation of the phase and amplitude
components of a signal. The wavelet used in this thesis is the Morlet wavelet, a
complex wave within a Gaussian envelope, which has unit standard deviation. The
real and imaginary sinusoids differ in phase by a quarter of a period [295]. The






















Time averaged wavelet power Fourier transform
Figure 4.7: Time averaged wavelet transform vs. Fourier transform. Even when
time-averaged, the wavelet transform provides superior resolution at lower frequen-
cies for time-varying oscillations.
The wavelet coefficients obtained using the complex Morlet wavelet are complex
numbers which define the amplitude and instantaneous phase for each frequency
and time [296].
Cone of influence
The CWT integrates over infinite time, but a real data set has finite length. As
a result, the wavelet transform becomes ill-defined near the time borders, close to
t = 0 or when t approaches the length of the time series. To overcome this, the
signal can be 'padded', i.e. made longer at both ends during the calculation, and
then trimmed to retain only the original time period. Various padding regimes
are used, including zero padding, predictive padding and periodic padding [261].
Even with a padding scheme in place, boundary effects are still observed due to
the wavelet running over the edge of the time series, with the unaffected portion
of the wavelet transform known as the cone-of-influence.
Implementation
An example algorithm for the implementation of the continuous wavelet transform
is as follows:
1. Decide the frequency limits within which you require the CWT, and create
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a logarithmic scale array, noting that with the Morlet wavelet of f0 = 1,
scale=1/frequency.
2. Calculate the wavelet for each scale, and implement the convolution with the
time series. The finite duration of the time series will result in the wavelet
transform becoming ill-defined near the ends of the signal. To tackle this
problem, the signal is usually padded (see above).
3. The convolution required in the calculation of the CWT can be implemented
using the convolution theorem:
g ∗ h ≡ G(f)H(f), (4.12)
i.e. the Fourier transform of the convolution is the product of the individual
Fourier transforms of the wavelet and the time series [297]. Therefore, the
convolution of the signal and the wavelet is equal to the inverse Fourier
transform of the product of their individual Fourier transforms.
4.2.4 Interactions
Wavelet phase coherence
When using a complex wavelet such as the Morlet wavelet in the wavelet trans-
form, the wavelet coefficients will also be complex, providing amplitude and phase
information at each time and frequency. The differences between instantaneous
phases in two signals can be monitored over time using wavelet phase coherence,
which may reveal phase relationships between them [298].
Wavelet phase coherence is computed by first calculating instantaneous phases
at each time tn and frequency fk for both signals φ1k,n and φ2k,n, and then finding
their relative phase differences ∆φk,n = φ2k,n − φ1k,n. The sine and cosine compo-
nents of the phase differences are then calculated and averaged in time, and the
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phase coherence defined as [298]:
Cφ(fk) =
√
〈cos ∆φk,n〉2 + 〈sin ∆φk,n〉2. (4.13)
The phase coherence Cφ(fk) will have a value between 0 and 1, with a value of
zero suggesting that the phase difference changes continuously in time, and thus
that the oscillations are likely to be unrelated, whilst a value of 1 is indicative
of a phase relationship which remains constant in time. However, wavelet phase
coherence values at lower frequencies may be artificially high, due to them being
represented by fewer periods of oscillation in the signal. The phase coherence
between even two completely unrelated signals will increase at lower frequencies,
and tend towards 1. Thus, to distinguish true phase coherence from this low
frequency bias, surrogate data can be used to define a boundary above which
phase coherence may be considered significant. Surrogate data testing involves
the generation of time series which are identical to the one being studied in every
way except in the property of interest [299].
Time-localised phase coherence can follow time-variations in the phase rela-
tionships between two signals by using a sliding window, which can be scaled to
always contain the same number of cycles, thus removing the low frequency bias
observed in the time-averaged case [300]. At least 5 cycles of the lowest frequency
oscillation are required to calculate windowed phase coherence, which results in
the loss of information at low frequencies.
Synchronization
Synchronization is the adjustment of rhythms of oscillators to a state in which
the relationship between their phases or amplitudes remains fixed, due to their
weak interaction [301]. Here, only phase synchronization is considered, as phase
dynamics is the main focus of subsequent chapters.
The simplest representation of synchronization is the synchrogram. Based on
the marked events method discussed previously, synchronization can be detected
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between two oscillators as follows: the wrapped phase of one oscillator, usually
the slowest, is sampled at the times of the marked events of the other oscillator,
with the resultant phase values plotted against time. If these events consistently
occur at the same point in the cycle of the slow oscillator, the synchrogram will
display horizontal lines, which suggests synchronization between the oscillators.
The number of horizontal lines determines the synchronization order, for example
2 visible lines when considering one period of the slowest oscillator would mean 2:1
synchronization. Whilst initially useful, synchrograms do not provide a quantifi-
able measure, and synchronization of higher orders is cumbersome to detect with
synchrograms because of having to manually edit the number of cycles over which
to wrap the phase.
To obtain a quantifiable measure, the phase synchronization index or phase
coherence can be calculated [302]. Dynamical Bayesian inference can also be im-
plemented to detect time-varying synchronization.
Dynamical Bayesian inference
Dynamical Bayesian inference can simultaneously detect time-varying synchroniza-
tion, directionality of coupling and time-evolving coupling functions [303, 304].
Following the determination of the phases of two time series, for example using
the continuous wavelet transform, their dynamics is assumed to be described by
[303, 304, 302]
ϕ˙i = ωi + fi(ϕi) + gj(ϕi, ϕj) + ξ(t), (4.14)
where ωi is the natural frequency of the oscillation, fi(ϕi) are the self-dynamics of
the phase, gi(ϕi, ϕj) are the cross couplings, and ξ(t) is a two-dimensional white
Gaussian noise 〈ξi(t)ξj(τ)〉 = δ(t − τ)Eij, included to represent a process in a
real system. Based on the periodic nature of the system, the coupling terms are
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where k, r, s 6= 0. In practice, it is reasonable to assume that the dynamics will
be well described by a finite number of Fourier terms, denoted Ai,k(ϕi, ϕj). The
corresponding parameters from a˜i and b˜i then form the parameter vector c
(i)
k . The
inference of these parameters utilises Bayes' theorem,
pX (M|X ) = `(X|M)pprior(M)∫
`(X|M)pprior(M)dM , (4.17)
where pX (M|X ) is the posterior probability distribution and `(X|M) is the like-
lihood function for the values of the model parametersM given the data X , and




















with implicit summation over repeated indices k, l, i, j. The log-likelihood is a
function of the Fourier coefficients of the phases [303].
Assuming a multivariate normal distribution as the prior for parameters c(i)k
with means c¯ and covariances
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The inferred parameters of the coupling functions can be used to determine
whether synchronization results. The presence of synchronization provides ev-
idence that the system could be chronotaxic; however it remains unclear from

















are the Euclidean norms of the parameters. The odd parameters correspond to
the coupling terms inferred for ϕ1 in the direction 2→ 1, and the even parameters
correspond to the coupling terms inferred for ϕ2 in the direction 1 → 2. See [306]
for further details and an in depth tutorial on dynamical Bayesian inference and
its implementation.
4.3 Identifying chronotaxic systems
Once the properties of an observed system have been recognised as possibly chrono-
taxic, the next problem is how to infer these dynamics and interactions from direct
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observations, i.e. via the inverse approach. In a chronotaxic system, particularly
one found in nature, whilst the underlying dynamics is defined by the external
driver, the system will likely still be affected by other influences and noise, and
these may mask the chronotaxic dynamics if the correct analytical approach is
not applied. For example, the inherent time-variability of the frequency of the
dynamics arising from a chronotaxic system means that it cannot be characterized
accurately by any method based on averaging. This novel class of systems requires
new inverse approach methods, with the focus on the extraction and identification
of the dynamics of the drive system, and its influence on the response system.
Here, the currently available inverse approach methods are demonstrated for the
identification of chronotaxicity from a single time series of the response system in
which the phase and amplitude dynamics are separable. These methods are then
applied to numerically simulated and real experimental data.
Two distinct inverse approach methods are utilised in the detection of chrono-
taxicity [302]: phase fluctuation analysis (PFA) and dynamical Bayesian inference
(see previous section on interactions). It should be noted that the current methods
are only applicable to phase dynamics, i.e. the focus is on the ability of the time-
varying frequency to resist continuous external perturbations. The two methods
rely on different inferential bases. Phase fluctuation analysis provides a measure
of statistical effects observed in a signal, whilst the dynamical Bayesian inference
method infers a model of differential equations and gives a measure of dynamical
mechanisms, i.e. the evaluation of chronotaxicity relies on the inferred parameters
of the model. PFA is said to infer a functional connectivity, while the dynamical
Bayesian inference method infers effective connectivity [307]. The optimal method
to use depends on the characteristics of the data, as detailed below.
In order to determine whether a system is chronotaxic, one can observe the
distribution of the fluctuations in the system. If the original distribution of the
perturbations is known, then the stability of the system can be determined relative
to the unperturbed trajectory, which in a chronotaxic system is determined by the
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time-dependent point attractor. How these perturbations grow or decay over time
will depend on the degree of external influence on the system, or its chronotaxicity.
Consider a non-chronotaxic phase oscillator with noise [308],
ϕ˙x = ω0(t) + η(t), (4.22)
where ω0(t)>0 is the time-dependent natural frequency and the observed phase
ϕx is perturbed by noise fluctuations η(t). If η(t) is an uncorrelated Gaussian
process, then integrating the system will result in the dynamics of ϕx consisting
of a monotonically increasing phase perturbed by a random walk noise. However,
this is not the case in a chronotaxic phase oscillator,
ϕ˙p = ω0(t), (4.23)
ϕ˙x = εω0(t) sin(ϕp − ϕx) + η(t),
where ϕp is an external phase and |ε| > 0. Here, the point attractor prevents η(t)
from being integrated over to the same extent. This will change the distribution
of the observed noise from Brownian to something closer to white noise, and it is
this difference in the distribution in observed phase fluctuations which is exploited
in the inverse approach methods for the detection of chronotaxicity.
4.3.1 Extracting the phase estimates
Given a single time series, the first step in determining whether it contains chrono-
taxic phase dynamics is the extraction of the perturbed and unperturbed phases
of any oscillatory modes present, as described above. First, when only consid-
ering phase dynamics, the amplitude and phase should be separated using time-
frequency analysis [289]. Phase information can also be obtained via the analytic
signal generated by the Hilbert transform, but this is only applicable when there
is only one oscillation in the time series [302, 309, 310], which cannot be assumed
in real data. The continuous wavelet transform (see Section 4.2.3) provides an
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optimal time-frequency resolution for the required extraction of the instantaneous
phases of oscillations in a time series. Oscillations can then be traced in the CWT
using a ridge-extraction method [311, 312] or the synchrosqueezed wavelet trans-
form [291]. Following the extraction of the instantaneous frequencies of oscillations
via these methods, the phase ϕx of the observed system is then arg(WT (s, t)), where
s and t denote the determined positions of the oscillations. Once the estimated
perturbed phase ϕx has been extracted, the next step is to obtain the estimated
unperturbed phase ϕA∗x . In order to separate the dynamics corresponding to ϕ
A
x
from the effects of the noise perturbations η(t), it can be assumed that the dynam-
ics of ϕAx are confined to timescales larger than a single cycle, and that the noise is
weak or comparable in magnitude to this dynamics [302]. Therefore, the estimated
unperturbed phase ϕA∗x can be obtained by filtering out high frequency components
of ϕ∗x, taking care to retain the dynamics of ϕ
A
x . This can be achieved by smooth-
ing over the instantaneous frequency extracted from the wavelet transform [289].
This can then be integrated over in time to give the estimated driver phase ϕA∗x .
For increased precision of phase extraction, and determination of whether an ex-
tracted oscillatory mode is physically meaningful, nonlinear mode decomposition
may be used [261].
4.3.2 Detecting chronotaxicity
One approach to the detection of chronotaxicity is the application of dynamical
Bayesian inference to the extracted perturbed (ϕx) and unperturbed (ϕAx ) phases
in order to model their interactions. The characteristics of the coupling functions
between ϕx and ϕAx may reveal the dynamics of the system in terms of chrono-
taxicity. Bayesian inference is able to track time-dependent system parameters,
meaning that it is particularly useful for the detection of chronotaxicity in systems
which move in and out of a chronotaxic state. To detect chronotaxicity, Bayesian
inference is applied to ϕ∗x and ϕ
A∗
x (of which the latter is assumed to follow the
same dynamics as ϕp), following their extraction from the time series. The time-
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evolution of the coupling parameters for each phase is inferred and these are used
to determine the synchronization state of the system, and the direction of coupling
between the phases. In a chronotaxic system we require the driver and response
systems to be almost or fully synchronized, and also that the direction of coupling
is only from the driver ϕAx to ϕx.
The basis of this method is the calculation of the synchronization and direc-
tion of coupling of the system in order to determine chronotaxicity. However, the
more synchronized the driver is with the response system, the less information flow
occurs between the two. With less information from which to infer parameters,
most directionality methods, including Bayesian inference, become less reliable,
and whilst synchronization may still be accurately detected, the direction of cou-
pling will become less accurate the closer the system gets to synchronization. With
frequent external perturbations, intermittent transitions, and moderate dynamical
noise, there is greater information flow, and thus the inference is more precise, but
this cannot be assumed in chronotaxic systems. In real systems, the synchroniza-
tion state is not known beforehand; thus a more robust method is required, which
can identify chronotaxicity even in systems close to synchronization.
Phase fluctuation analysis (PFA) is effective even when ϕx and ϕp are almost
synchronized [302]. Given the estimates of ϕx and ϕAx , the next step is to analyse
the distribution of fluctuations in the system relative to the unperturbed trajectory
by calculating the phase fluctuations ∆ϕx = ϕ∗x − ϕA∗x .
The distribution of these fluctuations will change depending on whether the sys-
tem is chronotaxic or not. To quantify the distribution of fluctuations, detrended
fluctuation analysis (DFA) is performed on ∆ϕx [293, 112]. For uncorrelated white
Gaussian noise, as is assumed here to perturb the system, α will have a value of 0.5.
Integrated white noise (Brownian noise), which is expected in a non-chronotaxic
system, will return a DFA exponent of 1.5. In reality, a chronotaxic system is
expected to have a DFA exponent between 0.5 and 1, due to the fact that the
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Figure 4.8: (a)(c) 5-second time series of sin(ϕx) (red line) in 3 cases: chrono-
taxic, non-chronotaxic, and chronotaxic with phase slips, from Eq. 4.24. The
grey line shows ϕp (chronotaxic), and ωxt (non-chronotaxic). (d)(f) ∆ϕx for the
whole time series, detrended with a moving average of 200s. In all cases ωx,p =
2pi, h = 0.001, L = 1000 seconds and σ = 0.3. ε = 5 and 0 in the chronotaxic
and non-chronotaxic cases, respectively. DFA exponents, α, are shown. The DFA
exponent of (f) incorrectly suggests the system is non-chronotaxic. To distinguish
between a non-chronotaxic system and a chronotaxic system with phase slips, the
delayed distributions were calculated (see Section 4.3.2) in the non-chronotaxic (g)
and chronotaxic (h) case.
integration of noise may still occur. These values are presented under the assump-
tion that the noise in the system is not strong enough to cause phase slips, which
would cause perturbations to appear over larger timescales even if the system was
chronotaxic. In these cases another approach is required [302].
If there are large perturbations which cause the system to move far enough
forward or behind the current cycle to be attracted instead by an adjacent cycle,
known as a phase slip, this will result in an increased DFA exponent. This can
result from large jumps in the extracted phase fluctuations. To distinguish between
this case, a chronotaxic system with phase slips, and a non-chronotaxic system, one
can consider the fact that in the latter, perturbations may cause ∆ϕx to change by
2pi, but these are part of a continuous probability distribution, in contrast to the
chronotaxic case. Phase slips can be detected by calculating the distribution of the
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difference between the phase fluctuations ∆ϕx(t) and these fluctuations delayed
by a timescale τ . d∆ϕτx(t) = ∆ϕx(t + τ) − ∆ϕx(t) therefore gives information
about the perturbations of the system over that timescale. When phase slips are
present, the distribution of |d∆ϕτx| changes [302]. An example of this difference is
shown in Figure 4.8 (g) & (h), and can also be seen in real biological systems, as
previously demonstrated in the heart rate variability [302].
4.4 Further development of the inverse approach
to chronotaxic systems
4.4.1 Numerical simulations
The basis of the phase fluctuation analysis (PFA) method is the quantification of
the fundamental difference between phase fluctuation distributions in oscillatory
systems, depending on their chronotaxicity. Here, this characteristic is illustrated
using the simplest realisation of a chronotaxic system, two unidirectionally coupled
oscillators (see Figure 4.1(b)):
ϕ˙p = ωp
ϕ˙x = ωx − ε sin(ϕx − ϕp) + η(t), (4.24)
where ϕp and ϕx are the instantaneous phases of the driving and the driven os-
cillators, respectively, ωp > 0 and ωx > 0 are the natural frequencies of the
oscillators, ε > 0 is the strength of the coupling and η is white Gaussian noise.
Note that when ε = 0 the system is reduced to ϕ˙x = ωx + η(t) and becomes
non-chronotaxic; when η = 0 and ε > |ωx − ωp| the system becomes chronotaxic
with ϕAx (t) = ϕp(t) + arcsin((ωp − ωx)/ε). The system was integrated using the
Heun scheme [289], with an integration step of 0.001 and noise strength σ = 0.3.
∆ϕx, shown in Figure 4.8, was obtained by subtracting the unperturbed phase
(ϕAx (t) and ωxt in the chronotaxic and non-chronotaxic cases, respectively) from
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Figure 4.9: Identifying chronotaxicity in signals with more than one oscillatory
mode. (a) The first 250 seconds of a time series of a simulated signal containing
two distinct oscillations, with coupling strengths ε = 2 for mode A (chronotaxic)
and ε = 0 for mode B (non-chronotaxic). (b) The continuous wavelet transform
of the signal in (a). (c) The instantaneous frequency (light grey) of both compo-
nents is extracted from the wavelet transform, with central frequency f0 = 0.5,
and smoothed (red), using a polynomial fit. The smoothed frequency is then inte-
grated in time to obtain an estimate of the unperturbed phase, ϕA∗x , which is then
subtracted from the perturbed phase ϕ∗x as extracted directly from the wavelet
transform. (d) & (e) show ∆ϕx = ϕ∗x − ϕA∗x for each mode. (f) & (g) show the
results of DFA analysis on ∆ϕx, with DFA exponents α correctly identifying mode
A as chronotaxic and mode B as non-chronotaxic.
the perturbed phase ϕx, as obtained numerically. DFA was then performed on
∆ϕx, yielding the exponents shown in Figure 4.8. The values of the exponents
demonstrate the differences in the noise distributions between chronotaxic and
non-chronotaxic systems. In the chronotaxic case, the noise is closer to white,
whereas in the non-chronotaxic case it is closer to a random walk. It is this differ-
ence which is exploited in the PFA method.
In many systems, particularly those originating from nature, there will be more
than one oscillation present in a signal, with different chronotaxic characteristics.
To test the PFA method in the case of multiple modes, a signal containing two
distinct oscillations was simulated, with dynamics as described by Eq. 4.24, with
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Figure 4.10: Identifying chronotaxicity using phase fluctuation analysis in a
system of bidirectionally coupled oscillators. The system presented in Eq. 4.26
was simulated in two different states of chronotaxicity. (a) phase trajectories for
the system when ε1 = 0.1, ε2 = 20, ε3 = 0.1 and ε4 = 10. (b) phase trajectories of
the system with ε1 = 0.5, ε2 = 0.1, ε3 = 0.1 and ε4 = 15. (c) 5 seconds of the time
series of both drivers and oscillators for parameters shown in (a). (d) 5 seconds
time series for parameters shown in (b). (e) & (g) phase fluctuations from PFA
on sin(ϕx1) and sin(ϕx2), respectively. (f) & (h) phase fluctuations extracted with
PFA on sin(ϕx1) and sin(ϕx2), respectively.
time varying angular frequencies,
ω˙var(t) = Acos(2pifmt) + η(t)
ωx,p(t) = 2pifp,x + ωvar, (4.25)
where fp and fx are the average frequencies of oscillation in Hz of the chrono-
taxic and non-chronotaxic case, respectively, and fm is the frequency of variation.
Frequencies of oscillation were chosen to vary around 1 and 0.25 Hz in the non-
chronotaxic and chronotaxic cases, respectively, with fm = 0.003. Both systems
were perturbed with white Gaussian noise of strength σ = 0.5. The logarithmic
frequency scale of the wavelet transform is very useful for identifying and sepa-
rating the presence of oscillatory modes, which may otherwise appear as merged
in other time-frequency representations, such as the windowed Fourier transform.
Figure 4.9 shows the results of PFA on the signal. It correctly identifies mode A
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(around 0.25 Hz) as chronotaxic, and mode B (around 1 Hz) as non-chronotaxic.
In single-variable time series obtained from real dynamical systems, it is highly
unlikely that the observed dynamics will result from a simple, unidirectional con-
stant coupling as described above. Rather, the system may be influenced by con-
tinuous perturbations, couplings to other oscillators, and temporal fluctuations in
chronotaxicity. Here, the applicability of the described inverse approach methods
to these more complex cases is demonstrated. Consider a system of two bidirec-
tionally coupled oscillators,
ϕ˙p1 = ωp1 (4.26)
ϕ˙p2 = ωp2
ϕ˙x1 = ωx1 + ε1 sin(ϕx1 − ϕx2)− ε4 sin(ϕx1 − ϕp1) + η(t)
ϕ˙x2 = ωx2 + ε2 sin(ϕx2 − ϕx1)− ε3 sin(ϕx2 − ϕp2) + η(t),
with drivers ϕp1 and ϕp2, and ωp1(t) = 2pi − 0.5 sin(2pi0.005(t)) and ωp2(t) =
pi − 0.5 cos(2pi0.005(t)). First, the case of strong influence of the driver ϕp1 on
the system is considered, resulting in chronotaxicity of both oscillators. Phase
fluctuation analysis was applied to the system, and successfully identified both
ϕx1 and ϕx2 as chronotaxic (see Figure 4.10(a)).
Secondly, the case in which ϕx1 is chronotaxic but ϕx2 is not is demonstrated.
One can observe that despite continuous influences from multiple drivers and other
oscillators, single variable time series arising from the same system can be distin-
guished in terms of their chronotaxic dynamics. Again, PFA correctly distinguishes
between the two oscillators. This could be of great importance when investigating
composite parts of a larger dynamical system, and seeking to identify causal rela-
tionships between observed oscillations. For example, recent advances in cellular
imaging are providing the means to observe the dynamics of individual cellular pro-
cesses in different cellular compartments [313]. Applying inverse approach meth-
ods for the detection of chronotaxicity to these dynamics could provide valuable
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information on the current state of the cell (see Chapter 7).
So far, only those scenarios in which a system constantly remains as either
chronotaxic or non-chronotaxic have been considered. Real dynamical systems
may exhibit time variation in their coupling strengths, allowing the system to
fluctuate between chronotaxic states. In these cases, it is possible to use dynamical
Bayesian inference to track variations of chronotaxicity in time. To demonstrate
this, ε3 was allowed to vary in time in Eq. 4.26, whilst ε1 = ε2 = 0.1 and ε4
= 0, resulting in intermittent chronotaxicity of the oscillator ϕx2. ϕA∗x2 and ϕ
∗
x2
were extracted from the wavelet transform of sin(ϕx2). Results of the application
of dynamical Bayesian inference to these extracted phases are shown in Figure
4.11. This method is able to track the intermittent changes in chronotaxicity,
through changes in synchronization and direction of coupling, demonstrating its
usefulness for the detection of chronotaxicity in systems where the interactions
between oscillators are time-varying, particularly when the system is intermittently
chronotaxic.
4.4.2 Practical considerations
Both presented methods, phase fluctuation analysis and dynamical Bayesian in-
ference, rely on precise phase extraction of the estimated attractor ϕA∗x and the
perturbed dynamics ϕ∗x. Therefore, the parameters in the respective methods must
be carefully selected depending on the characteristics of the given data.
The continuous wavelet transform provides an optimal compromise between
time and frequency resolution. In the majority of examples used here, f0 = 1
has been used. However, the wavelet central frequency, f0, can be altered to suit
specific needs. For example, in a case where there are many phase slips, it may
be necessary to extract the estimate of the attractor, ϕA∗x , with a higher f0 to
obtain a better frequency resolution and smoother dynamics, whilst the perturbed
phase ϕ∗x is extracted using a lower f0, leading to an increased time resolution for
the purpose of locating each phase slip. The parameter f0 may also be increased
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Figure 4.11: Identifying intermittent chronotaxicity using dynamical Bayesian
inference. Bayesian inference was performed on ϕ∗x2 and ϕ
A∗
x2 extracted from
sin(ϕx2) (Eqs. 4.26) with ε3 varying as shown in (d). (a) the CWT of sin(ϕx2).
(b) Instantaneous frequencies extracted from the wavelet transform. ϕA∗x2 was ex-
tracted with f0 = 2 and smoothed using a polynomial fit (red line), whilst ϕ∗x2
was extracted from the CWT with f0 = 0.5 (grey line). Bayesian inference was
applied, using a time window of 90 seconds. The inferred direction of coupling D
can be seen in (c). Positive values show coupling from the driver to the oscillator
only. (d) Isync was calculated and shows excellent agreement with changes in ε3.
Ichrono was also calculated, and was slightly less accurate due to the direction of
coupling becoming negative very briefly, due to reduced information flow between
systems to accurately infer parameters during synchronization.
to provide greater distinction between oscillatory modes, but this will be at the
expense of time resolution. It should be noted that modes must be separable in
time-frequency representations in order for these inverse approach methods to be
applicable.
One fundamental assumption of chronotaxicity is that the system under con-
sideration is oscillatory. Although the presented methods can be applied to any
extracted phases, one should take great care to ensure that these phases corre-
spond to a true oscillatory mode, otherwise all results will be meaningless. In the
numerical simulations presented here, the characteristics of the oscillations which
are present are predetermined, and not concealed by noise, allowing their success-
ful extraction directly from the wavelet transform. These extracted phases can be
verified using the specified parameters as a reference signal, and thus the reliability
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of the final results can be verified. On the contrary, in real experimental data, the
first question must be whether the signal contains any significant oscillations at all.
To determine whether this is the case, the recently developed method of nonlinear
mode decomposition (NMD) may be used. NMD is an adaptive, time-frequency
representation based decomposition tool, which decomposes any given signal into
a set of physically meaningful oscillations (if present) and residual noise. In the
detection of chronotaxicity, the crucial advantage of NMD over other decomposi-
tion methods, such as empirical mode decomposition (EMD) or bandpass filtering,
is its use of surrogate data testing in order to distinguish between deterministic
and random activity [261]. The success of surrogate testing for the identification of
nonlinear oscillatory modes in neural data has also been demonstrated previously
[314], and more generally in [315]. By verifying the presence of oscillations, and
their underlying nature, e.g. whether they are nonlinear, these methods reliably
inform the user which analysis approach to take. In this way, it is ensured that any
oscillatory modes extracted from real experimental data are physically meaningful,
and that their characteristics, including their instantaneous phases, are accurately
determined. Once a significant oscillatory mode has been located and extracted
using NMD, its smoothed instantaneous frequency provides ϕA∗x for use in phase
fluctuation analysis, ϕ∗x can then be extracted from the wavelet transform as be-
fore, with the parameter f0 chosen to give sufficient time resolution to follow the
noise fluctuations which are removed by NMD. An example of the use of NMD in
PFA is provided in Figure 4.13, and explained further in the application to brain
dynamics below.
The reliability of the presented inverse approach methods increases with data
availability, i.e. a longer time series will give a more reliable result. However, when
recording data from biological systems, it is not often feasible to collect hundreds
of cycles of oscillation. When recording data from live subjects, for example blood
flow recordings, the time of recording must be a compromise between long time
series and subject comfort. In the case of cellular recordings, such as cell mem-
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brane recordings via the patch clamp technique, the health of the cell can rapidly
deteriorate, and thus affect the reliability of results. Therefore, it is useful to de-
termine the lowest possible number of recorded oscillations for which we may still
reliably test for chronotaxicity.
In order to address this question, two unidirectionally coupled phase oscillators
(Eq. 4.24) were simulated for 1000 cycles with frequencies 1 and 0.1 Hz, with h =
0.01 and σ = 0.07. With coupling ε = 2, the system is chronotaxic. The important
parameters to consider in DFA are nmin and nmax, the lower and upper values for
the range of the first order polynomial fits performed in order to calculate α.
The lower value, nmin, is set to be 2 cycles of the slowest oscillation, to ensure
observation of the dynamics over a longer range than one cycle. The smallest nmax
required to still obtain a reliable DFA exponent was observed to be nmax = 3 cycles
of oscillation (see Figure 4.12), provided that the time series is sufficiently long.
The second test seeks to identify the required length of the whole time series when
using these values of nmin and nmax in DFA. The DFA exponent was calculated
from varying lengths of the same noise signals, from 3 to 10 times nmax, to identify
the point where the result is no longer reliable. It was found that the time series
should be at least 8 times nmax in order to obtain a reliable result, therefore at least
24 cycles of the slowest oscillation are required to test for chronotaxicity. However,
if possible, the time series should be at least 10 times nmax [316], to reduce noise by
providing more data windows. Overlapping within DFA is also possible, and will
go some way toward reducing noise, and improve reliability. The results shown in
Figure 4.12 were obtained with an overlap of 0.8.
Whilst the value of the DFA exponent α is expected to be around 0.5 in a
chronotaxic system, and 1.5 in a non-chronotaxic system, it is unlikely to be so
definitive in reality. In fact, the value of α will depend on a number of factors. The
type of noise in a real system is not necessarily white; however the point of phase
fluctuation analysis is to identify changes in its distribution. α will also vary de-
pending on how strong the chronotaxicity is in the system, i.e. how strongly driven
91
Figure 4.12: In order to test the reliability of the DFA exponent when reducing
nmax, the maximum number of cycles of oscillation used in its calculation was
varied. (a) chronotaxic oscillation of 1 Hz. (b) chronotaxic oscillation of 0.1 Hz.
(c) non-chronotaxic oscillation of 1 Hz. (d) non-chronotaxic oscillation of 0.1 Hz.
The same noise signals were then tested with nmax = 3 for different lengths of
the time series from 10 to 3 times nmax. Based on these results, the time series
should be at least 8 times nmax, thus, there should be at least 24 oscillations in
the time series. However, to ensure universal applicability, the length of the time
series should be at least 10 times nmax, the generally accepted value in DFA [316],
resulting in the requirement of 30 cycles.
the observed oscillator is. In the models presented here, this can be represented
by varying the coupling strength ε; weaker coupling will result in a higher DFA
exponent as the noise is partially integrated. The ratio of the natural frequency
of the chronotaxic oscillator to the frequency of the external driver, or detuning,
may also affect the value of α.
4.4.3 Application to brain dynamics
Chronotaxicity will manifest in nature as a result of a driving system which is
strong enough such that the oscillatory response system maintains stability in its
frequency and amplitude, even when subject to continuous external perturbations.
Chronotaxicity was previously demonstrated in the heart rate variability (HRV)
[302], when influenced by paced breathing. It has been shown that the main
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direction of coupling between the cardiac and respiratory oscillators is the influ-
ence of the respiration on the heart rate, known as respiratory sinus arrhythmia
(RSA), and this was clearly demonstrated. Here, an example of the application of
phase fluctuation analysis to real experimental data is provided, in the form of an
electroencephalogram (EEG) recording from an anaesthetised human subject.
Distinct oscillations have long been observed in brain waves, as recorded by
EEG. Briefly, from lowest to highest frequency, there are at least 5 frequency
bands which have been identified in approximately the following frequency inter-
vals: delta (0.84 Hz), theta (47.5 Hz), alpha (7.514 Hz), beta (1422 Hz) and
gamma (2280 Hz). Different frequencies of oscillation have been attributed to
distinct states of the brain. For example, the alpha and theta bands have been
shown to reflect cognitive and memory performance [317]. One active area of re-
search utilising the information provided by these oscillations is in attempts to
quantify the depth of anaesthesia based on their temporal evolution in different
states of consciousness. Despite the worldwide use of general anaesthesia (GA)
daily, the mechanisms leading to this state are still poorly understood in terms of
how it truly affects the brain. Thus, brain-state monitoring is still not an accepted
practice in GA, due to the lack of reliable markers [318]. However, recent studies
in which the spectral power of the oscillations in different frequency bands has
been tracked both temporally and spatially during anaesthesia with propofol have
shown promising results. For example, it was shown that during consciousness,
alpha oscillations are concentrated in occipital channels, whilst during propofol
induced anaesthesia, these oscillations are concentrated in frontal channels [318].
An increase in power in the frequency interval 0.11 Hz (delta) was also observed
in this study during anaesthesia. Understanding the mechanisms underlying these
changes in brain function could not only lead to new approaches to anaesthesia
monitoring but may be widely applicable in many areas of neuroscience, including
in the study of various neurological disorders.
It has been clearly demonstrated that phase interactions are highly important
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Figure 4.13: Example of the application of phase fluctuation analysis to an
EEG signal obtained from the forehead of an anaesthetised patient, shown in
(a). (b) The continuous wavelet transform of the EEG signal in (a). (c) Using
nonlinear mode decomposition (NMD)(see text), a significant oscillatory mode in
the alpha frequency band was identified and extracted (dark grey line). (d) The
instantaneous frequency extracted using NMD (grey line), and smoothed using a
moving average of 4 seconds (red line). (e) The extracted phases of the mode from
NMD (grey), smoothed NMD (red), and from the CWT (black) with f0 = 1.5.
(f) ∆ϕx was calculated as ϕ∗x − ϕA∗x . The DFA exponent was calculated and was
1.57, suggesting that the system is not chronotaxic. Checking for phase slips in
(g) shows no change in distribution.
for healthy brain functioning, with by far the most widely reported observations
revolving around phase synchronization, which can, as an example, be used to
infer information about short and long range behaviours [319]. Brain waves arise
from networks of synchronized neurons, and the detected phase of these oscilla-
tions determines the degree of excitability of the neurons, and influences precise
discharge times of the cells in the network, therefore affecting relative timing of
action potentials in different brain regions [320].
The problem of the extraction of phase from EEG data has been approached
from many directions, some more physically meaningful than others. Early ap-
proaches to the investigation of phase interactions between brain waves used spec-
tral coherence, but this does not separate phase and amplitude components, thus
amplitude effects may influence coherence values when only phase locking infor-
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mation is required [321]. A widely used phase extraction approach is the use of
the Hilbert transform (see above) to obtain the analytic signal [322], usually pre-
ceded by band-pass filtering in the frequency interval of interest, highlighting the
necessity of the separation of the oscillation of interest from background brain ac-
tivity, either other oscillations or noise. Lachaux et al. recognised the necessity of
the separation of amplitude and phase when seeking to detect synchrony between
brain waves, introducing phase-locking statistics (PLS) [321] to measure the phase
covariance between two signals, verified by surrogate testing. This method also
allows for non-stationarity in the signal. However, based on very narrow band-pass
filtering, this method does not allow for time-variability in the natural frequency of
oscillation, but it did highlight the usefulness of complex wavelets in the extraction
of phase dynamics. The Hilbert transform and wavelet convolution methods were
compared in the analysis of neural synchrony, and found not to differ substantially
[323], but both these methods relied on narrow band-pass filtering beforehand.
However, the use of band-pass filtering to extract an oscillatory EEG component
with a time-varying frequency has limited usefulness. An instantaneous frequency
defined from the analytic signal obtained from band-passing in a particular fre-
quency range in a real signal containing multiple spectral components and noise
may be ambiguous and meaningless [319]. To address this problem, ridge extrac-
tion methods [311] applied to the complex wavelet transform were used to track
the instantaneous frequency of a single oscillatory mode [319], providing a much
higher precision of phase extraction, and importantly allowing the phase dynam-
ics of nonautonomous systems to be traced accurately in time. Another, rarely
considered, issue when tracing instantaneous frequencies in time is the presence
of high harmonics in the signal. Narrow restriction of the frequency range will
remove these harmonics, and thus remove valuable intra-cycle phase information.
This issue has been addressed directly by the introduction of nonlinear mode de-
composition [261]. The inverse approach methods applied here take into account
all these issues in order to extract accurately the instantaneous phase of brain
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oscillations.
In order to demonstrate the method and search for evidence of chronotaxicity
in the phase dynamics of brain waves, phase fluctuation analysis was applied to
a real EEG signal. The EEG of an anaesthetised subject was recorded for 20
minutes at 1200 Hz (Figure 4.13 (a)) by researchers involved in a previous study -
Brain, Respiration And Cardiac Causalities In Anaesthesia (BRACCIA) (see ethics
declaration). The signal was resampled to 100 Hz by splitting the time series
into windows, and setting their mid-point to their mean. As expected, strong
oscillations were observed in the alpha and delta frequency bands. Nonlinear
mode decomposition extracted the oscillatory mode around 10 Hz in the alpha
frequency band and identified it as physically meaningful through surrogate testing
(Figure 4.13 (c)). The instantaneous frequency of this mode was then smoothed
using a moving average of 4 seconds. This value was chosen to provide the best
match between the instantaneous phase of the extracted nonlinear mode ϕx and
its smoothed version ϕA∗x . As NMD by nature removes the noise from the modes
which it extracts, ϕ∗x must then be extracted from the continuous wavelet transform
with a time resolution which will allow the noise fluctuations to be included in the
extracted mode. Here, it is very important to check that the extracted phase
corresponds to that extracted using NMD (see Figure 4.13 (e)). Once the viability
of the extracted fluctuations is confirmed, ∆ϕx can be calculated as ϕ∗x − ϕA∗x .
The DFA exponent of ∆ϕx was then calculated, and was 1.57. The distribution
|d∆ϕτx| was calculated to check for phase slips in the extracted phase fluctuations,
but the distribution did not change over any timescale, τ .
The analysis suggests that the alpha oscillation as extracted is not chronotaxic.
However, the current inverse approach methods are based on a single point attrac-
tor and single response system. As discussed by Sheppard et al. [324], the spectral
peaks observed in the EEG, including those observed in the alpha band, result
from frequency synchronization between thousands of neurons. In this sense, the
observed phase is in fact only a statistical measure, highlighting the preferred phase
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of the underlying ensemble of neurons. A method to quantify this was provided by
the mean-field variability index, κ, which changes depending on the interactions
in the observed network of oscillators [324]. For a non-interacting network, with
purely random phasors, κ will converge to 0.215, whereas in a state of complete
phase synchronization, κ will tend to zero. Based on the current assumptions of the
inverse approach methods, if the detection of chronotaxicity relied only on phase
dynamics, we would expect the value of κ to tend to zero in a chronotaxic system.
However, when applied to real EEG data, κ was actually greater than 0.215 in
most cases, suggesting amplitude synchrony (possibly intermittent), intermittent
phase coherence, or both. Therefore, it is apparent that in the case of brain dy-
namics, to truly test for chronotaxicity, it must be reconsidered within a network
of many oscillators, as known to be present in the brain, rather than the relatively
low numbers of coupled oscillators considered here. Here, the driving system may
be a subnetwork of synchronized oscillators or the mean-field or mean-phase of
ensembles of neurons, influencing other areas of the brain in complex ways, with
both temporal and spatial dynamics to take into account.
The presented methods are also restricted by the fact that they are currently
only applicable to determining chronotaxicity in phase dynamics. Traditionally, in
brain dynamics, it is the amplitude of the oscillations observed in the distinct fre-
quency bands which receives the most attention, although consideration of phase
dynamics is gaining popularity [325]. In addition to the dynamics within indi-
vidual frequency bands, there are also interactions between frequency bands [326],
known as cross frequency coupling (CFC). CFCs have not only been observed man-
ifesting themselves as phase-phase interactions [327], but also as amplitude-phase
[328] and amplitude-amplitude interactions [329]. Whilst some efforts have been
made to isolate phase information in neural oscillations [330], the importance of
amplitude-phase interactions cannot be ignored, for example the observed modu-
lation of gamma amplitude by the phase of theta oscillations has been identified as
a code utilised in multi-item formation in the brain [331]. Other functional roles
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of amplitude-phase coupling have also been highlighted [332]; thus it is clear that
both amplitude and phase must be considered simultaneously to characterise brain
dynamics accurately. Indeed, phase-amplitude coupling has been demonstrated
during anaesthesia [333], meaning that the current inverse approach methods may
be insufficient to determine chronotaxicity in this system.
4.5 Summary
The recent formulation of chronotaxic systems provided a completely novel ap-
proach to the characterisation of time-varying dynamics in real data. Crucially,
it provides a framework in which systems may be time-varying, both in terms of
their amplitude and phase dynamics, continuously perturbed, and yet still exhibit
determinism. Whilst the apparent complexity of some real time-varying oscillatory
systems previously led to their consideration as stochastic or chaotic, chronotaxic-
ity facilitates a much more natural approach to the description of their dynamics.
The introduction of this approach required the development of new inverse ap-
proach methods for the detection of chronotaxicity in time series arising from
dynamical systems. Here, the currently available methods for the identification of
chronotaxicity from a single time series were reviewed, and various issues regard-
ing their implementation were expanded, in order to facilitate the application of
the methods to any data set containing at least one oscillatory component. This
ability to characterise oscillations in terms of their chronotaxicity, i.e. to deter-
mine whether the observed dynamics arise as a result of influence from an external
driver, provides the potential to unlock new information about dynamical systems
and their interactions with their environment.
As they currently stand, the inverse approach methods for the detection of
chronotaxicity are only applicable in systems in which the amplitude and phase
dynamics are separable, as they are applied directly to the extracted phases of the
system, and all amplitude information is discarded. This assumption is valid if one
is considering that the amplitude dynamics of a chronotaxic system corresponds
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to the convergence of the system to the limit cycle, influenced only by a nega-
tive Lyapunov exponent and external perturbations, whilst the phase dynamics
corresponds to convergence to the time-dependent point attractor, which is also
characterized not only by a negative Lyapunov exponent and external perturba-
tions, but also by the motion of the point attractor itself [302]. As it is this point
attractor in phase dynamics which we are interested in, separation of amplitude
and phase follows naturally. Using this approach, an example of chronotaxic dy-
namics was successfully demonstrated in a real system, in the case of heart rate
variability [302]. However, in generalized chronotaxic systems [287], the amplitude
and phase are not required to be separable, providing even greater applicability
to real systems, allowing amplitude-amplitude and amplitude-phase interactions,
in addition to the phase-phase dynamics considered in [285, 286]. Therefore, the
incorporation of the ability to identify these new possibilities for chronotaxicity
is crucial in the further development of these inverse approach methods. This
will then provide the means to detect chronotaxicity in systems where amplitude
and phase are not separable, as previously discussed in the case of brain dynamics.
The current definition of chronotaxicity is based on a time-varying point attractor,
exerting influence over a system such that it can remain stable despite continuous
external perturbations. Numerical results presented here assume that this point
attractor results from a single oscillatory drive system, acting on a maximum of
two coupled oscillators. However, as highlighted in the brain dynamics example,
in reality it must be considered that this point attractor could result from multiple
interacting influences, for example a network of oscillators, perhaps acting as one
synchronized drive system.
Regardless of the mechanisms of the underlying oscillations, if they manifest
as a point attractor, characterisation of their chronotaxicity necessitates the ap-
plication of methods which can extract both their phase and amplitude dynamics
with utmost accuracy. Methods reliant on averaging do not provide the required
precision. Both amplitude and phase information can be extracted from the con-
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tinuous wavelet transform, a fact which may be utilised in the further development
of inverse approach methods for the detection of chronotaxicity. Extending these
methods to simultaneously take into account both phase and amplitude dynamics,
whilst incorporating the effects of their couplings, may lead to a method based
on an optimal combination of time-frequency representations and effective con-
nectivity methods such as dynamical Bayesian inference. This will then provide
even wider applicability to real oscillatory systems such as those observed in brain
dynamics.
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5. Blood flow dynamics in skin
melanoma
Skin melanoma provides a unique opportunity to monitor the blood flow of a ma-
lignant tumour in vivo. In this chapter, it will be described how blood flow data
obtained from the Hospital of Pisa, Italy, were analysed using the techniques dis-
cussed previously to investigate whether blood flow dynamics is altered in skin
malignant melanoma. The results provide insights into the physiological mecha-
nisms of melanoma vasculature, and were used in the development of a noninvasive
diagnostic test which may prevent many unnecessary biopsies if verified in a larger
study.
5.1 Cancer
In cancer research, attempts to reduce problems to their smallest possible con-
stituents has provided a wealth of new knowledge in fields such as molecular biol-
ogy and genetics, but a general cure for all cancers seems unfeasible when viewed
from these angles, due to their huge variability between cancer types. New col-
laborations with scientists from increasingly varying fields is leading to exciting
new perspectives on old problems, with attempts to quantify and understand the
characteristics that all cancers have in common, in addition to how they vary.
These `hallmarks of cancer' are: self sufficiency in growth signals and insensitivity
to anti-growth signals, limitless replicative potential, resistance to cell death, abil-
ity to invade tissues and metastasize, and induction of angiogenesis [334]. There
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Figure 5.1: Diagram showing the layers, components and different cells types
found in the skin. Modified from [335]
are also further emerging hallmarks receiving attention in their own right; the re-
programming of energy metabolism and the evasion of immune destruction [134].
This chapter will focus mainly on the effects of angiogenesis, whilst chapter 7 will
address the widely observed phenomenon of altered energy metabolism in cancer
cells.
5.1.1 Skin cancer
Skin cancers are usually divided into two groups, melanoma and non-melanoma
skin cancers (NMSC), of which the latter account for 90% of all skin cancers
registered in the UK and Ireland [336]. There are two main layers in the skin,
the upper layer, or epidermis, and the layer beneath it, known as the dermis (see
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Figure 5.1). The epidermis is made up of three types of cells, squamous cells, basal
cells and melanocytes, all of which may become cancerous, with varying prognoses.
Basal cells are located at the bottom of the epidermis and their carcinogenesis
results in basal cell carcinoma (BCC). BCC is the most common skin cancer in
the UK and Ireland, accounting for 74% of all NMSC diagnoses [336]. It is usually
very slow growing, almost never spreading to other parts of the body, although
it can, very rarely, spread downwards into deeper tissues, and sometimes bones,
causing treatment to be much more difficult. BCC generally begins as a small
shiny red spot, that may bleed, or develop into an ulcer that will not heal. When
found at an early stage, basal cell carcinoma is most likely to be completely cured,
though some may come back after treatment, known as local recurrence.
Squamous cell carcinoma (SCC) is a cancer of the cells called keratinocytes,
also found in the epidermis. SCC is the second most common skin cancer in the
UK, accounting for 23% of NMSC [336]. Squamous cell carcinoma is a slow growing
cancer, and is rarely aggressive, only spreading if left for a very long time. The
prognosis for SCC is generally very promising.
In contrast, melanoma is the skin cancer with the worst prognosis. Whilst
accounting for only a small proportion of overall incidence, melanoma is responsible
for 75% of all skin cancer related deaths in the USA [337]. Melanoma develops from
melanocytes, found at the very bottom of the epidermis. Half of all melanomas
start in normal skin, with the other half developing from pre-existing moles. New
cases of melanoma continue to increase, especially in young women (15-34) [338].
Skin cancer is still most common in older people, however, as the risk of most
cancers rises with age. Risk factors for melanoma include fair skin, excessive UV
light exposure, sunburn, previous occurrence of melanoma and reduced immunity.
Skin cancer is very rare in children under 14, and also in people with black or
brown skin, as their higher melanin levels provide more natural protection from
the harmful UV rays of the sun. Melanomas grow very quickly, and soon spread to
surrounding layers of skin, underlying tissues and then the rest of the body via the
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circulatory system. Therefore, early diagnosis is most crucial in melanoma above
all skin cancers.
5.1.2 Hypotheses
Combining the aforementioned time-frequency analysis methods and the coupled
oscillator model of the cardiovascular system as observed in blood flow provides
the tools to test the following hypotheses:
1. Blood flow regulation within a skin malignant melanoma differs from both
healthy skin, and other non-cancerous lesions which share similar character-
istics, such as atypical naevi, benign naevi and psoriasis.
2. Differences which arise may be used in the development of a diagnostic test
which can differentiate between malignant melanoma and atypical naevi.
5.2 Experimental protocol
To test these hypotheses, 94 patients in total were recruited in the dermatology
unit of the University Hospital of Pisa from February 1st 2011 to May 30th 2013.
55 of these subjects presented with clinically atypical naevi, suspected as malignant
melanoma by a dermatologist, and were sent for excision of the lesion of interest
and subsequent histological examination. A clinically atypical naevus was defined
as a skin melanocytic lesion which shared at least three of the clinical features of
melanoma (asymmetry, border irregularity, colour variability or a diameter greater
than 6mm [179]). As a control group, 30 clinically healthy patients were recruited
with typical benign naevi, also known as common moles. Nine patients with
psoriasis were also included in the study, as further controls. Psoriasis patients
were included due to their similar pathology to melanoma, including excessive
cell proliferation and angiogenesis [186], in an attempt to isolate the effects of
cancer on blood flow regulation from those known to be induced by inflammation
[339]. During histological examination, out of the 55 atypical lesions studied,
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Lesion type






Abdomen (1), leg (3), flank (1),






Clavicle (1), leg (6), chest (1),
flank (1), shoulder (6), lumbar
(2), thorax (7), gluteal (2),







Arm (3), ankle (1), shoulder (4),
foot (3), leg (6), flank (1), thorax
(2), front (1), side (1), abdomen








Clin. diagnosed 9 9(8) 3576 (63) Leg (6), shoulder (1), arm (1),
flank (1)
Table 5.1: Type, gender, age and location information for all subjects studied.
11 resulted in a positive diagnosis for melanoma, 33 were defined as histologically
atypical and 11 were histologically typical. For the purposes of blood flow dynamics
analysis, the 11 clinically atypical yet histologically benign lesions are considered
in the benign group, whilst during calculation of any diagnostic test they will
be considered atypical, due to the initial diagnosis which they received. Patient
information can be found in Table 5.1.
Blood flow monitoring was carried out on all recruited subjects using laser
Doppler flowmetry (LDF). Recordings occurred in the morning in an air condi-
tioned room (22-24oC), with the subject in supine position, after an acclimatization
period of 20 minutes. Subjects were asked to abstain from food, drugs, alcohol,
coffee and tea for 8 hours prior to the measurement. Following acclimatization,
blood flow was monitored in two locations, at the centre (geometric mean) of the
lesion of interest and in the contralateral location on healthy skin. In all cases but
psoriasis, a further recording was made immediately following these two, at the
105
Figure 5.2: Diagram of the laser Doppler probe placed above the lesion of interest,
in this case a melanoma lesion.
lesion margin. All recordings were for 30 minutes. Blood flow was measured using
single point LDF apparatus (Periflux PF4, Perimed, Jarfalla, Sweden) equipped
with an unheated probe (PF408). The probe had a fibre separation of 0.25mm.
This allows skin blood flow to be detected in a tissue volume of around 1 cubic
millimetre. Blood flow is expressed as arbitrary perfusion units (PU) of output
voltage (1 PU = 10mV). The LDF probe was fixed to the lesion of interest using
an annular double sided adhesive disc (see Figure 5.2). The laser characteristics
were: wavelength  780nm, bandwidth  10 Hz-19 kHz, time constant  0.1s, sam-
pling frequency  32 Hz. Probe calibration was performed before each session
using a specialized device (Perimed, Jarfalla, Sweden) containing colloidal latex
particles whose Brownian motion provides standardised values. Blood flow signals
were recorded continuously by an interfaced computer (Compaq, Hewlett Packard,
Netherlands) equipped with dedicated software (Perisoft, Perimed, Jarfalla, Swe-
den).
5.2.1 Exclusion criteria
Patients were excluded if they had one or more of the following conditions: age
> 80 years, congestive heart failure, recent myocardial infarction, serious cardiac
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arrhythmia, chronic inflammatory diseases, other neoplastic diseases, untreated
arterial hypertension, severe liver diseases, untreated type 2 diabetes mellitus,
type 1 diabetes mellitus, severe renal failure and haemodialysis treatment.
5.3 Analysis
5.3.1 Pre-processing
Signals were inspected for viability prior to analysis. Following this inspection,
5 subjects were removed from the analysis, due to erroneous spikes in the data,
most likely an optical effect. Movement artefacts and other obviously non-physical
events in the data were removed using either linear interpolation or by trimming
the signal. This resulted in a final data set of recordings from 10 melanomas, 33
atypical naevi, 37 benign naevi and 9 psoriasis lesions.
Other artefacts which appeared to be noise could result from different skin
types, for example glabrous skin, or heterogeneity of the area under observation,
and so were included. Every effort was made to retain as much original data
as possible, whilst removing unphysiological artifacts which would greatly alter
the results. In a clinical setting, these artefacts could be minimised by producing
hardware specifically designed to deal with these skin lesions, for example improved
probe attachment.
Prior to analysis all data were detrended using a moving average method to
remove low frequency information below the scope of this study, i.e. below the
lower limit of the lowest endothelial interval VI at 0.005 Hz, requiring a window
size of 200 seconds.
5.3.2 Statistics
The distribution of any group to be compared was tested using the Lilliefors test
for normality, which did not consistently find normal distributions of data in any
case. Therefore, all statistical tests used were non-parametric, i.e. did not assume
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an underlying distribution, facilitating more robust conclusions. When all groups
were compared, the Kruskal Wallis ANOVA test was used. The Kruskal Wallis
test is used to test whether two or more independent samples originate from the
same distribution, and does not assume a normal distribution. If significance was
found by this, then pairs of groups were then tested using either the Wilcoxon
signed rank test for paired data, or the Wilcoxon rank sum test for unpaired data
[340]. The signed rank test is used to test whether two matched samples come
from the same distribution, whilst the rank sum test does not require that the
samples are matched. For example, to compare two groups of simultaneous blood
flow recordings within a group, recorded on opposite sides of the body, the signed
rank test would be used. In contrast, to compare the blood flow recordings on
the left side of the body in one group (e.g. melanoma), to those recorded in
another group (e.g. benign), the rank sum test would be used. Both tests involve
the summation of ranks. Linear regression was computed using the Theil-Sen
estimator [341, 342] which is a nonparametric method for simple linear regression
which is very robust to outliers, and correlation quantified by Kendall's τ [343],
which is a measure of rank correlation (the similarity of the orderings of the data
when ranked). Significance was considered as p < 0.05. All boxes in box and
whisker plots demonstrate the median and 25th and 75th percentiles of the data.
The lowest point of the whiskers is located at q1−w(q3− q1) and the highest point
at q3 + w(q3 − q1) where q1 and q3 are the 25th and 75th percentiles, respectively.
w was 1.5 by default [344]. Points outside this range were classed as outliers.
5.3.3 Time domain analysis
Heart rate and heart rate variability
Instantaneous heart rates were calculated by extracting the cardiac oscillation from
the blood flow signals recorded in each subject using nonlinear mode decomposi-
tion. Mean heart rates were calculated as the mean of these extracted signals.
Significant differences in mean heart rate were found between groups (p = 0.0049),
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Average blood flow (PU)
Centre Margin Contralateral
Melanoma 126.8 (80.0158.6) 77.1 (53.491.8) 14.2 (11.820.6)
Atypical naevi 15.2 (10.129.1) 16.6 (10.432.5) 12.5 (10.816.0)
Benign naevi 18.6 (9.523.9) 19.1 (12.228.0) 13.9 (11.716.9)
Psoriasis 111.3 (85.8125.6) N/A 15.7 (9.817.5)
p 0.0000 0.0004 0.5662
Table 5.2: Medians (inter quartile range) of the means of all blood flow signals
in perfusion units (PU) for lesion centres, lesion margins and contralateral skin. p
values are as calculated for each location using the Kruskal Wallis test. n = 9, 10,
33 and 37 for psoriasis, melanoma, atypical naevi and benign naevi respectively.
with the melanoma group exhibiting significantly higher heart rates than all other
groups except psoriasis (see Figure 5.3). This may be a result of the significant
difference in the distribution of ages between groups, with the melanoma and pso-
riasis groups having a higher median age than the atypical and benign groups. It
has previously been shown that mean heart rate increases with age, and also that
this effect varies with gender [345]. However, there was no significant correlation
between age and mean heart rates when considering all subjects (τ = 0.1123, p
= 0.1230). Standard deviation of heart rate was calculated from the extracted
instantaneous heart rates for each group, and were found not to differ significantly
between groups (p = 0.0622). A significant negative correlation was observed be-
tween age and heart rate variability (τ = -0.3234, p = 0.0000). This effect has
been previously demonstrated in healthy individuals [112] and therefore cannot be
linked to the presence of melanoma or psoriasis.
Mean blood flow
Mean blood flows were calculated for all subjects and locations (Table 5.4). Blood
flow recorded at lesion centres differed significantly between groups (p = 0.000).
This significance arose from the increased blood flow in melanoma and psoriasis
when compared with both atypical and benign naevi. No difference was found
between melanoma and psoriasis (p = 1), or atypical and benign naevi (p = 0.7418)
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Figure 5.3: (a) Box and whisker plots of mean heart rate for all groups studied.
(b) Scatter plots of age vs. mean heart rate (c) Box and whisker plots of standard
deviation of heart rate calculated for all groups. (d) Scatter plot of age vs. standard
deviation of heart rate for all groups. M  melanoma (n =10), P  psoriasis (n
=9), A  atypical naevi (n =33), AB  histologically benign naevi (n =11), B 
clinically benign naevi (n =26). Outliers in boxplots are shown as red crosses. ns
= not significant. *** = p < 0.001. Theil-Sen regression lines are shown in red in
(b)&(d).
Blood flow recorded at lesion margins also differed significantly between groups (p
= 0.0004), with melanoma mean blood flow significantly higher than both atypical
(p = 0.0007) and benign lesions (p = 0.0000). As in lesion centres, blood flow
in atypical and benign lesions did not significantly differ at lesion margins (p =
0.9531), see Table 5.3. Contralaterally recorded blood flows on healthy skin did
not differ between groups (p = 0.5662). When comparing blood flows for each
subject between sides, i.e. centre vs. contralateral means, central blood flow was
significantly higher in melanoma (p = 0.0020), psoriasis (p = 0.0039) and atypical
naevi (p = 0.0179), but not in benign naevi (p = 0.3940).
Stucker et al. quantified the differences in blood flow between malignant















MelanomaPsoriasis Benign neviAtypical nevi
Figure 5.4: Box and whisker plots of mean blood flow calculated for each group
and location. Outliers in boxplots are shown as red crosses. ns = not significant.
*** = p < 0.001. Margin data is not available for psoriasis. n = 9, 10, 33 and 37
for psoriasis, melanoma, atypical naevi and benign naevi respectively.
Individual rank-sum results
P vs. M P vs. B P vs. A M vs. B M vs. A B vs. A
Centre 1 0.0000 0.0001 0.0000 0.0000 0.7418
Margin N/A N/A N/A 0.0000 0.0009 0.9531
Table 5.3: Rank sum comparisons of the distribution of mean blood flow between
all groups.
of signals recorded using laser Doppler perfusion imaging [11]. They found that the
mean blood flow recorded in malignant melanomas was always at least 1.8 times
higher than in healthy skin, and used this to develop a diagnostic test with a
sensitivity of 100% and sensitivity of 85% when including clinically benign lesions,
but this was reduced to 48% when only considering clinically suspicious lesions.
Applying this cut off to the results obtained in the current study by comparing
blood flow recorded in lesion centres and contralateral skin provides a sensitivity
of 100% and a specificity of 70% when considering atypical and benign lesions
and 61% when considering only atypical lesions. 10 out of 10 melanoma lesions
met the criteria of mean blood flow recorded at lesion centres being at least 1.8
times higher than that recorded in contralateral skin, whilst 17 out of 44 atypical
lesions and 4 out of 26 clinically benign lesions also met the criteria and would be
diagnosed as melanoma in this test.
This approach was also applied to the blood flow signals recorded at lesion
margins in the current study to investigate the effect of a different recording lo-
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Subject Sex Age Tumour Clark Breslow Ulceration
(years) size (cm) level depth (mm)
1 F 51 1.1 × 0.7 II 0.45 no
2 F 80 2.5 × 2.5 × 1.5 IV 15 yes
3 M 58 1.2 × 0.7 × 0.4 IIIIV 3 yes
4 M 58 1.7 × 1.0 IIIIV 0.35 no
5 F 80 1.1 × 0.7 x 0.3 IV 3.1 no
6 M 64 0.6 × 0.5 III 0.7 no
7 F 39 0.4 × 0.3 II 0.2 no
8 F 80 1.8 × 1.3 IV 0.8 no
9 M 74 1.5 × 0.9 II 0.45 no
10 F 43 0.5 × 0.4 III 0.4 no
Table 5.4: Histological characteristics of melanoma lesions.
cation on specificity. Sensitivity of 100% was achieved using a cutoff of the mean
blood flow at lesion margins being greater than at contralateral locations by at
least a factor of 1.26. 21 atypical lesions and 12 benign lesions also met this cri-
terion, resulting in sensitivity of 52% when considering only atypical lesions and
53% when also including benign lesions. These values are not an improvement
on the specificity achieved using dermoscopy [182]. This highlights the necessity
of further investigation beyond average perfusion values in the characterization of
melanoma blood flow for the purposes of diagnosis.
5.3.4 Histological results
All lesions diagnosed as clinically atypical underwent histological examination at
the 3rd Pathology Unit of Pisa University Hospital, for diagnostic purposes and to
examine the surrounding vasculature. Intra- and peri-lesional vessels were high-
lighted with anti CD34 Mab (Ventana Medical System). Each sample was exam-
ined under low power to identify the region with the highest number of microves-
sels, or `hot spot'. Two 250× fields (25× objective lens and 10× ocular lens) were
evaluated to assess the number of microvessels, or microvessel density. Figure 5.5
shows highlighted intra- and peri-lesional vessels in a malignant melanoma. Table



















Figure 5.5: Top  Anti CD34 Mab highlighted vessels in a malignant melanoma
lesion. Provided by Marco Rossi. Each sample was examined to find the region
with the highest number of microvessels, or `hot spot'. Bottom  Vessel counts in
the `hot spot' in all histologically examined lesions. M  melanoma (n = 7 intra,
9 peri), A  atypical naevi (n = 23 intra, 27 peri), B  histologically benign naevi
(n = 7 intra, 8 peri). ** = p <0.01, * = p < 0.05.
microvessel density was significantly higher in melanoma than in atypical naevi (p
= 0.0006), but this was not the case for peri-lesional vessels (p = 0.2131) (Figure
5.5). When including all lesions which underwent histological examination, a sig-
nificant, positive correlation was found between mean blood flow at centres and
intra-lesional vessel counts (τ = 0.2360, p = 0.0470) (see Figure 5.6). However,
no correlation was found between mean blood flows at margins and peri-lesional
vessel counts (τ = 0.0329, p = 0.7679). A significant positive correlation was found
between mean blood flow at centres and lesion area (τ = 0.3165, p = 0.0009), an
effect that is explained by another significant positive correlation found between
lesion area and intra-lesional vessel count (τ = 0.4136, p = 0.0005). This provides



















































Figure 5.6: Correlations between histological parameters and mean blood flows.
(a) Intra-lesion vessel count vs. mean blood flow. (b) Lesion area vs. mean blood
flow. (c) Intra-lesion vessel count vs. area. White  melanoma (n = 7), grey
 atypical (n = 23), benign  black (n = 7). * = p < 0.05, *** = p < 0.001.
Theil-Sen regression line is shown in yellow.
5.3.5 Time-frequency analysis
Wavelet analysis was performed on the signals using custom MatLab codes (see
Chapter 4), with a Morlet wavelet of central frequency f0 = 1. Time-averaged
wavelet power was calculated for all signals. Absolute power values were signif-
icantly higher in both psoriasis and melanoma when compared to atypical and
benign naevi. However, in contrast to their mean flows, the spectra of melanoma
and psoriasis highlight differences between the groups at some frequencies in the
neurogenic and myogenic intervals, whereas the power spectra of atypical and
benign naevi do not differ at any frequency (Figure 5.7). The clear differences
between the power spectra at lower frequencies between psoriasis and melanoma
were investigated in order to find out whether they could be used to discriminate
between groups. Figure 5.7(c) shows the calculated ratios between the total power
in the cardiac interval and the sum of the power in all low frequency intervals (III,
IV, V & VI). To obtain a sensitivity of 100%, a cut-off of 0.56 is required for this
data set, as this is the lowest value for this ratio that was observed in melanoma.
Using this as a test gave sensitivities of 55.6%, 63.6% and 84.6% for psoriasis,
atypical naevi and benign naevi, respectively. Whilst promising, this test alone
does not provide adequate specificity.































Figure 5.7: Absolute power spectra for all groups, highlighting the necessity of
normalization. Power of melanoma and psoriasis (a) is much higher than atypical
and benign naevi (b). Significant differences are highlighted in yellow. (c) Ratios
between total power in the cardiac interval and the sum of the total power in
frequency intervals III, IV, V & VI were calculated and compared between groups.
Boxplot outliers are shown as red crosses. The grey dotted line shows the threshold
set by the lowest value of the ratio in melanoma. n = 9, 10, 33 and 37 for psoriasis,
melanoma, atypical and benign naevi, respectively.
parison of specific oscillatory components, also demonstrated in Figure 5.7. Due
to the lesion specific nature of this study, lesions were located at widely varying
sites on the body, which has been shown to have significant effect on microvascular
blood flow recordings [93]. For both of these reasons, normalization is required to
create an accurate picture of blood flow dynamics. All wavelet power spectra were
normalized through division by their total powers. These were then compared at
all frequencies from 0.005 - 2 Hz (Figure 5.8 (a)(c)). To quantify spectral dif-
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Figure 5.8: (a)(c) Normalized wavelet power for all groups, with significant
differences as determined by the Kruskal Wallis test highlighted in yellow. (d)(f)
Boxplots of normalized wavelet power in the known frequency intervals. Outliers
are shown as red crosses. *** = p < 0.001, ** = p < 0.01, * = p < 0.05. n = 9,
10, 33 and 37 for psoriasis, melanoma, atypical and benign naevi, respectively.
specific physiological processes, the normalized wavelet powers were divided into
six intervals, as defined previously (see Chapter 2). Normalized powers in intervals
are shown in Figure 5.8 (d)(f) and Table 5.5.
At lesion centres, melanomas had significantly lower normalized power in the
frequency intervals associated with myogenic (III) and neurogenic (IV) activity,
and a significantly higher normalized power in the cardiac frequency interval, when
compared to both atypical and benign naevi. At lesion margins, melanoma showed
significantly lower normalized power in intervals III and IV when compared to
benign naevi, but only in interval IV when compared to atypical naevi. As was
the case for lesion centres, normalized power in interval I was significantly higher
in melanoma at margins than both atypical and benign naevi. Melanoma also
showed significantly lower normalized power in the frequency intervals associated




















































Figure 5.9: Comparison of mean blood flows and normalized wavelet power spec-
tra between lesion centres and contralateral skin in (a) psoriasis, (b) melanoma,
(c) atypical naevi and (d) benign naevi. Significant differences (p < 0.05) are
highlighted in red. Boxplot outliers are shown as red crosses. ** = p < 0.01, * =
p < 0.05. n = 9, 10, 33 and 37 for psoriasis, melanoma, atypical and benign naevi,
respectively.
when compared to contralateral skin in the same subjects, whilst exhibiting an
increase in normalized cardiac power (interval I). The same comparison in atypical
naevi revealed significantly lower power in intervals IV and V in lesion centres, and
significantly higher power in interval I. In contrast, centre and contralateral powers
only differed significantly in interval IV (the centre being lower) in typical benign
naevi, and psoriasis differed only in intervals I (centre significantly higher) and the
interval associated with respiration, II (centre significantly lower) (see Figure 5.9).
Comparison of centrally recorded normalized power between atypical and be-
nign naevi revealed no significant differences in any interval except the neurogenic
interval IV (center lower), while no differences were found during the same com-
parison for data recorded at margins.
5.3.6 Wavelet phase coherence
Wavelet phase coherence was calculated between wavelet transforms calculated
from blood flow signals recorded at lesion centres and in contralateral skin, to in-
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Normalized power in intervals
I MM AN BN P p
Cent 10.8 (8.214.3) 4.9 (2.27.3) 4.4 (2.45.5) 6.6 (3.88.3) 0.0003
Marg 9.4 (5.812.2) 3.6 (2.46.7) 3.5 (1.95.4) 0.0034
Cont 5.2 (2.77.1) 2.8 (1.24.8) 3.8 (2.65.7) 2.3 (1.64.7) 0.1331
p 0.0020 0.0004 0.7229 0.0078
II
Cent 1.0 (0.81.8) 1.8 (1.33.0) 2.2 (1.33.0) 1.3 (0.71.8) 0.1571
Marg 1.6 (0.92.3) 2.1 (1.43.5) 2.3 (1.33.7) 0.5163
Cont 1.5 (1.22.8) 1.9 (1.52.8) 2.0 (1.23.1) 2.8 (2.24.4) 0.6101
p 1 0.6877 0.3305 0.0039
III
Cent 1.7 (0.92.7) 4.7 (2.67.5) 4.8 (3.67.6) 3.0 (2.810.3) 0.0006
Marg 2.8 (2.04.0) 4.8 (3.08.0) 5.3 (3.68.2) 0.0230
Cont 5.7 (2.16.7) 4.7 (3.27.0) 4.6 (3.06.0) 4.0 (2.25.0) 0.7257
p 0.0020 0.9501 0.1184 0.2500
IV
Cent 1.0 (0.61.7) 1.9 (1.43.5) 2.6 (1.94.3) 1.8 (1.63.0) 0.0005
Marg 1.2 (1.02.0) 1.8 (1.33.1) 2.4 (1.54.5) 0.0408
Cont 3.1 (1.85.1) 3.9 (3.35.7) 4.2 (2.55.4) 3.3 (2.64.8) 0.4845
p 0.0020 0.0001 0.0074 0.0977
V
Cent 1.0 (0.61.7) 1.8 (1.03.7) 2.0 (1.52.6) 1.5 (1.21.8) 0.0746
Marg 1.2 (0.72.5) 1.6 (0.92.3) 1.8 (1.03.4) 0.6096
Cont 2.2 (1.42.5) 3.4 (1.54.4) 3.0 (1.23.7) 3.2 (2.13.5) 0.3417
p 0.0039 0.0049 0.1868 0.0547
VI
Cent 1.9 (0.63.0) 1.5 (0.82.4) 1.5 (1.12.7) 2.6 (1.44.9) 0.8659
Marg 1.2 (0.61.9) 1.5 (0.92.4) 1.6 (1.02.6) 0.5098
Cont 0.8 (0.71.4) 1.6 (1.13.4) 2.1 (0.93.9) 2.8 (1.65.2) 0.1867
p 0.6953 0.4915 0.7229 0.9102
Table 5.5: Normalized power values for all studied frequency intervals. Results
of significance testing from the Kruskal Wallis test (between groups) and the sign
rank test (between centres and contralateral) are shown. Significant differences (p
< 0.05) are highlighted in grey.
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Figure 5.10: Significant wavelet phase coherence calculated by subtracting the
95th percentile of 100 IAAFT surrogates per subject. (a) Phase coherence between
recordings from lesion centres and contralateral skin. (b) ANOVA results for all
groups. (c) p values from the ranksum test between melanoma and psoriasis. (d)
p values between melanoma and atypical naevi. (e) p values between melanoma
and benign naevi. Significant differences (p < 0.05) are highlighted in yellow. n =
9, 10, 33 and 37 for psoriasis, melanoma, atypical and benign naevi, respectively.
vestigate whether the phase relationships of the observed oscillatory components
differ between groups [298]. Wavelet phase coherence could not be calculated be-
tween blood flow at lesion margins and contralateral skin because these signals
were not recorded simultaneously. Significant coherence was defined as coherence
values above the 95th percentile of 100 IAAFT surrogates. Significant phase co-
herence was found in all groups, in intervals I, II, III & IV (see Figure 5.10).
However, whilst coherence differed significantly between groups according to the
Kruskal Wallis test, this difference was mainly as a result of differences between
psoriasis and benign naevi. Melanoma differed from atypical naevi at a very small
number of frequencies in the respiration interval and differed from atypical naevi
and benign naevi in the upper part of the cardiac interval, as a result of the higher
heart rate demonstrated in melanoma subjects.
119
Figure 5.11: Evaluation of the discriminatory power of ratios between cardiac
and myogenic/neurogenic power. I/III and I/IV Ratios are shown for lesion cen-
tres and margins, with sensitivities shown based on a cut-off of the lowest value
observed in melanoma (shown by grey dashed line). Boxplot outliers are shown
as red crosses. n = 9, 10, 44 and 26 for psoriasis, melanoma, atypical and benign
naevi, respectively.
5.3.7 Non-invasive diagnosis of melanoma
For the development of a diagnostic test, it is important that the differences ob-
served are not only significant, but that they are sufficiently discriminatory to
provide a cut-off point which can be used to distinguish between groups. The
main significant differences observed in this study arise from differences in mean
blood flow, differences in normalized cardiac power in lesion centres and margins,
and differences in normalized myogenic and neurogenic power in lesion centres
and margins. As melanoma exhibits a significant increase in normalized cardiac
power at centres and margins when compared to all other groups, and a decrease
in normalized power in the neurogenic and myogenic frequency, the ratio between
these two parameters is likely to be higher in melanoma than in other groups.
Therefore, the ratios of I/III and I/IV power were calculated for centres and mar-
gins for all groups and compared in order to assess their success in discriminating
between groups. As shown in Figure 5.11, these ratios are much more successful
in lesion centres than in lesion margins, and the I/III ratio alone provides better
specificity than the I/IV ratio. Differences in normalized cardiac power were also
compared between groups in order to ascertain whether the diagnostic test could
be improved further. A minimum normalized cardiac power of 0.0038 was found
for both lesion centres and lesion margins, and used as a cut-off. In lesion centres,
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this cut-off provided a specificity of 43% in atypical and 50% in benign lesions.
At lesion margins these values were 59% and 50%, respectively, showing that this
test is more successful at lesion margins. Using these three tests, mean blood
flow ratio, cardiac/myogenic and cardiac/neurogenic ratio and normalized cardiac
power, the combination which gave the highest specificity overall was revealed to
be, for melanoma:
1. Mean blood flow recorded at margin/ mean blood flow at the contralateral
location > 1.26,
2. Normalized cardiac power at the lesion margin > 0.0038 and
3. Total power in I / total power in IV in wavelet power spectrum calculated
from blood flow recorded in lesion centres > 3.7.
Combining these characteristics results in a sensitivity of 100% and a specificity
of 90.9% in discriminating between melanoma and atypical naevi, based on the
available data (see Figure 5.12). Values for all parameters for each subject are
shown in Table A.1.
5.4 Summary
With respect to the hypotheses presented previously, clear differences have been
demonstrated in blood flow dynamics between melanoma, psoriasis, atypical naevi
and benign naevi, contributing to our understanding of the physiological processes
occurring within melanoma microvasculature. In addition, a diagnostic test has
been developed based on LDF recordings and wavelet analysis which differentiates
between melanoma and atypical naevi with sensitivity 100% and specificity 90.9%,
based on the presented data. As demonstrated in previous studies on melanoma
blood flow [346], it was observed in this study that melanomas had significantly
higher blood flow when compared with atypical and benign naevi, both in lesion

































































































Figure 5.12: Sensitivity and specificity ranges for the diagnostic parameters
based on the available data. (a) Ratio between mean blood flow at the margin
and mean blood flow in contralateral skin. (b) Normalized wavelet power in the
cardiac interval. (c) Ratio between the power in the cardiac interval and the power
in the neurogenic interval. (d) Results of diagnostic test for all naevi. The score
is how many of the criteria were met by the lesion being tested. Boxplot outliers
are shown as red crosses. M  melanoma (n = 10), A  atypical naevi (n = 44),
B  benign naevi (n = 26).
skin. The latter was also the case for atypical naevi and psoriasis, but not for
benign naevi. Histological examination of melanoma showed an increased number
of blood vessels in lesion centres compared to atypical naevi, which can be at-
tributed to the increased angiogenesis occurring within the melanoma vasculature
[153, 193]. A significant positive correlation between intra-lesional vessel density
and blood flow at the centres of melanomas was found, which is in agreement with
the fact that it is not only the number and velocity of erythrocytes in microvessels,
but also vessel density which influences microcirculatory blood flow [346]. Though
significant, this correlation was not as strong as expected, likely due to the fact
that melanomas are characterized by irregularly shaped microvessels which also
exhibit increases in cross sectional area, features which are not quantified through
the vessel count performed in this study. This correlation was not found between
blood flow at margins and peri-lesional vessel count, due to the heterogeneity of
melanoma vasculature, and it being unlikely that the margin signals were recorded
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in the same place as the vessel count was performed. In terms of blood flow dynam-
ics, melanomas, despite their increased blood flow, had significantly reduced power
in the frequency intervals associated with myogenic and neurogenic activity, when
compared to atypical naevi and benign naevi. This abnormality in melanoma has
important relevance from a pathological and a therapeutic point of view, in light
of results of recent experimental and human studies [77, 84] suggesting that blood
flow dynamics is essential for efficient nutrient delivery and removal of waste from
tissues. In fact, without adequate removal of the by-products of glycolysis, such as
lactic acid, the tumour microenvironment becomes more acidic [198], with conse-
quent reduction in vessel reactivity [257]. It has also been shown that many cancer
treatments fail due to hypoxia induced by the inadequacy of the blood perfusion
to the tumour site [202]. In addition, significantly lower normalized power in the
frequency intervals related to myogenic, neurogenic and NO dependent endothe-
lial activity (III, IV & V) was observed in melanoma when compared to healthy
skin in the same subjects. This was also observed in intervals IV & V in atypical
naevi and interval IV in benign naevi. Taking into account that atypical naevi are
more prone to development into malignant melanoma than benign naevi [179], this
similarity in blood flow dynamics between melanomas and atypical naevi suggests
that the transformation from benign melanocytic lesion to melanoma could be a
gradual process.
Due to the large number of false positives in the clinical identification of
melanoma, a number of non-invasive approaches have been developed over the
years to provide an objective means of evaluating and diagnosing skin melanoma.
However, the current gold-standard in melanoma diagnosis is still examination of
a skin lesion by the trained eye of a physician, followed by histological examination
of an invasive excisional biopsy of the skin specimen. Therefore, the diagnosis of
melanoma by non-invasive methods remains an active area of research. In line
with this aim, a cut-off was developed based on differences in blood flow dynamics
between melanomas and atypical naevi, with a sensitivity of 100% and specificity
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90.9%. Considering that the clinical accuracy of diagnosing melanoma in this
study was around 20%, the cut-off appears to be very promising as a compli-
mentary method to biopsy. Psoriasis was also chosen as a control lesion in this
study, due to its similarity to malignant melanoma in terms of angiogenesis and
microvasculature characteristics, including elongated and dilated vessels and in-
creased endothelial cell proliferation [186]. In agreement with this similarity, no
significant differences in mean blood flow between melanoma and psoriasis lesions
were found. On the contrary, melanomas and psoriasis lesions differed in terms
of their blood flow dynamics in frequency intervals I & IV. The rhythmical be-
haviour of blood flow in psoriasis lesions was previously studied and compared to
that in skin basal cell carcinomas [186]. Similarly to the melanoma group in our
study, basal cell carcinomas differed from psoriasis lesions in terms of blood flow
dynamics, showing a reduction in power of the neurogenic dependent frequency
interval compared to healthy skin, a finding which was not observed in psoriasis
lesions in the same study. However, basal cell carcinomas have been shown to be
less perfused than melanomas [184].
A limitation of this study was the variations in age distribution between groups,
with the melanoma and psoriasis patients being significantly older. It has been
shown previously that physiological processes, such as heart rate and heart rate
variability, and microvascular responses to vasoactive substances, change with in-
creasing age. To completely rule out the effects of age on results, further re-
cruitment of age matched melanoma or atypical naevi patients would be required.
Another possible limitation of this study is that many of the subjects (6 out of
10 melanoma and 6 out of 9 psoriasis) had arterial hypertension, a pathological
condition which has been shown to reduce skin vasoreactivity and to perturb blood
flow dynamics [10]. However, all hypertensive patients enrolled in this study had
normal blood pressure values due to antihypertensive treatment, a condition which
was shown to normalize blood flow dynamics in hypertensive patients in a previ-
ous study [10]. Consistent with normalization of blood flow dynamics in treated
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hypertensives, significant differences between hypertensive and non-hypertensive
subjects in spectral power were not observed in any frequency intervals analysed in
healthy skin. A further limitation of this study is the relatively low reproducibility
of single point LDF measurements that was observed in studies averaging relatively
short time segments. However, in this study, recordings were for 30 minutes, al-
lowing more reliable characterization of the signal, including its time-variability
[76]. Furthermore, this limitation of LDF measurements was less important here,
due to the fact that blood flow signals were analysed in terms of their frequency
components, through the use of the continuous wavelet transform. Now that the
diagnostic markers have been identified, recording time may be reduced to 15
minutes, enhancing the clinical applicability of the method.
In conclusion, this study showed changes in both mean blood flow, and blood
flow dynamics in melanomas, in comparison to atypical naevi, benign naevi and
psoriasis lesions, allowing a better understanding of melanoma microvascular physi-
ology. A diagnostic cut-off for the differentiation of melanoma from atypical naevi
is presented, developed based on differences observed in both blood flow, and
blood flow dynamics, extracted through wavelet analysis. Whilst this method is
very promising, further research is necessary before it can be recommended in the
replacement of biopsy for the diagnosis of melanoma.
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6. Oxygenation and blood flow
dynamics
As discussed previously, blood flow dynamics has been used as a model for mi-
crovascular health, and has been shown to be altered in various pathologies. This
chapter aims to assess whether simultaneously recorded skin blood flow and oxy-
genation are altered in terms of their dynamics during dry static apnoea using free
diver data recorded in a previous study [347], and age and sex matched control
data recorded in non-divers specifically for this thesis. In addition to the com-
parison of the divers with controls, new analysis on data recorded during apnoea
provides further insights into the local effects of hypoxia on blood flow and oxygen
dynamics. This may provide information about blood flow and oxygen dynamics
during hypoxia, and thus may provide clues to the behaviour of the vasculature in
tumours.
6.1 Hypothesis
This study aims to investigate blood flow and oxygen dynamics during dry static
apnoea in trained free divers. The extensive training of these divers provides longer
breath-holds than are possible with normal untrained humans. It may therefore
be possible to observe previously unseen dynamics during this prolonged oxygen
deprivation, i.e. whether this induces hypoxia in these subjects, and how this affects
their physiological regulation of blood flow and blood oxygenation, in particular
the dynamics of these parameters. Observations in this scenario may be applicable
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to the state of hypoxia in general.
6.2 Experimental protocol
In a previous study [347], 16 free divers were monitored according to the following
protocol. Sensors were attached to the skin of each subject as shown in Figure 6.1
and explained in detail below. The protocol involved a period of 30 minute resting
recordings of all physiological parameters. The divers were then asked to follow
a further protocol involving breathe-ups, breath-holds and one short rest period.
The structure of this protocol is shown in Figure 6.10 and explained further in
Section 6.3.3. Before investigating whether blood flow and oxygen dynamics are
altered during apnoea, it is necessary to find out whether the apnoea training
regularly performed by free divers has permanently altered their physiology. To
investigate the similarities and differences between divers and non-trained individ-
uals, the previous study based on this data used control subjects from [86], but
this study did not use the TOSCA500 (see below), so arterial oxygen saturation
and transcutaneous carbon dioxide could not be compared. These data sets also
differed in that all data recorded by the O2C device were recorded in different
locations. In the study in [86], they were placed on the right shinbone and centre
of the inner right forearm, whilst in the divers they were placed on the right foot
dorsum and the volar aspect of the right arm, approximately 70mm from the elbow
[347]. To provide the possibility of a more accurate comparison of physiological
data during the rest period, 16 age- and sex-matched, healthy controls were re-
cruited, following the exact protocol of the free divers at rest, with the addition
of 10 extra minutes of recording time. As in the diver group the controls were re-
cruited provided they met the following criteria: they had not consumed caffeine
on the day of the experiment, alcohol in the 24 hours prior to the experiment, or
food within the previous 4 hours, they were healthy as determined by a medical
questionnaire, they had normal blood pressure (i.e. did not exceed 150 mm Hg),














Figure 6.1: Location and function of probes in the apnoea study and in the
control group. EEG was not measured in the control group. Modified from [347]
6.2.1 Measured parameters
Electrocardiogram
ECG was measured at 1200 Hz, using a three lead setup, with one electrode on
each shoulder and one on the lowest left rib. The electrodes used were disposable
Ag/AgCl electrodes (40493D)(Philips Healthcare, UK).
Arterial oxygen saturation
Based on the differences in absorption of light by oxyhaemoglobin and deoxy-
haemoglobin, and pulsatile changes in blood volume, the arterial oxygen satura-
128
Subject 1 2 3 4 5 6 7 8
Age (D|C) 21|20 29|28 31|32 34|33 39|38 45|45 25|25 28|28
Sex F F F F F F M M
Subject 9 10 11 12 13 14 15 16
Age (D|C) 31|30 34|34 35|34 36|36 38|38 38|40 39|41 41|42
Sex M M M M M M M M
Table 6.1: Free divers were age matched (± 2 years) and sex matched. D =
Divers, C = controls.
tion, SpO2, can be measured using pulse oximetry. In this study, SpO2 was mea-
sured at the right ear lobe, using the TOSCA500 (Radiometer, UK), which uses a
two-wavelength pulsatile system of LEDs to distinguish between oxygenated and
deoxygenated blood [348]. Red (658nm) and infrared (880nm) light are passed
through the capillary bed of the earlobe to a photodetector, connected to the
TOSCA500 where parameters are calculated based on the absorption of light in
the tissue. The TOSCA500 calculates functional saturation, the amount of oxy-
genated haemoglobin as a percentage of the haemoglobin that can carry oxygen,
and does not include dysfunctional haemoglobin, e.g. carboxyhaemoglobin. Unlike
some other pulse oximeters, the TOSCA500 corrects the SpO2 signal by subtracting
contributions arising from venous blood movement [348].
Respiration
In free divers, respiration was measured using two different methods, due to dif-
ficulties with accommodating the range required during apnoea. Respiration was
measured in terms of chest volume changes using either a respiration wire (not
available for some divers) or a Velcro belt consisting of a TSD201 conductance
transducer [347]. It is the latter method that was used in the control group pre-
sented here.
Blood flow
Skin blood flow was measured using laser Doppler flowmetry in eight locations
on each subject. Four of the measured signals were recorded using Moor In-
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struments (UK) LDF recording equipment, consisting of one DRT4 laser Doppler
monitor with two channels, and two Moor Servers with one channel each. The
Moor Doppler probes 1 and 2 were placed on the medial malleolus of the left and
right ankles, respectively. Moor probes 3 and 4 were placed over the protrusion
of the ulna on the left and right wrists, respectively. These locations were chosen
to ensure that the measurement area consists only of microvasculature, and not
larger vessels such as arterioles, whose large volume lead to different blood flow
dynamics than that observed in the microvessels. The other four LDF signals were
recorded using the O2C (LEA Medizintechnik, Germany), which allows simulta-
neous recording of blood flow at two depths in the same location (see Figure 6.2).
O2C probe 1 was placed on the top of the right foot, and O2C probe 2 on the
right forearm as described previously.
Oxygenation parameters
Relative amount of haemoglobin (rHb) and venous oxygen saturation (STO2) were
measured by the O2C device, in the same locations as the O2C blood flow de-
scribed above. Each O2C probe provides recordings from two tissue depths, due
to two different separations of emitters and detectors. One set of signals, recorded
with a fibre separation of 2mm, arises from shallow tissue, whilst simultaneous
recording with a fibre separation of 8mm also allows the observation of physiolog-
ical parameters from deeper tissue.
6.3 Results
6.3.1 Statistics
The distribution of any group to be compared was tested using the Lilliefors test
for normality, which did not consistently find normal distributions of data in any
case. Therefore, all statistical tests used were non-parametric, i.e. did not assume
an underlying distribution. Comparisons within the diver group were made using
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Figure 6.2: Diagram of the two tissue depths measured by the O2C. The depth
of recording depends on the spacing between the light source and the detector.
Larger spacing will result in deeper recordings. The laser light is used to measure
blood flow and blood velocity, whilst the white light is used to measure venous
oxygen saturation (STO2) and relative haemoglobin (rHb).
the Wilcoxon signed rank test, and comparisons between the divers and control
group were made using the Wilcoxon rank sum test. Significance was considered
as p < 0.05.
6.3.2 Comparison of divers and controls at rest
Sixteen age and sex matched controls were recruited in order to compare the resting
state in non freediver controls with that of the previously measured freedivers. This
was to ascertain whether the regular training undergone by free divers affects their
physiological parameters, in particular their resting blood flow and oxygenation
dynamics. Information on the two groups of subjects can be found in Table 6.1.
Systemic comparisons
Heart rate, heart rate variability (HRV), respiration and arterial oxygen saturation
(SpO2) were compared between groups at rest. Mean heart rate was found by
extracting the instantaneous frequency of the heart activity from the ECG signal,
and calculating the mean. To ensure the extracted heart rate signals were correct,
they were also compared with the heart rate recorded by the TOSCA 500 at the
ear lobe. Both methods were found to provide the same results. Mean heart
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Figure 6.3: (a) Example instantaneous heart rate as extracted from the ECG
(black line), and as recorded by the TOSCA 500 (red line). (b) Mean heart rates
were found not to differ significantly between divers and controls using the rank
sum test (pECG = 0.25, pTOSCA = 0.15). n = 16 for both groups.
Figure 6.4: Median time averaged wavelet power of heart rate variability (HRV).
Significant differences between divers and controls are highlighted in grey. n = 16
for both groups.
rates are shown in Figure 6.3. No significant differences in heart rate were found
between the divers and the controls (pECG = 0.25, pTOSCA = 0.15), confirming
the result obtained in [347] with a different control group. Heart rate variability
was investigated using peak detection of the R-peaks (see Section 4.2.1) in the
ECG signal before resampling (1200 Hz), to provide precise temporal resolution.
Heart rate variability signals were calculated based on the varying time intervals
between R-peaks (see Chapter 3.1.2), and their wavelet transform calculated. Time
averaged wavelet power of heart rate variability was compared between divers and
controls, with significant differences found at frequencies below around 0.08 Hz,
with the exception of the interval 0.0310.048 Hz (see Figure 6.4).
This is a similar result to the previous study involving this data, where differ-
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Figure 6.5: (a) Example arterial oxygen saturation, SpO2, time series recorded
from the right earlobe of a diver (red line) and a control subject (black line) using
the TOSCA500. (b) Mean SpO2 did not differ significantly between groups (p
= 0.6109). (c) Median wavelet power of SpO2 for both groups. Significance was
tested at each frequency, significant differences are highlighted in light grey. (d)
Peak locations compared between divers (red) and controls (black). Peak locations
were significantly higher frequency in divers (p= 0.0348). Outliers are shown as red
crosses, one outlier not shown. (e) Standard deviation of SpO2 differed significantly
between groups (p = 0.0021). n = 16 in all cases. ** = p < 0.01.
ences in HRV were found below 0.04 Hz [347]. Respiration rates were calculated
from signals from either the respiration belt or wire, depending on which gave
clearer peaks. These signals were then smoothed to facilitate peak detection, and
the differences between peaks calculated to provide the respiration rate variabil-
ity. Respiration rates could only be recovered from 14 out of 16 divers, thus their
matched controls were also not used in this comparison. Mean respiration rates
did not differ significantly between groups (p = 0.9817), with a median respiration
rate of 0.24 Hz in both groups.
Arterial oxygen saturation SpO2 was recorded at the right earlobe using the
TOSCA500 device. No significant differences in mean SpO2 were found between
the divers and their controls (p = 0.6109). However, a significant difference was
observed in the standard deviation, with the divers exhibiting higher variability
in their SpO2 levels (p = 0.0021). Comparisons were also made between absolute
minimum and maximum values, which were found not to differ significantly (p
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Figure 6.6: Respiration responds to reductions in SpO2. Troughs in the arterial
oxygen saturation appear to induce an increase in the amplitude of the respiration
to compensate.
= 0.0678 and p = 0.2828, respectively). The observed differences in standard
deviation highlighted the necessity of further investigation into the time-dependent
dynamics of SpO2 in both groups. Wavelet transforms of the SpO2 signals were
calculated, and their time-averages compared between groups. As the TOSCA500
provides absolute values of SpO2, the spectra were not normalized. Significant
differences were found across the frequency spectrum, as demonstrated in Figure
6.5(c), with a clear peak in the median wavelet power around 0.016 Hz visible in
both groups. This low frequency peak was observed in all subjects, at varying
peak frequencies, shown in Figure 6.5(d). If more than one peak was present in
the spectrum, the peak with the highest magnitude was considered. The locations
of this peak differ significantly between groups, with the controls demonstrating
peak SpO2 power at lower frequencies (p = 0.0348).
It is well known that breathing is closely linked with changes in arterial blood
oxygenation. Blood oxygen levels are continuously monitored within the carotid
body, a small cluster of chemoreceptors situated at the bifurcation of the carotid
artery. Even very small decreases in blood oxygenation are sensed immediately,
and this leads to cardiovascular and respiratory reflexes, including variations in
breathing rate or amplitude to compensate [349]. Figure 6.6 demonstrates that in
the case of decreasing SpO2, the breathing pattern alters to normalize SpO2 levels.
Therefore, to investigate the relationship between SpO2 and respiration at rest,
and whether this relationship is altered in freedivers, wavelet phase coherence was
calculated between the two signals for both groups. Figure 6.7(a) shows the re-
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sults of wavelet phase coherence calculations between SpO2 and respiration for the
divers and their controls. The bias at low frequencies of wavelet phase coherence
calculations (see Chapter 4.2.4) was accounted for by calculating 100 iterative am-
plitude adjusted Fourier transform (IAAFT) surrogate data sets [299] per subject
and considering all phase coherence above the 95th percentile of the surrogate data
set as statistically significant. This allowed comparison of wavelet phase coher-
ence between groups, and it was found that there were no significant differences
in total phase coherence between respiration and SpO2 in divers and controls (p =
0.3462). However, comparisons of significant phase coherence between groups at
each frequency revealed significant differences around 0.015 and 0.093 Hz, with the
divers exhibiting lower coherence in both cases. The difference around 0.015 Hz
is likely due to the previously discussed higher frequency of oscillations of SpO2.
The median phase coherence appears to show a double peak in both groups, but
inspection of the coherence in individual subjects shows that this is not a universal
observation. Comparison of the phase coherence between SpO2 and respiration in
divers and their matched control shows a narrower range of coherence in divers in
the majority of cases.
Another well known phenomenon is respiratory sinus arrhythmia, where the
heart rate varies depending on the phase of the respiration cycle (see Section 3.1.2)
[350]. This cardio-respiratory interaction was also investigated using wavelet phase
coherence between the respiration and heart rate variability at rest in both groups.
No significant differences in total phase coherence were observed (p = 0.6625), but
significant differences were observed at the individual frequencies highlighted in
Figure 6.7(b), with divers showing higher phase coherence at lower frequencies.
Local comparisons
Eight blood flow signals were recorded in total, one on each wrist, one on each
ankle, two from the right forearm, and two from the top of the right foot, as
shown in Figure 6.1. Mean blood flows are compared between divers and controls
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Figure 6.7: (a) Median wavelet phase coherence between SpO2 and respiration
for divers and controls. (b) Median wavelet phase coherence between respiration
and heart rate variability. Only significant coherence is shown, as calculated from
subtracting the 95th percentile of 100 IAAFT surrogates. Total coherence did not
differ significantly between groups, but significant differences (p < 0.05) were found
at some frequencies using the rank sum test, highlighted in grey. n = 14 in both
cases.
in Table 6.2.
Significant differences in mean blood flow were observed only in the right and
left wrists. Interestingly, the difference in the left wrist is due to the divers having
a significantly lower mean blood flow, whilst the difference in the right wrist is the
opposite; the divers have higher mean blood flow.
To investigate the time-dependent dynamics of blood flow, and whether these
vary between groups, wavelet transforms were calculated for all blood flows, and
their time-averaged wavelet power compared between groups. To take into account
the fact that blood flow is not an absolute value, and possible small variations in
recording location, the power spectra were normalized by dividing them by their
total power. Comparisons were made at each frequency using the Wilcoxon rank
sum test, and significant differences were revealed in all cases (see Figure 6.8). In
addition to testing the whole spectrum, the total power in each of the previously
defined frequency intervals was calculated and compared, to look for trends in the
differences between groups. Differences in normalized power were observed in 5






Left ankle 10.33 (9.0811.56) 10.99 (8.1914.61) 0.4178
Right ankle 9.76 (8.0212.79) 12.87 (9.1514.90) 0.3365
Left wrist 10.20 (8.1519.66) 19.54 (14.0025.67) 0.0167
Right wrist 15.24 (14.0925.41) 12.15 (10.1015.55) 0.0365
Right foot (S) 6.49 (3.9210.30) 10.11 (4.7628.95) 0.2662
Right foot (D) 37.37 (18.8945.60) 48.20 (35.2770.09) 0.1092
Right arm (S) 17.35 (12.4525.51) 19.48 (13.8633.67) 0.5095
Right arm (D) 42.87 (24.96102.65) 65.85 (45.9896.08) 0.3179
Table 6.2: Mean blood flows calculated for all locations and compared between
divers and controls. Values shown are medians and inter-quartile ranges of the
means. Significance was tested using the Wilcoxon rank sum test. Significant
differences are highlighted. Grey  significant increase in controls, pink  significant
decrease in controls. S  shallow, D  deep. n = 16.
in the divers significantly lower in all of these cases. In the respiration interval (II),
differences in normalized power were observed in half of the recording locations,
and again power was lower for the divers than the controls. The myogenic interval
(III) displayed significant differences in only 3 out of 8 recording locations. In two
locations (right ankle and left wrist), the myogenic power was lower in the diver
group, in contrast to the right arm where it was higher in the diver group. In 5 of
8 locations changes in normalized power were observed in the neurogenic interval
(IV). In all cases the power was higher in the diver group. Power in interval V
(endothelial), differed significantly in 4 out of 8 recording locations, with divers
showing higher power in all cases. Finally, in the lower endothelial interval (VI)
differences were revealed in 5 out of 8 recording locations, with divers again showing
higher power across all cases. All these differences are shown in Figure 6.8 and
Table 6.3.
Mean venous oxygenation values (STO2) and relative haemoglobin (rHb) values
as measured using the O2C can be seen in Table 6.4. Only values recorded from
shallow tissue are considered, as testing of the equipment revealed characteristic
peaks in the signal which records oxygenation in deeper layers even when attached




































































































































































































































































































































I II III IV V VI
Left ankle 0.0005 0.0400 0.1011 0.0039 0.0000 0.0000
Right ankle 0.0185 0.3558 0.0332 0.0302 0.0039 0.0035
Left wrist 0.3365 0.0167 0.0205 0.5591 0.1269 0.0621
Right wrist 0.0079 0.7774 0.1092 0.3179 0.8653 0.8065
Right foot (S) 0.1576 0.0063 0.6923 0.0098 0.2662 0.0400
Right foot (D) 0.9850 0.0167 0.1689 0.0864 0.5847 0.6647
Right arm (S) 0.0021 0.0864 0.3558 0.0302 0.0185 0.0050
Right arm (D) 0.0006 0.2067 0.0063 0.0021 0.0035 0.0013
Table 6.3: Results of significance testing of the total normalized power in fre-
quency intervals on blood flow intervals between divers and controls (see Figure
6.8) using the Wilcoxon rank sum test. Significant differences are highlighted.
Grey  significant increase in controls, pink  significant decrease in controls. n =




Right foot (S) 29.52 (18.4837.53) 47.18 (35.7555.98) 0.0027





Right foot (S) 52.40 (46.9562.75) 57.25 (50.5264.57) 0.4624
Right arm (S) 44.62 (36.1652.75) 49.09 (44.3756.20) 0.1011
Table 6.4: STO2 and rHb means calculated for both locations and compared
between divers and controls. Values shown are medians and inter-quartile ranges
of the means. Significance was tested using the Wilcoxon rank sum test. Significant
differences are highlighted in grey. S  shallow. n = 15.
have been excluded from the analysis. Mean STO2 values differed significantly
between divers and controls in the right foot (controls higher, p = 0.0027), but
not in the right arm. Standard deviations of STO2 did not differ significantly
between divers and controls at the right foot or the right arm (p = 0.0734 & 0.4397,
respectively). Mean rHb values did not differ significantly between groups in either
recording location (p = 0.4624 & 0.1011, respectively). Standard deviation of rHb
did not differ significantly at the right foot (p = 0.4856), but was significantly
higher in controls in the right arm (p = 0.0010).
Wavelet transforms of the STO2 signals were calculated. One STO2 signal
recorded contained sustained unphysiological peaks, thus was removed from the
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Figure 6.9: Comparison of STO2 wavelet power between groups and locations.
Significant differences are highlighted in grey. n = 15 for both groups.
following analysis, in addition to its counterpart from the control group. Dif-
ferences in STO2 are shown in Figure 6.9 for the remaining 15 divers and their
controls. Significant differences between STO2 wavelet power in divers and con-
trols was observed below 0.026 Hz at both locations and below 0.4 Hz in the right
foot.
6.3.3 Blood flow and oxygen dynamics during apnoea
Following the comparison of the freedivers with non-diving controls, it is apparent
that the blood flow and oxygen dynamics of people trained to regularly deal with
hypoxemia and hypoxia differ from those who are untrained. In order to assess
the underlying mechanisms of this altered physiological state, here the blood flow
and oxygenation signals of the freedivers are characterised during and between
breath-holds, to ascertain how their bodies respond to oxidative stress. The results
presented in this section cannot be compared with a control group, as it would
be physically impossible and dangerous for the non-divers to attempt such long
periods of apnoea. Therefore, controls are provided in the form of rest periods
within the apnoea protocol.
Data were recorded from the free divers [347] as shown in Figure 6.10. The
volunteers were supine and asked to remain as still as possible throughout. A
sequence of instructions was played to the volunteers from a pre-recorded cassette
tape. The volunteers were advised that they should breath normally if they felt
140
Rest 1 Rest 2
Figure 6.10: Timeline of free diver breath-hold protocol for the data previously
recorded in [347]. The breath-hold portion of the protocol begins after 2100 sec-
onds. Breath-holds are numbered. The length of breath-holds 5 & 6 varied between
subjects. The 30 minute relaxed period and the breath-hold period were separated
by a five minute free period in which the subjects were able to move.
any discomfort.
The resting period shown in the first 30 minutes is that investigated in Sec-
tion 6.3.2. This was followed by a five minute period of free breathing in which
movement was allowed; this section is not analysed. The breath-hold protocol was
then applied, beginning with 4 consecutive sets of 150 seconds breathe-up, fol-
lowed by 150 seconds of breath-hold. These were followed by another 150 second
breathe-up before a `best endeavours' breath-hold, subject to safety constraints. A
period of relaxed breathing for approximately 540 seconds followed, before a final
naive `best endeavours' breath-hold. No countdown warning was given for the final
breath-hold. The heart rate, arterial blood oxygen saturation and transcutaneous
carbon dioxide were monitored throughout, to maintain safe levels. These were
determined as a heart rate of 35 to 135 beats per minute, arterial oxygen satura-
tion > 75% and transcutaneous partial pressure of carbon dioxide within the range
3kPa to 8kPa. This protocol provides 6 breath-holds per subject for analysis, with
breath-holds 5 & 6 varying in length between subjects (see Table 6.9).
The experiments were undertaken within the Physics Department at Lancaster
University. Each volunteer was required to provide certification from a physician
confirming a recent examination of cardiovascular and respiratory health.
Example signals as recorded from one subject are shown in Figure 6.11, and
example wavelet transforms of a respiration, blood flow and STO2 signal are shown

































































































































































































































































































































































































Figure 6.13: (a) Example heart rate signals from four breathe-up periods from
one free diver. (b) Example heart rate signals from four breath-hold periods for
the free diver in (a). (c) Boxplots of mean heart rates for all free divers during rest
(R), breath ups (BU) and breath-holds (B). (d) Boxplots of standard deviation of
heart rates for all free divers during the three states. (e) Example SpO2 signals
from four breathe-up periods from one free diver. (f) Example heart rate signals
from four breath-hold periods for the free diver in (e). (g) Boxplots of mean
SpO2 for all free divers the three states. (h) Boxplots of standard deviation of
SpO2 for all free divers during the three states. Outliers are shown as red crosses.
Significant differences were found in both mean and standard deviation of heart
rate and SpO2, and are discussed in detail in Section 6.3.3 of the text. n = 16 for
all comparisons, which were performed with the Kruskal Wallis test.
the first five breathe-up periods and the breath-hold which immediately followed
them. The second part, consisting of the longest resting period in the breath-hold
protocol for which breathe-ups were not permitted, followed by the only naive
breath-hold, provides an opportunity to compare data in a more natural scenario.
Systemic changes during apnoea
First, the signals were investigated in the first part of the breath-hold period, as
described above, in terms of their average values, and compared between the rest-
ing state, the breathe-up state, and during breath-holds. For the breathe-up and
breath-hold periods, five data sets were available for each subject. These data sets
were averaged for each subject, ensuring that a paired signed-rank significance
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test could be performed on the data to account for baseline perfusion differences
between subjects. Mean heart rate as measured by the TOSCA500 differed signif-
icantly between the three states (p = 0.0003). Further inspection highlighted that
this difference arose from the resting heart rate being significantly lower than in
both the breathe-up and breath-holds periods (p = 0.0004 in both cases). How-
ever, heart rate did not significantly differ between the breathe-up and breath-hold
periods (p = 0.4691). Similarly, the standard deviation of the heart rate differed
significantly between groups (p = 0.0020), and again the values at rest were lower
than in both breathe-ups and breath-holds (p = 0.0008 & p = 0.0016, respectively).
The standard deviation of the heart rate did not significantly differ between the
breathe-up and breath-hold states (p = 0.1477) (see Figure 6.13).
SpO2 was compared between the same three states, at rest, during breathe-ups
and during breath-holds, and significantly differed in terms of both mean (p =
0.0200) and standard deviation (p = 0.0000). Mean resting SpO2 was significantly
lower than during breathe-ups (p = 0.0061), but did not significantly differ to SpO2
during breath-holds (p = 0.2343). Mean SpO2 also significantly differed between
the breathe-up and breath-hold periods (p = 0.0006), with breath-holds exhibiting
lower mean SpO2. Standard deviation of SpO2 was significantly lower in the resting
period than during breathe-ups (p = 0.0038) and breath-holds (p = 0.0005). SpO2
during breathe-ups showed significantly lower standard deviation of SpO2 than
during breath-holds (p = 0.0023).
Systemic changes during naive apnoea
To investigate how heart rate and SpO2 changes during a naive breath-hold, these
parameters were also compared between the 30 minute rest period (rest 1), the
short rest period during the breath-hold protocol (rest 2) and breath-hold 6 which
immediately follows it, importantly after no breathe-ups. An example of the signals
from these groups is shown in Figure 6.14. Mean heart rate differed significantly
between these groups (p = 0.0010) with mean heart rate during the breath-hold
145
Figure 6.14: (a)(c) Example heart rate signals recorded from one subject using
the TOSCA500 during rest 1, rest 2 and breath-hold 6. (d) Boxplots of mean
heart rates, which differed significantly between groups (p = 0.0010). (e) Boxplots
of standard deviation of heart rate, which differed significantly between groups
(p = 0.0162). (f)(h) Example SpO2 signals from one subject during the three
states. (i) Boxplots of mean SpO2, which did not differ significantly (p = 0.5933).
(j) Boxplots of standard deviation of SpO2 which differed significantly between
groups (p = 0.025). Outliers are shown as red crosses. n = 16 for all comparison,
which were performed with the Kruskal Wallis test.
higher than both rest 1 (p = 0.0000) and rest 2 (p = 0.0003). Heart rate during
rest 2 was also significantly higher than rest 1 (p = 0.0002). Standard deviation
also significantly differed between groups (p = 0.0162). SD of heart rate during
rest 2 was significantly lower than in rest 1 (p = 0.0125) and breath-hold 6 (p =
0.0084). Standard deviation of heart rate did not differ significantly between rest
1 and breath-hold 6 (p = 0.3894). Mean SpO2 did not differ significantly between
groups (p = 0.5933), but standard deviation did (p = 0.025), with SD of SpO2
significantly higher in B6 than rest 1 (p = 0.0034), but not rest 2 (p = 0.7615).
SD of SpO2 did not significantly differ between R2 and R1 (p = 0.0730).
Local changes during apnoea following breathe-up
Blood flows recorded from all eight locations were compared in terms of mean flows
and standard deviation of flow, between resting, breathe-up and breath-hold states.
The results of significant tests between groups for all locations and all divers are
shown in Table 6.5. The significance values reported under the heading `All' are
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the results of the Kruskal Wallis ANOVA test on all groups, which does not find
significant differences in most cases. This is likely due to the fact that different
mechanisms and conditions are being tested between groups, and therefore the test
may not be appropriate in this context, but is included for completeness. Based
on the results of the signed-rank paired test between groups it was found that
at all blood flow recording locations, mean blood flow is significantly lower during
breath-holds than during breathe-ups. In five out of eight recording locations mean
blood flow is also significantly lower than that recorded at rest. Even in the three
cases which were not significant (left ankle, right wrist and right arm (deep)), the








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6.15: Example blood flow, STO2 and rHb signals, during the breathe-
up period and during breath-holds. Signals are not all from the same subject,
but were chosen to represent cases in which significant differences were revealed.
(a)&(b) Example blood flow signals from the right arm (shallow) of one diver
during breathe-ups and breath-holds. (c)&(d) Boxplots of mean and standard
deviation of blood flow for all subjects at the right arm (shallow). (e)&(f) Example
STO2 signals from the right foot (shallow) of one diver during breathe-ups and
breath-holds. (g)&(h) Boxplots of mean and standard deviation of STO2 for all
subjects at the right foot (shallow). (i)&(j) Example rHb signals from the right
arm (shallow) of one diver during breathe-ups and breath-holds. (k)&(l) Boxplots
of mean and standard deviation of rHb for all subjects at the right arm (shallow).
Standard deviation of blood flow was found to be significantly lower during
breath-holds than during breathe-ups at all recording locations. In three out of
eight locations standard deviation of blood flow is also significantly lower during
breath-holds than at rest.
Mean values of STO2 and rHb signals were compared between the same three
states. Results are shown in Table 6.6. In both recording locations, on the right
foot and right arm, mean STO2 was significantly lower during breath-holds than




















































































































































































































































































































































































































































































































































































































































































































































































breathe-ups and breath-holds than during rest. On the right arm, mean rHb val-
ues significantly increased during breathe-ups when compared to rest, and during
breath-holds when compared to rest and breathe-ups. In contrast, no significant
changes in mean rHb were observed on the right foot. The standard deviation of
STO2 differed significantly on the right arm, with reduced SD during breathe-ups
and breath-holds when compared to rest, but not on the right foot. Only one
significant difference in the standard deviation of rHb values was observed, with a
lower SD of rHb during breathe-ups than during rest on the right foot. Example
signals can be seen in Figure 6.15.
Local changes during naive apnoea
Comparisons of mean blood flow between the initial 30 minute rest period (R1),
and the approximately 540 second rest period (R2), showed significant differences
in 3 out of 8 recording locations, with the right foot exhibiting lower mean blood
flow (p = 0.0032) whilst the two recordings from the right arm showed an increase
(p = 0.0340 & p = 0.0113). Standard deviation of blood flow did not differ signifi-
cantly between states R1 and R2 except in the shallow recording of the right foot
(p = 0.0437). Mean blood flow was significantly reduced in 2 out of 8 locations
(right ankle & right foot (S)) when comparing R1 with breath-hold 6 (B6) (see
Table 6.7), whilst the standard deviation of blood flow was significantly reduced in
half of all locations. When comparing R2 with B6, mean blood flow was revealed
to be significantly reduced in 3 out of 8 locations. The standard deviation of flow
in this case differed in only 2 locations.
Oxygenation parameters were also compared between R1, R2 and B6 (see Table
6.8). Mean STO2 only significantly differed on the right foot, where it was lower in
B6 than in R1. Standard deviation of STO2 significantly differed in both locations
between R1 and R2, with a decrease observed in both. SD of STO2 also significantly
differed on the right arm between R1 and B6 (decrease) and R2 and B6 (increase).
Mean rHb values significantly increased on the right arm, in all tested comparisons,
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Figure 6.16: Example of the effect of involuntary contractions on LDF signals.
Top - Large deviations in the respiration signal (black line) are observed during the
latter part of the breath-hold, caused not by breathing but by involuntary chest
contractions, which directly affect the blood flow signal (red line) recorded at the
left wrist. Bottom - windowed phase coherence demonstrates very high coherence
between the respiration and blood flow signals once contractions begin.
whilst on the right foot the only significant difference was an increase in B6 from
R2. Standard deviation of rHb did not differ in the right foot, but decreased in
R2 when compared to R1 on the right arm, and increased in B6 when compared
to R2.
Involuntary chest contractions
In the majority of subjects, involuntary chest contractions were observed during
the latter part of breath-holds. These phenomena, and many physiological param-
eters related to them were studied in [347]. These physical movements of the chest
directly affect many of the recorded signals, with those most sensitive to move-
ment, including LDF, most affected. Therefore great care must be taken when
interpreting signals recorded during this period. An example of involuntary con-
tractions, and their effect on a blood flow signal, is shown in Figure 6.16. It is clear
that any time-frequency analysis on these affected signals may lead to unreliable
results. Therefore, the influence of the contractions must be removed from the





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































latter part of the signal. Attempts were made to extract the effects of respiration
from the LDF signals using nonlinear mode decomposition, using the respiration
signal as a reference, but this was unsuccessful in the majority of cases. When
an extraction was successful, NMD returned a sinusoidal waveform, which is not
precise enough for this purpose. Wavelet phase coherence was calculated between
respiration and all blood flow signals during breath-hold six. Although significant
coherence was not found in all instances during contractions, the uncertainty of
how much each LDF signal is affected by the involuntary contractions necessitates
the exclusion of all data recorded for their whole duration. Therefore, only the
periods before they begin are considered. Updated signal lengths are presented in
Table 6.9.
Blood flow and oxygenation dynamics during naive apnoea
It is clear from the presented results that there is a huge difference in the way the
body reacts to apnoea depending on whether it follows a period of breathe-ups or
not. Thus, only signals recorded during the naive breath-hold (B6) are considered
in this section. Whilst the investigation of the studied parameters in terms of av-
erage values has revealed insights into systemic and local physiological behaviour,
these do not provide any information regarding the time-evolution of these param-
eters, and whether this varies between states. To extract this information from the
data, time-frequency analysis methods are required. The rest period of approxi-
mately 540s allows the observation of oscillatory activity down to the neurogenic
interval to be studied, but not all breath-holds are long enough to allow the neu-
rogenic interval to be studied. In most cases, this rest period contained a large
peak at the beginning, as the parameters recovered from the previous breath-hold.
This peak was removed for time frequency analysis to avoid the increased power at
lower frequencies in which this would result. The lengths of breath-holds five and




B5 length B6 length B5 length R length B6 length
(s) (s) BC (s) (s) BC (s)
1 183.6 161.2 114.7 574.0 94.2
2 168.6 41.1 157.5 597.3 41.1
3 210.6 192.8 124.4 550.3 83.9
4 232.7 158.8 131.3 541.1 90.2
5 294.3 216.9 240.2 470.3 157.5
6 225.6 159.8 87.6 540.4 71.7
7 247.8 225.4 176.5 515.4 192.3
8 338.2 105.3 166.0 423.4 100.6
9 248.6 266.7 248.6 524.1 206.1
10 127.2 82.4 113.7 651.3 79.8
11 245.1 260.0 209.0 519.0 210.5
12 234.3 199.9 114.0 536.2 87.3
13 212.8 221.9 146.1 561.7 134.5
14 398.1 350.2 246.3 386.7 244.7
15 240.3 293.6 150.2 528.4 137.4
16 194.8 189.5 157.9 569.0 138.3
Table 6.9: Lengths of breath-holds five and six for all subjects, and their lengths
after removing periods affected by involuntary contractions (BC).
The varying length of breath-hold 6 led to varying lower limits of frequencies
observable in the wavelet transform. To allow reliable comparisons between groups
in different frequency intervals, spectra were required to span the whole frequency
interval to be included in the calculations for that interval, for example, to be
included in comparisons in the neurogenic interval, data must be available in the
frequency spectrum down to at least 0.021 Hz. Breath-hold 6 for subject 2 was
very short (41 seconds) and so subject 2 was removed from the analysis. Many
signals from subject 10 contained unphysiological spikes, thus subject 10 was also
removed from this analysis. Based on these constraints, the following data are
calculated from 14 subjects in frequency intervals I, II & III, and 4 subjects in
intervals I, II, III & IV. Due to this small sample size available in the neurogenic
interval, care must be taken with interpretation of the results. Before analysis,
signals were detrended with a moving average with a window size of 50 seconds.
Wavelet transforms of blood flows were calculated for all recording locations, and



















































































































































































































































































































































































Figure 6.18: Boxplots of absolute wavelet power in frequency intervals IIV dur-
ing rest (black) and during breath-hold 6 (red) for both STO2 recording locations
in 14 subjects down to the myogenic interval and 4 subjects down to the neurogenic
interval. Statistically significant differences are denoted with yellow asterisks. *
= p < 0.05, ** = p <0.01, *** = p < 0.001. Outliers are shown in red.
Significant differences were revealed in all locations, as shown in Figure 6.17.
Comparisons of power in individual frequency intervals revealed significant differ-
ences in cardiac power in all locations, with a lower power observed during B6
than in R2 in all cases. In the respiration interval, 5 out of 8 locations showed
significant differences in power, with the power being lower during breath-hold,
as expected. Only blood flow recordings from the right arm showed significant
differences in the myogenic interval (p = 0.0134 (shallow), p = 0.0419 (deep)),
whilst no differences were observed in the neurogenic interval. Comparisons of
STO2 recorded at the right foot and right arm revealed significant differences only
in the respiration interval (p = 0.0134 and 0.0009, respectively).
This approach to the characterization of blood flow dynamics, i.e. applying sta-
tistical tests at all frequencies for all subjects, may not be optimal if the natural
frequencies of vasomotion varies between subjects, as is likely the case. Whilst this
spectral averaging approach would highlight any systematic, large differences be-
tween states, it may cause small variations to be overlooked, due to averaging over
many different frequencies and subjects. To ensure that individual differences in
blood flow dynamics were taken into account, all blood flow signals were inspected
for signatures of vasomotion, and their characteristics recorded. Using again the
blood flow signals recorded during the rest period R2 and the naive breath-hold
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Figure 6.19: Example blood flow signal recorded during rest and breath-hold 6.
(a) Blood flow recorded in subject 14, during R2 and B6, the beginning of the
breath-hold is shown by a red line. (b) Continuous wavelet transform of R2. (c)
CWT of B6. (d) Time averaged wavelet power spectra for the rest period (black
line) and breath-hold 6 (red line). In this case the power and frequency of low
frequency oscillations are reduced during breath-hold.
B6, signals were investigated provided that they met the following criteria: 1) sus-
tained oscillations were present in the resting portion of the signal, 2) the length
of B6 is long enough to include at least two of these oscillations, 3) there is no
transient present at the start of B6, or if there is, it does not completely dominate
the spectrum. An example of one of the tested blood flow signals is shown in
Figure 6.19. In this case, the oscillations present during R2 are reduced in both
power and frequency during breath-hold. The peaks of oscillatory activity were
recorded for all signals which met the criteria in order to ascertain whether there
were any common effects of apnoea on blood flow dynamics. In total, 39 data sets
met the above criteria. Power and frequency of the dominant peaks were recorded
in each data set during R2 and B6. To allow the observation of lower frequencies,
the wavelet transform was calculated with a less strict cone of influence, at the
expense of reducing accuracy. All signals were carefully inspected to ensure that
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recorded peaks were real. Based on individual differences in power and frequency,
no distinct patterns arose for the alterations in vasomotion during apnoea. During
apnoea, the power of oscillations increased in 18 out of 39 cases, and decreased
in 21. The frequency of oscillations increased in 14 out of 36 cases and decreased
in 20, with no change in 2 cases, showing a slight preference for a decrease in
frequency of oscillations.
6.4 Summary
This chapter aimed to determine whether blood flow and oxygenation dynamics
are altered during apnoea. Apnoea provides an opportunity to study physiological
parameters during a state of oxygen deprivation. In a previous study, free divers
were recruited and requested to follow a protocol involving periods of rest and
breath-holds. The very nature of the training practised by the free divers means
that their physiology may be permanently altered in order to adapt to the de-
mands of long periods of apnoea. To investigate the extent of these alterations, a
control group of age- and sex-matched, healthy, non-divers were recruited. Clear
differences were found between divers and controls. Whilst mean heart rate did
not vary between the groups, heart rate variability significantly varied below 0.04
Hz, with the divers showing more variability in their heart rates. This could indi-
cate that their hearts are much more efficient at responding to the needs of their
bodies, an adaptation that could have arisen from their apnoea training. Similarly,
arterial oxygen saturation recordings showed no difference in mean values between
divers and controls but significantly higher variability in divers.
Wavelet phase coherence analysis between respiration and SpO2 showed signifi-
cant coherence in both groups, showing that the observed peaks in SpO2 are related
to respiration, and this coherence differed significantly between divers and controls,
with coherence in divers occurring in a slightly narrower range. Phase coherence
was also calculated between respiration and heart rate variability, to investigate
whether respiratory sinus arrhythmia is altered in divers. The results suggest that
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this phase coherence significantly differs between groups at lower frequencies, with
divers demonstrating higher coherence, perhaps due to their increased heart rate
variability. Comparisons of blood flow between divers and controls did not reveal
a global difference in mean blood flows, with significant differences found only
in the right and left wrists, which are only two out of eight recording locations.
In contrast, significant differences were found in the time-averaged normalized
wavelet power spectrum in all recording locations, at varying frequencies between
groups. The blood flow dynamics results show that the normalized power spectra
of the divers differ in that they generally show a decrease in power in the cardiac
frequency interval, and an increase in power in the lower frequency intervals IV,
V, and VI. This again points to an increased efficiency in free divers, this time
at a local level. As vasomotion is beneficial to tissue perfusion, an increase in
vasomotion in divers could suggest that their mechanism of substrate delivery is
optimised due to their apnoea training. However, the normalization of these blood
flow spectra necessitates careful interpretation of the results. The differences seen
could also arise from the observed reduction in cardiac power, which may not be
related to the efficiency of tissue perfusion, but the elasticity and regulation of
the vessels themselves. It has previously been shown that vessel elasticity reduces
with age [351], and that this may cause the cardiac component of an LDF signal
to dominate the spectrum. This is because of a gradual decline in the health of the
blood vessels, but may be applicable here. It is possible that the divers may have
healthier, more efficient vasculature in general than their counterparts; this may
also manifest as the result seen here. Another possibility is that the vasomotion
in the control group is less synchronized, and thus the power at each frequency
would be more variable and lead to lower power overall.
Signals recorded during apnoea were used to characterise blood flow and oxy-
genation dynamics during a period of reduced oxygen intake. The most interesting
states to consider would be hypoxaemia, a systemic low concentration of oxygen
in the blood, or hypoxia, a local reduction in oxygen. Unfortunately, whilst hy-
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poxaemia did occur during some breath-holds, it corresponded to the periods in
which involuntary chest contractions were observed in some divers, meaning that
the data recorded during these periods was not reliable. Hypoxia, a local lack of
oxygen, was also observed very rarely, defined for the O2C device as an oxygen
saturation of <10%. The values recorded by the O2C are relative however, so
the differences in local oxygenation were considered, rather than considering this
possibly unreliable marker of hypoxia.
The data recorded during the apnoea protocol were considered in two parts.
Part 1 consisted of data recorded in breath-holds following breathe-ups, and part
2 considered naive breath-holds. Part 1 compared physiological parameters during
the 30 minute rest period (R1), the breathe-up periods (BU) and the breath-
holds following them (BH), whilst part 2 compared the long rest period (R1),
short rest period preceding breath-hold 6 (R2) and breath-hold 6 (B6). In both
parts, systemic differences were observed between R1 and breath-hold. Mean heart
rate was significantly increased during breath-hold in both parts, as was standard
deviation of SpO2. However, whilst standard deviation of heart rate was increased
in breath-holds during part one, there was no significant difference in part 2. Mean
SpO2 did not change in either part between R1 and breath-holds, but differences
were observed when taking into account the intermediate signals from the breathe-
up period in part 1 and the R2 period in part 2. This highlights the fact that
neither period BU nor R2 can be considered as a true rest period, as they differ
significantly from the data recorded in R1. This leads to the question of whether
the breath-holds following these periods would be affected by such changes. The
closest to rest is the period R2, as there is no artificial breathing for the purposes
of lung packing, and thus breath-hold 6 is the closest to a natural breath-hold
available in this data.
Mean blood flows were calculated for each part. The differences found between
mean blood flows in breath-holds and rest periods heavily depended on whether
they were preceded by a breathe-up period or not. In part 1, mean blood flow
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significantly decreased during breath-hold in five out of eight recording locations
when comparing to R1 and in all recording locations when comparing to BU. In
contrast, in part 2, mean blood flow was only significantly reduced in two recording
locations when comparing to R1 and 3 recording locations when comparing to R2.
This highlights the effect breathe-ups can have on the mean blood flow of the
subsequent breath-hold. In terms of mean STO2, the results were similar between
part 1 and part 2, with a decrease in mean STO2 observed on the right foot but
not the right arm in both parts, when comparing the breath-hold to the true rest
period R1. Mean rHb showed a significant increase on the right arm but not on
the right foot in both cases.
In light of the differences introduced to blood flow and oxygenation recordings
by breathe-ups, blood flow and oxygenation dynamics analyses were only per-
formed for naive breath-holds. In order to observe directly the differences induced
by apnoea, the power spectra of R2 and B6 were compared for each subject. The
short time periods of available data, made shorter by removal of data recorded
during involuntary chest contractions, limit the information available at lower fre-
quencies. All included subjects could be compared down to the myogenic frequency
interval, whilst 4 subjects provided recordings long enough for the neurogenic in-
terval to be compared. Possibly as a result of this small sample size, no significant
differences were found in interval IV for any recording location. Significant differ-
ences in the myogenic interval (III) were only observed in the right arm, at both
shallow and deep recording locations. In both cases, the power in interval III is
significantly lower during breath-hold than during rest. Cardiac power decreased
significantly during breath-hold in all recording locations. These results suggest
that apnoea does not have a significant effect on local blood flow dynamics overall,
at least in free divers. However, this does not mean that there would not be a
significant effect in untrained individuals.
Inspection of the data from each subject revealed unique responses for each
individual, with some signals showing barely any difference during apnoea, whilst
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others showed significant alterations in their oscillatory activity. Therefore, each
data set was individually inspected for evidence of vasomotion, i.e. sustained os-
cillations, in the rest period R2. If these were found, the absolute power and the
frequency of the most prominent peak in the spectrum was recorded, both during
R2 and B6 to see if this activity was altered during apnoea. Results from this
analysis proved to be inconclusive, with no significant trends revealed, other than
a slight preference for a decrease in frequency of oscillations during apnoea.
The main results of this chapter reveal the physiological differences between
normal healthy humans and free divers, in terms of systemic and local dynamics
of blood flow and oxygenation. Differences likely arise from increased efficiency of
delivery of nutrients as a direct result of the training of the divers, possibly coupled
with a genetic predisposition to be able to deal with such conditions. Whilst
a very interesting state to observe, it is clear that divers possess very specific
physiological responses, and thus no conclusions can be drawn about blood flow
and oxygenation dynamics in normal humans from these data. Further research
would be necessary to enable the same observations in non-divers. As it would
be impossible for untrained individuals to follow a protocol involving such long
periods of apnoea, the desired state of oxygen deprivation could be achieved using
an altitude simulation device, which simulates the reduced oxygen partial pressures
found at high altitudes. In a carefully controlled environment, this protocol could
provide the opportunity to safely study the hypoxic state, and also provide much
more opportunity to ensure the protocol for each individual was identical, rather
than the varying breath-hold lengths studied here.
In summary, this chapter demonstrates the following:
 The physiology of free divers is permanently altered when compared to non-
diving controls, in terms of heart rate variability and arterial oxygen vari-
ability.
 Wavelet phase coherence analysis showed that divers exhibit higher phase co-
herence between respiration and heart rate variability at frequencies around
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0.0250.075 Hz.
 Comparisons of mean blood flow between divers and controls at rest showed
no global differences, whilst the time-averaged normalized wavelet power
spectra were significantly different in all recording locations, generally show-
ing a decrease in power in the cardiac frequency interval and an increase in
intervals IV, V & VI in divers when compared to controls. This suggests an
increased efficiency in local blood flow regulation in divers.
 These results suggest that the training undertaken by free divers has sig-
nificantly altered their physiology, to meets the demands of regular oxygen
deprivation.
 Breathe-ups significantly alter the physiological response in the subsequent
breath-hold, and thus cannot be used as a rest period for accurate compar-
isons.
 During apnoea, in general, mean heart rate increases, the cardiac contri-
bution to blood flow decreases, mean blood flow decreases and mean STO2
decreases.
 In cases where sustained oscillations were present, indicating the presence
of vasomotion, the frequency of these oscillations decreased in the majority
of cases during apnoea. This agrees with the model presented by Goldman
and Popel [82], in that low frequency oscillations appear to be most useful
for effective tissue oxygenation.
 The results presented in this chapter from the apnoea protocol go into more
detail than previously [347] regarding the blood flow dynamics observed dur-
ing breath-holds. The previous study only considered vasomotion in one
volunteer during apnoea.
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7. Modelling metabolic oscillators
Energy production within a living cell is far from constant. Variations in sup-
ply and demand may result in continuous fluctuations of adenosine triphosphate
(ATP) concentration. Recently developed experimental techniques for the obser-
vation of cellular metabolism, including fluorescence microscopy [232, 220] and
fluorescence resonance energy transfer (FRET) biosensors [219], clearly illustrate
metabolic fluctuations, though sometimes they are overlooked due to averaging
[352] or considered as purely stochastic [353]. However, whilst their existence is
not universally accepted, metabolic oscillations have been observed in many stud-
ies in the mitochondria [245, 241, 220], in glycolysis [243, 227, 354, 219] and in
both simultaneously [1].
Thus, both glycolysis and oxidative phosphorylation (OXPHOS) can be con-
sidered as biological oscillators with variable frequencies depending upon external
concentrations of oxygen and glucose [241, 239]. Moreover, they are coupled and
can drive and modulate each other [226, 1, 227], which is essential to the main-
tenance of sufficient ATP levels. It is these interactions which determine the
metabolic state of a cell. When the conditions within a system change (e.g. in hy-
poxic or cancerous cells), the interactions between metabolic oscillators also change
[1, 227], thus changing the oscillatory dynamics of metabolism. These changes are
complex and not well understood.
In addition to being oscillatory, energy production in a cell is inherently time-
dependent. Taking a single snapshot in time of a system with time-varying dy-
namics, be it a single cell or a whole organ, cannot provide sufficient information
166
about its past or future evolution, or its interactions with its environment. In-
stead, it must be considered as a non-autonomous dynamical system [355, 289] to
fully gain a realistic understanding of its behaviour. Thus, in this chapter, cellu-
lar metabolism is modelled using non-autonomous oscillatory dynamical systems,
with the aim of characterizing these oscillations in healthy and altered metabolic
states. More specifically, coupled chronotaxic phase oscillators were used to in-
vestigate the interplay between glycolytic and mitochondrial involvement in ATP
production in the presence of glucose and oxygen. It is demonstrated that using
this model it is possible, in different scenarios, to identify which metabolic path-
way plays the dominant role. In particular, the metabolic dysfunction which is
well known to be present in cancer is considered. It is shown that chronotaxicity
may change during the transition from the normal to cancerous state, and be used
to detect this transition. Finally, it is demonstrated how this method could lead
to the observation and identification of these states experimentally. This could
provide an opportunity to follow the temporal evolution of metabolic dysfunction,
and its possible links to carcinogenesis.
7.1 Modelling cellular energy metabolism
A simple diagram of cellular energy metabolism was presented in Fig. 2.4. Here,
cellular energy metabolism is modelled using the following assumptions, based on
the observed characteristics of cellular energy metabolism discussed previously:
1. Energy metabolism in a cell consists of two main processes, glycolysis and
mitochondrial respiration.
2. Oscillations have been observed in both glycolysis and mitochondrial respi-
ration.
3. ATP is produced within a cell through a combination of these pathways,
depending on the state of the cell.
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4. Cellular energy metabolism responds to environmental changes, up or down-
regulating glycolysis as necessary, through sensing of ATP levels.
5. Glycolytic oscillations have been shown to depend on sugar transport, and
mitochondrial membrane potential oscillations have been associated with
cycles of oxidation, in addition to plasma membrane potential oscillations
and Ca2+.
Characteristics 1 & 2 are represented by two phase oscillators. Glycolysis is
considered as one oscillator, the glycolytic oscillator (GO). Mitochondrial respira-
tion, i.e. the Krebs cycle and OXPHOS, is represented by another oscillator, the
mitochondrial oscillator (MO). The output of both the GO and MO is oscillatory
ATP, denoted ATPGO and ATPMO, respectively. In accordance with 3 & 4, these
oscillators are bidirectionally coupled. The dependence of the GO on the MO is
represented by a repulsive coupling, to replicate the downregulation, via inhibi-
tion of phosphofructokinase (PFK) [226], of ATP produced by glycolysis when
mitochondrial ATP output is high. Glycolysis is not completely suppressed, but
remains at a level which is sufficient to provide the substrates required for the MO
to remain the dominant pathway. Based on this coupling, reduction of ATPMO,
as expected in the transition towards cancer, will reverse the inhibition of PFK
in the GO, causing increased ATPGO. Thus, oscillations in metabolism would be
driven by glycolysis, due to it becoming the primary producer of ATP. This is
exactly what has been observed experimentally at near anoxia [227], as well as
under semi-anaerobic conditions [1]. In this case however, it also has to be consid-
ered that glycolysis will be more responsive to ATPMO oscillations, as they provide
glycolysis with information on the current status of the mitochondria. Taking this
into account, the MO has an increased ability to modulate the GO in this state.
The dependence of the MO on the GO is represented by an attractive coupling
due to the dependence of mitochondrial respiration on the products of glycoly-
sis. Here, nicotinamide adenine dinucleotide (NADH) is considered as the primary
influencing factor of the MO, representing glycolytic output. Considering this cou-
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pling in an altered state [211], increasing NADH levels from up-regulated glycolysis
will positively affect the ATPMO production. Here, it must also be considered that
the mitochondrial oscillator has a finite ability to utilise NADH, which will be low-
ered if the mitochondria are damaged, even if all required substrates are available.
This is represented as a saturation of the response, and thus in ATPMO output. As
the system moves towards this saturation, the influence of glycolysis on the MO
decreases, until being completely lost at saturation. This is in contrast to a state
with lower NADH concentration, where the GO is capable of modulating the MO.
Requirement 5 is represented in the model by two further oscillators, introduc-
ing external substrate availability in the form of oxygen for the MO and glucose
for the GO. These drivers unidirectionally influence the GO and MO with variable
coupling strengths.
Taking all of the above interactions into account leads to a phase oscillator
model of cellular metabolism,
ϕ˙g = ωg + ε1 sin(ϕg − ϕm)− ε4 sin(ϕg − ϕgluc);
ϕ˙m = ωm − ε2 sin(ϕm − ϕg)− ε3 sin(ϕm − ϕox),
(7.1)
where ϕg, ϕm, ϕgluc and ϕox are the phases of the GO, the MO, the glucose driver
and the oxygen driver, respectively, ε1 is the strength of the coupling from the
MO to the GO, ε2 the coupling strength of the GO to MO, ε3 the strength of the
oxygen driver on the MO and ε4 the strength of the glucose driver on the GO (see
Figure 7.1). Parameters ωg and ωm in (7.1) represent the natural frequencies of
GO and MO, respectively, and may be time-varying. ϕgluc and ϕox may also be
time-varying.
Only the interactions discussed above are included in the model, as shown
in Figure 2.4; other possible interactions between the GO and MO are neglected.





Figure 7.1: Model (7.1) of metabolic oscillations in a cell. The glycolytic and
mitochondrial oscillators (GO and MO, respectively) are represented by two phase
oscillators coupled to each other via repulsive ε1 (due to the inhibitory nature
of the influence of the MO on the GO) and attractive coupling ε2 (due to the
excitatory influence of the GO on the MO). Oscillators may be made chronotaxic
due to attractive couplings ε3 and ε4 to the glucose and oxygen drivers. The
GO and MO oscillators are chronotaxic when synchronised to an external driver
directly or via another oscillator.
of the system. Thus, despite its simplicity, the level of detail in the model is
sufficient to describe changes in metabolic states.
7.1.1 Determining metabolic states through chronotaxicity
When observing the frequency or amplitude of metabolic oscillations, it is difficult
to deduce any information about the metabolic state of the cell from a single time
series, as their variability may seem negligible [352]. The nonautonomous nature
of the system means that these frequencies or amplitudes can fluctuate irrespective
of the current metabolic conditions, making it difficult to study state transitions.
In this case, a parameter which changes exclusively during metabolic transitions
is needed. As it is expected that the interactions within the system will change
during transitions, a measure of these changes will allow the observation of switches
between metabolic states.
Metabolic oscillations as observed experimentally appear to be time-variable
yet very stable. Indeed, several studies of mitochondrial and glycolytic oscillations
demonstrate that metabolic fluctuations within a cell are not fully stochastic, but
they appear to have non-autonomous and deterministic oscillatory components,
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e.g. [232, 220, 1]. This suggests that although they exhibit time-dependent dynam-
ics, these dynamics are stable and resistant to external continuous perturbations
within certain ranges. Therefore, these oscillations may reflect underlying deter-
ministic processes, which may be used to identify the state of a cell. The stability
of the observed dynamics will change as the interactions in the system change,
therefore making it possible to observe metabolic transitions. This property of
stability, or ability to resist external perturbations, is described by the recently
introduced theory of chronotaxic systems [285, 286, 302, 287] (see Section 4.1.2).
Based on measurements from healthy cells and those with altered metabolism, the
apparent stability of glycolytic and mitochondrial oscillations suggests that they
may have chronotaxic properties. Chronotaxicity may exist when oscillations are
modulated [1, 227]; thus changes in the modulation, which will occur during a
transition to an altered metabolic state such as that observed in a cancer cell, will
be reflected in chronotaxicity.
7.2 Numerical simulations
The phase oscillator model presented above was simulated numerically with vary-
ing parameters using the Heun integration scheme with a time step of 0.1s and
white Gaussian noise added to the right hand side of Equations 7.1. Each param-
eter set was simulated for a period of 10,000 seconds. For each set of parameters,
the chronotaxicity of both the GO and the MO were tested. An oscillator was
considered to be chronotaxic if it was synchronized with an external driver, either
glucose or oxygen. Oscillators were considered synchronized if their phase differ-
ence remained within a 2pi interval during the second half (5,000 seconds) of the
full time-series (10,000 seconds). This condition restricts oscillators from making
phase slips, after allowances for transient effects.
Synchronization to the unidirectionally coupled driver results in the existence
of a point attractor, a key component of a chronotaxic system. In more complex










Table 7.1: Approximate characteristic frequencies of GO and MO in the regions
shown in Figure 7.3. In A, B & D each oscillator is synchronized to either its
driver or to the other oscillator. In these cases, frequencies are influenced by
the driving oscillators. In C, the oscillators are not synchronized to anything,
hence the characteristic frequencies are determined by the natural frequencies of
the oscillators. In E oscillators are synchronized to each other only, hence the
frequency ω∗ corresponds to the frequency of a synchronized state assuming ε∗ =
ε4 = 0, and it can be found from the condition of synchronization φ˙m − φ˙g = 0,
ω∗ = (ε1ωm− ε2ωg)/(ε1− ε2). In F & G one oscillator is synchronized to its driver
whilst the other is somewhere between the two drivers.
nization sometimes does not satisfy the contraction condition, Equation 4.7. In
this case, there is at least one direction in phase space where trajectories temporar-
ily diverge and deviate from the point attractor. However, as this is a temporal
deviation, it is unlikely to influence the observed dynamics. Therefore, the syn-
chronization of oscillators in the model presented is studied and considered as ap-
proximate chronotaxicity. Example phase trajectories for each region are shown in
Figure 7.2 and explained below. Seven different types of dynamics were revealed,
shown in Figure 7.3. Approximate frequencies of these oscillations in different
regions are summarised in Table 7.1.
The characteristics of the observed regions are as follows:
A  GO synchronized with glucose, MO synchronized with oxygen, GO & MO
not synchronized. Both GO & MO are chronotaxic.
B  GO synchronized with MO, both synchronized with glucose. Both GO &
MO are chronotaxic.
C  No synchronization. Neither GO nor MO are chronotaxic.
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D  GO synchronized with MO, both synchronized with oxygen. Both GO &
MO are chronotaxic.
E  GO synchronized with MO. Both oscillators experience multiple phase
slips. Neither GO nor MO are chronotaxic.
F  GO synchronized with glucose, MO not synchronized with oxygen, GO &
MO not synchronized. GO is chronotaxic, MO is not chronotaxic.
G  GO not synchronized with glucose, MO synchronized with oxygen, GO &
MO not synchronized. GO is not chronotaxic, MO is chronotaxic.
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Figure 7.2: Phase trajectories of the 7 types of dynamics which have been ob-
served in the model shown in Equation 7.1. In all cases ε3 = ε4 = 0.025. Cases
A, B, D, F & G show chronotaxicity in at least one oscillator, whilst the other
cases do not. The transition from the state where the system is chronotaxic due

















Figure 7.3: Chronotaxicity plot for ε1 vs. ε2 with ε3 = ε4 = 0.25. In this example,
the model was simulated for varying values of ε1 vs. ε2 whilst the influence of the
glucose and oxygen drivers remained the same. The type of dynamics observed
for each pair of values is shown with the colours shown on the right, showing the
GO as a circle on the left, the MO on the right, and their drivers as arrows from
the top and bottom, respectively. Dominant couplings are shown in black, whilst
absent or weak couplings are shown in grey.
















































Figure 7.4: Changing modulation from glucose and oxygen, ε3 = ε4. Glucose and
oxygen drivers may influence the system equally, as in Figure 7.3, but their values
can change. (a) ε3 = ε4 = 0.025. (b) ε3 = ε4 = 0.05. (c) ε3 = ε4 = 0.1. With
increasing influence of drivers, chronotaxic areas increase. (d) and (e) represent
a state in which the glucose driver has a larger influence on the system than the
oxygen driver, i.e. ε4 > ε3. (f) represents a state in which the oxygen driver has
a larger influence on the system than the glucose driver. In all cases ωg = 2pi/200
and ωm = 2pi/100. Colour code as in Figure 7.2 & 7.3.
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Figure 7.3 demonstrates the dynamics of the system when the influence from
the glucose and oxygen drivers is equal and relatively small. This results in a
large range of values for which the system is not chronotaxic. Increasing the
influence of glucose and oxygen on the system increases the proportion of cases
which are chronotaxic in the range studied (see Figure 7.4). Figure 7.4 also shows
the dynamics of the system when ε3 and ε4 are not equal.
So far, all simulations have been performed using the natural frequencies ωg =
2pi/200 and ωm = 2pi/100. Changing these frequencies, and thus the detuning
within the system will also have an effect on the dynamics of the system. Figure
7.5 shows the dynamics of the system with changing natural frequencies of the
GO and MO, with equal and unequal influences from glucose and oxygen. In a
real cell, it is highly unlikely that the natural frequencies of the oscillators or the
drivers will be constant. Therefore, in order to check the dynamics of the system
in the case of time-varying natural frequencies, the frequencies of the drivers,
glucose and oxygen, were allowed to vary in time. Thus, instead of the drivers in




were modelled as a slow sinusoid modulated by white Gaussian noise, and their
periods of oscillation were allowed to vary in the ranges: GO = 4 - 7 minutes and
MO = 2 - 3 minutes. This gives ranges for ωgluc of 0.0151 - 0.0264, and ωox of
0.0352 - 0.0522. The drivers were generated with a modulation frequency of 0.0003
Hz, and are shown in Figure 7.6.
It was demonstrated that chronotaxicity is found in the same regions as in the
non-variable case, with slight changes at the boundaries, but this may not hold
for very large variations, which may increase the frequency detuning sufficiently
to destroy the synchronization and thus the chronotaxicity.
7.2.1 Detection of chronotaxicity via the inverse approach
Following the dynamics of the system in terms of its chronotaxicity, the evolution
of the system from the normal to an altered metabolic state can be observed. One
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Figure 7.5: Effects of changing frequencies of GO and MO when ε3 = ε4 and
ε3 6= ε4. Different natural frequencies of oscillations may be considered, for ex-
ample in different cell types. Changing frequency detuning will affect regions of
chronotaxicity. In (a)(c) ε3 = ε4 = 0.025. (c) shows the chronotaxicity plot for
the system as considered in the main text, with natural frequencies ωg = 2pi/200
and ωm = 2pi/100. (a) shows the effects of increasing ωg. (b) shows the effects
of reducing ωg. In (d)(f) ε3 = 0.01 and ε4 = 0.1. The frequency of GO may
increase due to upregulated glycolysis, while the frequency of MO may decrease
due to mitochondrial dysfunction. (d) 'Healthy' natural frequencies in the case
where glucose is the dominant driver. (e) Substrate dependencies as in (d) but
with faster glycolytic and slower mitochondrial oscillations. (f) Effect of fixing the
glycolytic frequency and increasing the mitochondrial frequency.
pathway considered is the transition of the system from region B (chronotaxic
with glucose driver) to region D (chronotaxic, but now with oxygen driver), via
regions C and E (both non-chronotaxic). Identification of the chronotaxicity of
the system, and its dominant driver, allows the identification of the current sta-
tus of the metabolism, and whether it is in transition to an unfavourable state.
Utilising chronotaxicity as the defining parameter of the system is superior to the
consideration of synchronization alone, as it can be identified experimentally from
any single time series. To demonstrate the applicability of this approach to real
metabolic systems, inverse approach methods for the detection of chronotaxicity
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Figure 7.6: Effect of a time-varying driver on the chronotaxic dynamics of the
phase oscillator model. The dynamics are very similar, the only difference be-
ing that the boundaries between states are not as well defined, due to the slight









































Figure 7.7: Phase fluctuation analysis results from simulated ATP dynamics in
all 7 observed regions. PFA was correct in identifying whether the system was
chronotaxic or not in all cases. Time series shown are sin(ϕg,m).
were applied to the dynamic ATP signals arising from the model to ensure that
numerical and inverse approach chronotaxicity tests give the same results.
Methods for the detection of chronotaxicity were demonstrated in a complex
real life system  the cardiorespiratory system [302]. This study demonstrated
evidence of chronotaxicity in the heart rate variability when influenced by paced
breathing. In the case of cellular energy metabolism studied here, it would be
sufficient to have measurements of only ATPGO and ATPMO to determine the
chronotaxicity of each metabolic oscillator. To demonstrate this, inverse approach
methods were applied to the signals obtained from the different regions shown in
Figure 7.3 to identify their chronotaxicity status (see Figure 7.7). The chrono-
taxicity of each oscillator was determined separately, using only single time series.
Phase fluctuation analysis (PFA) (see Section 4.3.2) was used to distinguish be-
tween chronotaxic and non-chronotaxic dynamics. PFA shows very good agree-
ment between the chronotaxicity as calculated by the model using synchronization
conditions, and chronotaxicity as calculated via the inverse approach with no prior
knowledge. This illustrates that the method is a very promising tool for the ob-
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Figure 7.8: Example of the detection of chronotaxicity from a single ATP time
series using phase fluctuation analysis. (a) Example ATP signal obtained from the
model (region B) and its continuous wavelet transform. (b) The phase is extracted
twice, one with good frequency resolution (smoothed) and once with good time
resolution (noisy). DFA is performed on the difference between these phases (c)
and the DFA exponent is obtained (d). In this case, α = 0.5363, therefore the
signal is chronotaxic. From the wavelet transform we can see that the frequency
is around that expected during glycolysis, and thus we can say that the system is
chronotaxic due to the glucose driver.
servation and identification of chronotaxicity in real systems, where the dynamics
is unknown. A detailed example of PFA as applied to an ATP signal is shown in
Figure 7.8.
7.2.2 Experimental verification
In order to measure the required ATP levels as described, FRET-based ATP
biosensors could be used, which allow the measurement of ATP levels in differ-
ent cellular compartments [313], and could therefore be used to isolate the dy-
namics of each oscillator. The methods described in [247] and [248] could also be
used. Applying the inverse approach test for chronotaxicity as described above to
these data would provide valuable information about the current metabolic state
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of the cell, in terms of whether it is externally driven, or attracted to a moving
point attractor. In addition, the connection between ATP and cell membrane po-
tential may be utilised. As the intracellular ATP concentration determines the
work of ATP-dependent membrane pumps (e.g. Na-K-pumps and H+-pumps),
it determines the cell membrane potential according to the causal theory of the
cell membrane potential [356]. Therefore, oscillations in ATP may be visible in
oscillations of cell membrane potential.
7.2.3 Verification of the glycolytic oscillator
Another way to test the chronotaxicity of glycolytic oscillations in particular is to
utilise the closely linked dynamics of intracellular ATP and NADH arising from
glycolysis. It has been shown previously that both ATP and NADH are oscil-
latory in yeast cells during glycolytic activity, and that these oscillations have
the same frequency but are out of phase by around 180°[248, 249]. This means
that measurements of NADH in yeast cells may be used to provide an approxi-
mation of ATP dynamics. Although the amplitude of these parameters will differ,
their phase relationship will remain the same, and can thus be represented by the
phase oscillator model. Using this information, the model can be tested for the
case of the glycolytic oscillator based on NADH measurements, which are more
readily available. Glycolysis in yeast cells is one of the most widely studied and
well characterised biological oscillators. It was previously thought that glycolytic
oscillations only arose as a result of synchronization between yeast cells, but re-
cently Gustavsson et al. demonstrated glycolytic oscillations in individual isolated
yeast cells [357, 358]. Importantly, the observed oscillations, whilst occurring with
similar frequencies, were not synchronized. As the external glucose level in these
experiments was constant, the oscillations must occur as a result of an internal
mechanism, which is a possible cause of chronotaxicity in the model.
Here, data recorded by Gustavsson et al. [357] is tested for chronotaxicity,
to investigate the applicability of the model to real metabolic oscillators. Sac-
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charomyces cerevisiae cells were harvested at the time of diauxic shift, starved of
glucose for 3 hours and then stored at 04°C until use. The cells were then placed
in a microfluidic chamber at a distance of ∼ 10µm apart using optical tweezers.
The cells were covered with 20 mM glucose solution for 4 minutes before flows
were increased in order to cover the cells with 20 mM glucose/5 mM KCN solu-
tion. NADH fluorescence was monitored for 60 minutes at a sampling frequency
of 0.25 Hz. NADH in individual yeast cells was shown to oscillate following star-
vation and the addition of cyanide. In this state, glycolysis can be the only means
of energy production, as cyanide halts respiration, effectively removing the effects
of the mitochondrial oscillator. It is therefore expected that the metabolic state
induced in this experimental setup should correspond to the `altered' state, i.e. re-
gion B in Fig. 7.3, where glycolytic oscillations drive the dynamics of the system,
and the GO is chronotaxic.
NADH data was available from 34 yeast cells, 6 of which did not demonstrate
visible oscillations so were excluded from the analysis. It was demonstrated in Sec-
tion 4.4 that at least 30 cycles of oscillation are required to test for chronotaxicity,
therefore all cells which did not meet this requirement were excluded. 16 cells met
this criteria. PFA was then applied to the remaining NADH signals to determine
whether the oscillations observed in these cells exhibited hallmarks of chrono-
taxicity. The model was used to numerically simulate the GO in a chronotaxic
(ε1 = 0, ε2 = 0, ε3 = 0, ε4 = 0.25, σ = 0.2) state using the instantaneous frequency
extracted from the real experimental data. To make the system chronotaxic, the
extracted frequency was used as the driver ωgluc of the glycolytic oscillator. This
provided a chronotaxic oscillator with the same oscillation frequency as the exper-
imental data, allowing the DFA exponent α to be compared between cases (see
Fig. 7.9). Due to the relatively short recording time causing variation between
simulations, they were repeated 3 times and the average value of α taken. The
mean value of α for the 16 included cells was 0.768, compared to α = 0.772 in the
chronotaxic simulations. The distributions of exponents did not significantly differ
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between those calculated in the cells and those calculated in the simulated chrono-
taxic system (p = 0.86) as calculated using the Wilcoxon ranksum test. This shows
that the model, although simple, incorporates enough features to allow the cal-
culation of the presented characteristic, chronotaxicity, and that evidence of this
characteristic appears to be present in yeast glycolytic dynamics. This verifies
the applicability of the model to the glycolytic oscillator. Further investigation is
required into the mitochondrial oscillator, and other metabolic states.
7.2.4 Links to carcinogenesis
To link the model to real metabolic dynamics in cancer, evidence provided in the
study of cardiomyocytes in a state of metabolic stress [227] is used, as well as in
the study of yeast cells under semianaerobic conditions [1]. Yeast cells have been
shown to have metabolic similarities with cancer cells [228]. Both studies [1, 227]
conclude that glycolysis drives metabolic oscillations, while MO modulates GO.
Here, the driving is represented by the fact that glycolysis influences the amount
of ATP produced, which determines the amplitude around which oscillations take
place. In turn, the modulation of GO by MO manifests as MO influencing the
frequency of GO.
Based on previous studies [1, 227], the cancerous state is considered to corre-
spond to the dynamics of the model in which the phase of GO entrains the phase
of MO. In the model, the necessary (but not sufficient) condition for entrainment
of GO by MO is ε2 > ε1. In contrast, the normal state may correspond to the
case where the phase of MO entrains the phase of GO, and consequently the nec-
essary condition of this is ε1 > ε2. However, it may also be possible that in the
normal state both oscillators remain driven only by their external drivers, with
their mutual interactions not strong enough for entrainment.
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Figure 7.9: Testing real experimental data for chronotaxicity. a Example NADH
signal from an isolated yeast cell, recorded in [357]. b Time series of sinϕGO from
the model using the instantaneous frequency extracted from a as the driver ωgluc.
c & d Continuous wavelet transforms of the time series in a & b, respectively.
e The instantaneous frequency of the oscillatory modes were extracted from the
wavelet transforms, and smoothed using a moving average. f Integrating over the
smoothed frequency provides the phase for each case. g Subtracting the smoothed
phase from the observed phase provides the phase fluctuations, ∆ϕ, in the system.
h Detrended fluctuation analysis performed on ∆ϕ suggests that the glycolytic
oscillations observed in a real yeast cell (orange line) are chronotaxic.
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7.3 Summary
This chapter proposes a quantifiable characteristic, chronotaxicity [285, 302, 287],
of metabolic oscillations for the purpose of describing the transition of a cell from
a state with healthy energy metabolism, to a state where it is altered or abnormal,
in particular the metabolic switch to glycolysis observed in many cancer cells.
The ability to observe this transition in just a single time series was demonstrated
using a very general qualitative model of metabolic oscillations, with the advantage
that it captures only the most general and universal oscillatory dynamics and
interactions. As a result, this model does not depend on details which vary across
cancer states, thus being more likely to be applicable to cancer cells in general.
Oscillations are often overlooked in experimental studies, as if there are several
oscillations present in the system, they may cancel each other out [352]. Alter-
natively, due to their highly complex nature, they are often treated as stochastic,
e.g. [353]. Even in cases when oscillations and the interactions between them have
been studied, the exact characteristics of their amplitude and phase relations have
not been considered. The interactions of oscillatory processes may be amplitude-
amplitude, phase-phase, or phase-amplitude, resulting in many possible scenarios
of metabolic regulation. Here, for the sake of simplicity, the model is restricted
to phase-phase interactions, justifiable by the nature of chronotaxicity relying on
phase synchronization in the current case.
Particular attention has been paid to the time-variability of characteristic fre-
quencies of oscillations as one of the key properties of living systems. Namely,
the exchange of energy and matter involved in each process is always associated
with imperfect timing, or a fundamental inability to instantaneously match supply
and demand, resulting in time-varying oscillatory dynamics that is now captured
within the theory of chronotaxic systems. Using this simplified version of chrono-
taxic phase oscillators, a possible new way of studying metabolic processes within
a cell has been introduced.
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Cellular energy metabolism may be affected by many more processes and in-
teractions than those considered here. The simplicity of the model could easily
facilitate the inclusion of further couplings, for example in the consideration of cal-
cium dynamics or genetic factors in energy production. Calcium has been shown
to influence mitochondrial dynamics directly via many pathways [359], whilst ge-
netic mutations can have a direct effect on mitochondrial function [360]. These
effects could be included in the model as influences to couplings, extra oscillators,
or adaptations of the external drivers.
Chronotaxicity in cellular energy metabolism could arise as a result of a number
of influences, all of which would require experimental verification. The required
drive system could be provided by external oscillatory influences. In the case of
glycolysis, the time-varying availability of glucose may be considered as the drive
system of the GO. Similarly, the dynamical oxygen availability may be considered
as the drive system of the MO. Alternatively, if glucose and oxygen are abundant
within the cell, they are unlikely to be the driver for each process. In this case,
it is assumed that the inner structure of the oscillator, i.e. finite reaction times,
provides the stable, time-dependent point attractor which defines a chronotaxic
system. Here, these cases are not considered separately, and the external resources
glucose and oxygen are presented as the drivers which define the chronotaxicity of
the oscillators, independent of the exact mechanism by which this occurs. As it
is only the change in chronotaxicity which is of importance here, knowledge of its
specific origins, whilst interesting, is not essential.
The exact shape of the metabolic oscillations is also not described here, as this
would not impact the outcome of the chronotaxicity detection methods. Here it
is shown that chronotaxicity can identify dynamical changes during the metabolic
transition from a normal to an altered metabolic state in the model. Finally,
inverse approach methods show that these changes can be measured in the model
with no prior knowledge of whether the system is chronotaxic or not, as well as in
real complex systems, similarly to the application to the cardio-respiratory system
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in [285, 302].
In summary, a simple model of cellular energy metabolism has been introduced
with the aim of capturing the oscillatory dynamics of cellular energy metabolism
in a healthy cell, and one in which cellular metabolism is altered, for example a
cancer cell. Transitions between different types of dynamics, representing different
metabolic states, were followed by considering their chronotaxicity. This means
that from a single oscillatory ATP time series it can be determined whether the
system is driven, i.e. whether its frequencies are prescribed by some deterministic
process. It is also possible to extract the characteristics of the driver, and thus
these can be compared during metabolic transitions. This information could be
used to monitor cells during hypoxia or carcinogenesis. Evidence of chronotaxicity
in energy metabolism was shown in real experimental data, in glycolytic oscilla-
tions in yeast cells. This demonstrates the applicability of the model to cellular





In brief, the main aspects of this thesis are as follows:
 The physiological background of microvascular flow oscillations in health and
disease is reviewed.
 The techniques required for the measurement of the physiological parameters
considered are discussed.
 A background to nonautonomous dynamical systems, in particular chrono-
taxic systems, is presented, and inverse approaches for their detection are
elaborated upon.
 The blood flow dynamics of melanoma and control lesions were compared
using the presented techniques, and an accurate noninvasive diagnostic test
was developed.
 The role of hypoxia in microvascular flow dynamics was explored using data
previously recorded during apnoea in free divers, and a control group re-
cruited specifically for this comparison.
 The possible role of altered cellular energy metabolism in cancer on the
results observed in the melanoma microvasculature were considered using a
coupled chronotaxic phase oscillator model.
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 The glycolytic oscillator in the phase oscillator model was verified using real
experimental data recorded from yeast cells, which demonstrated that the
system was chronotaxic.
The primary aim of this thesis was to investigate blood flow dynamics in skin
melanoma. Blood flow data recorded using laser Doppler flowmetry were anal-
ysed using time series analysis techniques tailored specifically to the underlying
properties of these time series, namely that they are oscillatory, nonstationary,
nonlinear and nonautonomous. The required analysis techniques were reviewed.
These analyses provided new insights into the melanoma vasculature, based on dif-
ferences in the oscillations present in blood flow as measured in healthy skin and
benign moles when compared to cancerous lesions. The previous characterization
of these oscillations allows the observed spectral differences to be attributed to
the oscillations associated with vasomotion, in both the myogenic and neurogenic
frequency intervals. This could be a result of a microvascular detachment from
local regulatory mechanisms, a reduction in vessel reactivity due to the harsh tu-
mour microenvironment, or a loss of synchronization between smooth muscle cells.
The observed differences in melanoma were large enough to facilitate the devel-
opment of a set of criteria which have been successfully used in a diagnostic test
with a sensitivity of 100% and specificity of 90.9%. Whilst further data collection
would be necessary before this technique could be considered for routine clinical
practice, this work provides the foundations for the development of a quick, easy,
noninvasive diagnostic test which could significantly reduce the number of biopsies
required in melanoma diagnosis.
In addition to the investigation into melanoma, blood flow and oxygenation
dynamics were explored in data previously recorded from free divers during periods
of dry static apnoea and in specifically recruited control subjects at rest, in order
to ascertain whether free divers differ from non-trained individuals in terms of
their oscillatory physiological signals at rest, and whether the characteristics of
these signals are altered in divers when comparing rest periods to those obtained
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during breath-holds. The aim of this part of the thesis was to identify whether any
differences in blood flow or oxygenation dynamics could be observed as a result
of oxygen deprivation, or hypoxia, and to compare them to the changes in blood
flow dynamics observed in melanoma lesions. If similar behaviour was found, this
could then be considered a hallmark of hypoxia, well known to occur in tumours.
Contrary to the observations in melanoma, blood flow dynamics during apnoea
did not vary in the frequency intervals associated with vasomotion, but did vary
significantly in the cardiac and respiration intervals, as expected. This suggests a
much more systemic response than the local effects observed in melanoma lesions.
However, it was shown that the divers were physiologically very different to their
age and sex matched controls, which may explain the lack of local effects of the
oxygen deprivation for which they have likely built up an efficient response.
Another, almost universal, hallmark of cancer was also investigated. Cellular
energy metabolism was modelled as a system of coupled chronotaxic phase oscilla-
tors, based on experimental observations of metabolic oscillations in many studies.
The newly introduced class of chronotaxic systems were considered in this context,
and used as a model to explain the underlying stability of metabolic oscillations,
and their seemingly intrinsic frequencies. Using this property of chronotaxicity, it
was shown that transitions between metabolic states in the model could be iden-
tified numerically. It was also shown that chronotaxicity can be identified via the
inverse approach from a single time series. This was demonstrated in simulated
and real experimental data. Altered cellular energy metabolism can directly affect
the tumour microenvironment, and this change is considered as a potential cause
of the altered blood flow regulation observed in cancer.
8.2 Original contributions
The original contributions of this work are listed below:
 The inverse approach to chronotaxic systems presented previously has been
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developed further in terms of application specifically to signals containing
low frequency oscillations, and determining the minimum number of cycles
required for successful detection of chronotaxicity.
 These inverse approach methods were also applied for the first time to brain
dynamics, with the alpha wave of an anaesthetized patient turning out not
to be chronotaxic, highlighting the further developments required for the
detection of chronotaxicity in networks of oscillators.
 The blood flow dynamics of melanoma, psoriasis, atypical naevi and benign
naevi were compared in the frequency interval 0.0052 Hz. Time-averaged
normalized power significantly differed between groups in the intervals asso-
ciated with cardiac, myogenic and neurogenic activity.
 The observed differences in blood flow dynamics between melanoma and
atypical naevi, the most difficult lesion to distinguish from melanoma, were
developed into a diagnostic test with sensitivity of 100% and specificity of
90.9%.
 Significant wavelet phase coherence was observed between blood flow signals
recorded in the centre of lesions and on contralateral skin, in intervals I, II
& III, but this coherence did not significantly differ between groups, except
in the cardiac interval, due to a significant difference in mean heart rate
between groups.
 Arterial oxygen saturation was compared between divers and controls and
investigated using wavelet analysis. It was found to contain low frequency
oscillations which were coherent with respiration, but this coherence did not
differ between divers and controls. The peak frequency of these oscillations
was higher in divers than in controls at rest, and the standard deviation of
arterial oxygen saturation was higher in divers than in controls at rest.
 Normalized wavelet powers calculated from blood flows recorded at rest
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showed a significantly lower cardiac power in divers than in controls in 5
out of 8 locations, and increased power at lower frequencies in divers in 5
out of 8 locations when compared to controls.
 Where a change in frequency of vasomotion could be observed during apnoea,
it was found to decrease in the majority of cases.
 A model of cellular energy metabolism was developed using chronotaxic
phase oscillators, and numerically simulated with varying parameters to rep-
resent different metabolic states. Of particular interest was the metabolic
switch to glycolysis observed in most cancer cells, which was represented in
the model by an upregulation of glycolysis due to a decrease in the ATP
produced by the mitochondria. It was shown that this transition may be
detected using the inverse approach methods for the detection of chronotaxi-
city, though this requires experimental verification.
 The inverse approach for the detection of chronotaxicity was applied to real
energy metabolism data for the first time. Recorded in yeast cells, results
from the analysis of this data provided evidence of chronotaxicity of the
glycolytic oscillator during an altered metabolic state.
8.3 Future work
Future directions of this work are expected to include the following:
 Further development of the inverse approach to chronotaxic systems to be
applicable to amplitude dynamics in addition to the current applications to
phase dynamics.
 Consideration of chronotaxicity in a network of coupled oscillators, for ex-
ample neurons in the brain.
 Possible use of altitude simulation as a means to induce a more controlled
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oxygen deprivation for the study of blood flow and oxygenation dynamics in
hypoxia.
 Recruitment of more patients with melanoma, difficult to diagnose lesions
and more controls to build up the data set used in the diagnostic test for
melanoma.
 Development of a `melanometer', a device which can characterise blood flow
dynamics in skin lesions.
 Inclusion of the effects from other important cellular oscillators in the energy
metabolism model, especially calcium.
 Acquisition of experimental intracellular ATP recordings and application of
the presented inverse approach methods for the detection of chronotaxicity,













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































B. Sample size and statistical power
calculations
This appendix considers the statistical power of the diagnostic test for melanoma
developed in Chapter 5.
Sample size is rarely reported in diagnostic accuracy studies [361], so no stan-
dard treatment of the problem exists. Consider the main hypothesis, that: statis-
tically significant alterations in skin blood flow dynamics will be observable when
comparing skin malignant melanoma with atypical naevi and healthy skin. Also
consider our secondary aim, to consider the utilisation of any observed differences
in the noninvasive diagnosis of skin melanoma.
Based on the aims and outcomes of this study, it may be concluded that it is
an observational study. Important considerations in sample size calculation are as
follows [362]
 The null hypothesis - there is no difference between blood flow dynamics in
melanoma and atypical naevi.
 The alternative hypothesis - there is a difference between blood flow dynam-
ics in melanoma and atypical naevi.
 The level at which we wish to avoid a type I error (pα) - A type I error is
the incorrect rejection of the null hypothesis, i.e. finding differences where
there are none, usually set to 0.05.
197
 The level at which we wish to avoid a type II error (pβ) - A type II error
in the incorrect acceptance of the null hypothesis, i.e. stating there is no
difference when there is, typically 0.8.
 What difference do we want to detect? What is the magnitude of this dif-
ference?
 Standard deviations of the variables of interest.
 The distribution of the data. Many statistical tests and sample size calcu-
lations are based on assumptions of normal distributions. In our study, the
non-normal distribution of data warranted the use of non-parametric tests.
The same criteria which caused us to use these tests will apply to sample
size calculations, and inevitably lead to the need for larger sample sizes.
Power of significance tests
Statistically significant differences in blood flow were revealed between groups.
Here the statistical power of the tests used to obtain these results is assessed. As
not all distributions of final test parameters were normal (as determined by the
Lilliefors test), these differences were found using non-parametric tests, namely
the Wilcoxon rank sum test for unpaired data (the parametric equivalent is the t
test for independent samples), and the signed rank test for paired data (parametric
equivalent - paired t test). When comparing more than one group, the Kruskal
Wallis ANOVA test was used (parametric equivalent - one way analysis of variance,
F test). The statistical power of these tests will depend on sample size.
Sample size, effect size, significance level and power are related, and given any
three, one can simply calculate the fourth, based on a normal distribution. When a
normal distribution cannot be assumed, the situation is more complex. Neverthe-
less, the required parameters from the existing data are calculated in order to give
an estimate of the required sample size, the missing variable. Asymptotic relative
efficiency (ARE), loosely describes the ratio of sample sizes required (parametric
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to non-parametric) for a parametric procedure to have the same ability to reject a
null hypothesis as the corresponding nonparametric procedure. It has been shown
that the ARE of the Wilcoxon-Mann-Whitney (rank sum) test is always at least
0.864, regardless of the underlying population [363]. Although this value may in-
crease depending on the data, this worst case scenario will be used in the following
calculations, and therefore increase all calculated sample sizes by 15%.
Effect size
Three sets of parameters used in the final test are to be considered. Effect sizes
are calculated for all cases, and the smallest effect size will be used in calculations,
as this will result in the largest requirement for sample size. In these compar-
isons, only the difference between parameters in the melanoma and atypical naevi
groups are considered, as atypical naevi provide the biggest diagnostic challenge,
and from observations are more similar to melanoma in their blood flow charac-
teristics than benign naevi, thus providing a more rigorous test of statistical power.
Test 1 - Ratio of mean blood perfusion at lesion margins and contralateral skin,
recorded simultaneously.
Test 2 - Normalized spectral power of cardiac interval at the lesion margin.
Test 3 - Ratio of total spectral power in the cardiac and neurogenic frequency
intervals in blood perfusion at lesion centres.





where s is the standard deviation and x¯1− x¯2 is the difference between the two
means of the samples. The standard deviation required can be a pooled standard
deviation of the two groups, but this should not be used if the two standard
deviations are likely to be systematically different. Therefore, the control standard
deviation is used in the calculation. Effect sizes are therefore obtained for tests 1,
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2 and 3 of 1.393, 1.095 and 3.536, respectively. The effect size of parameter 2, the
smallest effect size, is taken forward into the sample size calculation. Sample size
was calculated using the `pwr' package in R, the statistical programming language.
R was used to compute the required sample size of the melanoma group (n1), to
perform a two sample, independent, one tailed, t-test, based on the following input:
n2 - sample size of the atypical naevi group. There are 33 subjects, but because
the tests used are non parametric, this will be reduced according to the extra
15% requirement explained above. The effective sample size thus becomes
28.696 subjects. Rounding down gives n2=28.
d - effect size - the effect size calculated from parameter 2 - 1.095 is used.
sig.level - probability of a type I error, α. As standard, this is set to 0.05
power - the probability that the test will correctly reject the null hypothesis (1-β,
where β is the probability of a type II error). As standard, this is set to 0.8.
alternative - specifies whether the test is two tailed, or one tailed (less or greater). Here,
greater is used.
pwr.t2n.test(n2=28, power=0.8, d=1.095, sig.level=.05, alternative="greater")








The test indicates that a sample size of at least 6.658 (rounded up to 7) is
required to provide adequate statistical power. Including a further 15% to account
for the non-parametric nature of the tests leads to a minimum required sample
size of 8.05, which is rounded up to 9. As there are currently 10 subjects in the
malignant melanoma group, the null hypothesis that there are no differences in
blood flow dynamics in the cardiac interval can be rejected. As all other test
parameters resulted in even larger effect sizes, one would expect to also be able
to reject the null hypotheses that those parameters do not differ between groups.
This is demonstrated by using the effect size from parameter 1 and observing the
reduction in n1 that is required to maintain sufficient statistical power:
pwr.t2n.test(n2=28, power=0.8, d=1.393, sig.level=.05, alternative="greater")







Here it can be seen that increasing the effect size has provided an even lower
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